Tuesday, November 17, 2015
Print Entire 2015 Program:
|
|
SESSION 1 SCHEDULE | |
Tuesday
SESSION 1:
PROGRESS IN TRANSCATHETER HEART VALVES AND NEW APPROACHES TO ASCENDING AORTIC DISEASE
Moderators:Lars G. Svensson, MD, PhD / Nicholas J.W. Cheshire, MD
|
|
x | |
6:45 AM - 6:49 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
View Slides in PDF | |
6:50 AM - 6:55 AM | Valve-In-Valve Transcatheter Aortic Valve Implantation (TAVI) And Mitral Valve-In-Valve Endovascular Repair: How Well Do They Work |
Presenter(s):Dietmar H. Koschyk, MD | |
View Slides in PDF | |
6:56 AM - 7:01 AM | Current Status Of Transcatheter Mitral Valve Repair: New Technology And Techniques |
Presenter(s):Ted Feldman, MD | |
View Slides in PDF | |
7:02 AM - 7:07 AM | Current Status And Future Prospects For TAVI: A Cardiac Surgeon’s Perspective |
Presenter(s):Allan Stewart, MD | |
View Slides in PDF | |
7:08 AM - 7:13 AM | Current Status And Future Prospects For TAVI: An Interventional Cardiologist’s Perspective |
Presenter(s):Ted Feldman, MD | |
View Slides in PDF | |
ASCENDING AORTIC ENDOGRAFTING | |
7:14 AM - 7:19 AM | Ascending Aortic Endografting: Where Are We And What Are The Issues |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Slides in PDF | |
7:20 AM - 7:25 AM | Endograft Repair Of Ascending Aortic Lesions And Type A Dissections With A Physician Sponsored IDE (PSIDE) For A Modified Valiant Device: Lessons Learned And What Are The Prospects For An Endograft-Valve Combined Device |
Presenter(s):Carlos E. Donayre, MD / Rodney A. White, MD | |
View Slides in PDF | |
7:26 AM - 7:31 AM | Ascending Aortic Endografting: Lessons Learned, Present Status And Future Potential: From A PSIDE Experience |
Presenter(s):Rodney A. White, MD / Ali Khoynezhad, MD, PhD | |
View Slides in PDF | |
7:32 AM - 7:37 AM | Access Routes And Off-The-Shelf Devices For Ascending Aortic Endovascular Repair |
Presenter(s):Grayson H. Wheatley, MD | |
View Slides in PDF | |
7:38 AM - 7:43 AM | Panel Discussion |
END OF SESSION 1 | |
SESSION 2 SCHEDULE | |
Tuesday
SESSION 2:
NEW DEVELOPMENTS IN TREATMENT OF AORTIC ARCH LESIONS AND DISSECTIONS
Moderators:Hazim J. Safi, MD / Timothy A.M. Chuter, DM
|
|
x | |
7:44 AM - 7:49 AM | Aortic Arch Hybrid Repair With Supra-Aortic Trunks Re-routing: Current Indications, Long-Term Results And Complication Management In Patients With Degenerative Aneurysms And Dissections |
Presenter(s):Yamume Tshomba, MD / Roberto Chiesa, MD / Germano Melissano, MD | |
View Slides in PDF | |
7:50 AM - 7:55 AM | Current Management Of Aortic Arch Lesions With Hybrid Procedures: What Are Key Details And Precautions |
Presenter(s):Eric E. Roselli, MD | |
View Slides in PDF | |
7:56 AM - 8:01 AM | Redo Procedures For Aortic Arch Lesions: When Open; When Endo |
Presenter(s):Michael J. Jacobs, MD | |
View Slides in PDF | |
8:02 AM - 8:07 AM | Update On Endovascular Repair Of Arch Aneurysms Using The Internally Branched Endograft (Cook): Advantages, Limitations And 3-Center Midterm Results |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
8:08 AM - 8:13 AM | What Are The Best Endovascular Techniques For Managing Arch Lesions – Including Branched Endografts And In Situ Fenestration |
Presenter(s):Timothy A. Resch, MD, PhD / Bjőrn Sonesson, MD, PhD / Martin Malina, MD, PhD | |
View Slides in PDF | |
8:14 AM - 8:19 AM | Status Of Sandwich (Parallel) Grafts For Total Endovascular Arch Replacement |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Slides in PDF | |
8:20 AM - 8:25 AM | Parallel Grafts (Chimney And Periscope Grafts) For Arch Lesions: Advantages And Limitations |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Slides in PDF | |
8:26 AM - 8:31 AM | What Is The Future For Endovascular Repair Of Aortic Arch Lesions: Advantages And Limitations Of Two Different Techniques Of Endograft Repair |
Presenter(s):Tilo Kölbel, MD, PhD | |
View Slides in PDF | |
8:32 AM - 8:37 AM | Update On Advantages Of Custom-Made Precurved Fenestrated Endograft (Naguta) For Arch Lesions: Durable Long-Term Results Are Better Than With Other Endo Techniques |
Presenter(s):Yoshihiko Yokoi, MD | |
View Slides in PDF | |
8:38 AM - 8:43 AM | Value And 3-Year Results With Branched Endograft From Bolton For Treating Complex Arch Lesions |
Presenter(s):Toru Kuratani, MD, PhD | |
View Slides in PDF | |
8:44 AM - 8:49 AM | Branched Endograft vs. Chimney Techniques For Treating Complex Arch Lesions: Which Is Best: When And Why |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
View Slides in PDF | |
8:50 AM - 8:58 AM | Panel Discussion |
END OF SESSION 2 | |
SESSION 3 SCHEDULE | |
Tuesday
SESSION 3:
TYPE B AORTIC DISSECTIONS (TBADs) AND THEIR TREATMENT: THORACIC AORTIC
Moderators:Christoph A. Nienaber, MD, PhD / Joseph S. Coselli, MD
|
|
x | |
8:58 AM - 9:03 AM | What Do We Know About Intensive Medical Treatment For Acute TBADs: How Well Does It Work |
Presenter(s):Frank A. Lederle, MD | |
View Slides in PDF | |
9:04 AM - 9:09 AM | Natural History Of TBAD Patients Treated Medically: Predictors Of Deterioration And Which TBAD Patients Benefit Most From TEVAR (Based On 5-Year Results) |
Presenter(s):Mark Conrad, MD, MMSc | |
View Slides in PDF | |
9:10 AM - 9:15 AM | 4D Magnetic Resonance Imaging (MRI) In TBADs: Will It Enable Prediction Of Behavior (Aneurysm Formation, Etc.), Individualization Of Treatment And Assessment Of Its Effectiveness |
Presenter(s):Rachel E. Clough, MD, PhD | |
View Slides in PDF | |
9:16 AM - 9:21 AM | With Uncomplicated Acute TBAD Patients, What Factors Point To Deterioration On Medical Treatment And The Need For TEVAR: When Should TEVAR Be Performed: Based On New Data From The IRAD Registry |
Presenter(s):Santi Trimarchi, MD, PhD / Christoph A. Nienaber, MD, PhD | |
View Slides in PDF | |
9:22 AM - 9:27 AM | Optimal Management Of Malperfusion Syndrome From TBADs: What To Do When TEVAR Is Not Enough |
Presenter(s):Weiguo Fu, MD | |
View Slides in PDF | |
9:28 AM - 9:33 AM | Early Predictors Of Late Complications Including Aneurysm Formation In Patients With Acute TBADs |
Presenter(s):Jean-Marc Alsac, MD, PhD | |
View Slides in PDF | |
9:34 AM - 9:39 AM | Management Of Complications Of TBADs Before And After TEVAR: Intestinal, Spinal Cord And/Or Limb Ischemia |
Presenter(s):Xin Li, MD / Chang Shu, MD | |
View Slides in PDF | |
9:40 AM - 9:45 AM | False Lumen Occlusion Techniques With TBADs: When Are They Needed, How Are They Done, What Are The Complications: What Is The World Experience |
Presenter(s):Tilo Kölbel, MD, PhD | |
View Slides in PDF | |
9:46 AM - 9:51 AM | Strategies And Devices For Eliminating False Lumen Flows With TBADs And When Are They Needed |
Presenter(s):Eric E. Roselli, MD | |
View Slides in PDF | |
9:52 AM - 9:58 AM | Panel Discussion |
9:58 AM - 10:10 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 3 | |
SESSION 4 SCHEDULE | |
Tuesday
SESSION 4:
MORE NEW DEVELOPMENTS IN TEVAR, THE AORTA AND MANAGING TBAD PATIENTS
|
|
x | |
10:10 AM - 10:15 AM | Status Of Brain Embolic Protection Devices For TEVAR And TAVI: How Effective Are The Embrella, Sentinel And Triguard Neuroprotection Devices |
Presenter(s):Jeffrey P. Carpenter, MD | |
View Slides in PDF | |
10:16 AM - 10:21 AM | Effect Of TEVAR Timing On Freedom From Aortic Events And The Need For Reinterventions In TBADs: TEVAR Before 6 Months Is Better |
Presenter(s):Toru Kuratani, MD, PhD | |
View Slides in PDF | |
10:22 AM - 10:27 AM | A New Classification System For Aortic Dissections: DISSECT - Duration, Intimal Tear, Size Of Aorta, Segmental Extent, Complications, Thrombosis In False Lumen |
Presenter(s):Michael D. Dake, MD / Christoph A. Nienaber, MD, PhD | |
View Slides in PDF | |
10:28 AM - 10:33 AM | Correlation Between False Lumen Remodeling And Patent Intercostal Arteries |
Presenter(s):Wei Guo, MD | |
View Slides in PDF | |
10:34 AM - 10:39 AM | How The Petticoat Technique (Proximal Covered Stent And Distal Bare Stent) Is Better Than Standard TEVAR For TBAD Patients: Update On The STABLE I And II Trials |
Presenter(s):Joseph V. Lombardi, MD | |
View Slides in PDF | |
10:40 AM - 10:45 AM | Long-Term Results Of Medical Treatment And TEVAR For TBAD: False Lumen Thrombosis Is Not The End Of The Story: Thus The Need For Long-Term Surveillance And Late Reinterventions |
Presenter(s):Götz M. Richter, MD, PhD | |
View Slides in PDF | |
10:46 AM - 10:53 AM | Panel Discussion |
Moderator(s): Michael D. Dake, MD / Frank J. Veith, MD | |
10:53 AM - 10:58 AM | What Defines Chronic TBAD: When And How Should It Be Treated Conservatively; By Endo Repair; By Open Repair |
Presenter(s):Joseph E. Bavaria, MD | |
View Slides in PDF | |
10:59 AM - 11:04 AM | Fenestrated And Branched EVAR (F/B EVAR) Is The Best Treatment For Thoracoabdominal Aneurysms (TAAAs) After TBADs – Especially Chronic TBADs: Advantages And Limitations |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
11:05 AM - 11:10 AM | Current Optimal Treatment Of Patients With Chronic TBADs And Associated Complications And Aneurysms From Them |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
11:11 AM - 11:16 AM | Comparison Of Endovascular And Open Repair Of Degenerative And Dissecting Thoracic Aneurysmal Lesions In Patients Who Are Candidates For Both Types Of Repairs |
Presenter(s):Yamume Tshomba, MD / Germano Melissano, MD / Roberto Chiesa, MD | |
View Slides in PDF | |
11:17 AM - 11:22 AM | Secondary Interventions After TEVAR: Indications, Techniques And Results |
Presenter(s):Mark K. Eskandari, MD | |
View Slides in PDF | |
11:23 AM - 11:28 AM | Size (Diameter) And Normal Growth Rates Of The Aorta From Top To Bottom: At What Thoracic Aortic Size Is There A Real Risk Of Rupture |
Presenter(s):John A. Elefteriades, MD | |
View Slides in PDF | |
11:29 AM - 11:34 AM | The Mechanics Of TEVAR Device Conformability To Aortic And Arch Anatomy: How Do The Various Devices Compare |
Presenter(s):Ludovic Canaud, MD, PhD | |
View Slides in PDF | |
11:35 AM - 11:40 AM | True Lumen Volume/False Lumen Volume Ratio (<.8) On CT Can Predict The Need For TEVAR In Uncomplicated Acute TBAD |
Presenter(s):Jean M. Panneton, MD | |
View Slides in PDF | |
11:41 AM - 11:46 AM | Long-Term Results After TEVAR Are Not So Great: Some Notes Of Caution |
Presenter(s):Dittmar Boeckler, MD | |
View Slides in PDF | |
11:47 AM - 11:52 AM | Antegrade Delivery Of A Stent-Graft Into The Descending Aorta During Open Repair Of A Type A Aortic Dissection With Arch Involvement: A “Frozen Elephant Trunk”: How To Do It |
Presenter(s):Joseph S. Coselli, MD / Ourania Preventza, MD | |
View Slides in PDF | |
11:52 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 4 | |
SESSION 5 SCHEDULE | |
Tuesday
SESSION 5:
NEW KEY DEVELOPMENTS IN THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
Moderators:Frank J. Veith, MD / Wesley S. Moore, MD
|
|
x | |
1:00 PM - 1:05 PM | Update On The ACT I Trial Comparing CAS And CEA In Patients With High-Grade Asymptomatic Carotid Stenosis (ACS) |
Presenter(s):Jon S. Matsumura, MD | |
1:06 PM - 1:11 PM | |
Presenter(s):William A. Gray, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | DEBATE: Not So: Lessons Learned From US Datasets On Outcomes After CEA And CAS Show CAS Results Are Substantially Worse Than In CREST: The Brighter The Light The Darker The Shadow |
Presenter(s):Ross Naylor, MD, FRCS | |
View Slides in PDF | |
TWO-WAY DEBATE | |
1:18 PM - 1:23 PM | DEBATE: Late Results Of ICSS Trial Show CAS And CEA To Be Equivalent In Patients With Symptomatic Carotid Stenosis |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS / Martin M. Brown, MD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | DEBATE: Late Results Of ICSS Do Not Show Equivalence Of CAS And CEA: CEA Still Wins For Symptomatic Carotid Stenosis |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Stroke And Death Rates (Early And Late) After CAS Are Higher Than The Randomized Controlled Trials (RCTs) Would Indicate: Therefore, We Should Be Less Aggressive With Our Use Of CAS – Especially In The Elderly And Asymptomatic Patients |
Presenter(s):J. David Spence, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Asymptomatic Carotid Stenosis (ACS) Up To 80% Is Benign: What About Those Stenoses Over 85% - Especially When Associated With A Contralateral Occlusion: Which ACS Patients Should Be Treated Invasively And How |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
View Slides in PDF | |
1:42 PM - 1:47 PM | Long-Term Results Of The SAMMPRIS (Intracranial Stenting) Trial In Patients With Intracranial Stenoses: What Does It Tell Us About Best Medical Treatment (BMRx); Compliance And Long-Term Benefits: The Recent VISSIT Trial Confirms The Negative Effects Of Intracranial Stenting |
Presenter(s):Colin P. Derdeyn, MD | |
View Slides in PDF | |
1:48 PM - 1:54 PM | Panel Discussion |
Moderator(s): Wesley S. Moore, MD / Thomas S. Riles, MD | |
1:55 PM - 2:00 PM | Why Transcranial Doppler (TCD) Is Essential Before, During And After CAS, CEA And TAVI |
Presenter(s):Zsolt Garami, MD | |
2:01 PM - 2:06 PM | Status Of Endovascular Treatment Of Total Carotid Occlusions: Advantages, Technique, Complications And How To Avoid Them |
Presenter(s):Paul H.L. Kao, MD | |
View Slides in PDF | |
2:07 PM - 2:12 PM | Diaphragm Of The Internal Carotid Artery: An Underdiagnosed Cause Of Stroke |
Presenter(s):Emmanuel M. Houdart, MD | |
View Slides in PDF | |
2:13 PM - 2:18 PM | DEBATE: Carotid Plaque Morphology Is Only Important In Symptomatic Patients |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Slides in PDF | |
2:19 PM - 2:24 PM | DEBATE: Not So: Carotid Plaque Morphology Is Helpful (With Other Criteria) In Predicting Stroke Risk In ACS Patients: What Percent Of ACS Patients Are High Risk And Justifiably Need CEA Or CAS |
Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD | |
View Slides in PDF | |
2:25 PM - 2:30 PM | Risk Stratification Of Patients With Carotid Stenosis: How To Quantify: An Aging Brain Is More Important Than Plaque Characteristics – And Even Symptom Status |
Presenter(s):Thomas G. Brott, MD | |
View Slides in PDF | |
2:31 PM - 2:36 PM | Importance Of Preoperative And Perioperative Statin Dosage In Patients With Carotid Stenosis: Can They Change And Shrink Plaque: How Often |
Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD | |
View Slides in PDF | |
2:37 PM - 2:42 PM | What Is New In The Effects Of Carotid Disease And Carotid Treatments (CEA And CAS) On Cognitive Function: Are There Differences Between CEA And CAS |
Presenter(s):Wei Zhou, MD | |
View Slides in PDF | |
2:43 PM - 2:48 PM | Tips And Tricks For Obtaining Distal Exposure Of The Internal Carotid Artery – To The Skull Base: Your ENT Surgeon Colleagues Can Help |
Presenter(s):Ross Naylor, MD, FRCS | |
View Slides in PDF | |
2:49 PM - 2:55 PM | Panel Discussion |
2:55 PM - 3:05 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 5 | |
SESSION 6 SCHEDULE | |
Tuesday
SESSION 6:
EXCITING PROGRESS IN THE TREATMENT OF ACUTE STROKES
Moderators:Sriram S. Iyer, MD, FACC / Horst Sievert, MD
|
|
x | |
3:05 PM - 3:10 PM | Urgent CEA And CAS Are Safe And Without A Bleeding Risk After A Small-To-Moderate Sized Stroke Is Treated By Thrombolysis |
Presenter(s):Hernan Bazan, MD, FACS | |
View Slides in PDF | |
3:11 PM - 3:16 PM | Carotid Interventions (CEA/CAS) In Acute Stroke Patients: Which Procedure On Which Patient And When |
Presenter(s):R. Clement Darling III, MD | |
View Slides in PDF | |
3:17 PM - 3:22 PM | Emergency CEA For Stroke In Evolution: When Is It Indicated And How Should It Be Done |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
3:23 PM - 3:28 PM | Recent Progress In Endovascular Intracranial Treatment Of Acute Ischemic Strokes: Dramatic Positive Results Of ESCAPE, SWIFT-PRIME, EXTEND – IA, REVASCAT And MR CLEAN Trials: Why Are These Trials Positive And When Should Patients Be Treated And When Not |
Presenter(s):L. Nelson Hopkins, MD | |
View Slides in PDF | |
3:29 PM - 3:34 PM | Results And Techniques Of The ADAPT-FAST Trial Of A Newer Better Thrombus Removal Method For Treating Acute Strokes |
Presenter(s):Alejandro M. Spiotta, MD | |
View Slides in PDF | |
3:35 PM - 3:40 PM | New Developments In The Treatment Of Acute Strokes: It Is A New Treatment Horizon: Tips, Tricks, And Precautions And The Importance Of Balloon Tipped Guide Catheters To Decrease Prograde Flow During Clot Removal |
Presenter(s):Klaus D. Mathias, MD | |
View Slides in PDF | |
3:41 PM - 3:46 PM | Critical Elements In Stroke Interventions And Who Should Be In The Game |
Presenter(s):Colin P. Derdeyn, MD | |
View Slides in PDF | |
3:47 PM - 3:52 PM | Comments On Acute Stroke Treatment From A Pioneer: Why Others Than Neurointerventionists Must Be Involved And How Can They Be Trained |
Presenter(s):Horst Sievert, MD | |
View Slides in PDF | |
3:53 PM - 3:59 PM | Panel Discussion |
END OF SESSION 6 | |
SESSION 7 SCHEDULE | |
Tuesday
SESSION 7:
MORE ABOUT TBADs, THORACIC ANEURYSMS AND TEVAR
Moderators:Matt M. Thompson, MD / Nicholas J.W. Cheshire, MD
|
|
x | |
4:00 PM - 4:05 PM | DEBATE: Stent-Grafts And Endovascular Repair Are Usually A Poor Option For Treating Aneurysm Patients With Connective Tissue Disorders |
Presenter(s):Michael J. Jacobs, MD | |
View Slides in PDF | |
4:06 PM - 4:11 PM | DEBATE: Stent-Grafts And Endovascular Repair Can Be A Reasonable Option For Treating Aneurysm Patients With Connective Tissue Disorders And Ehlers-Danlos Syndrome |
Presenter(s):Vicente Riambau, MD, PhD | |
View Slides in PDF | |
4:12 PM - 4:17 PM | How To Fix Endoleaks From 2° Intimal Tears At The Celiac Axis And SMA After Remote TEVAR For TBADs |
Presenter(s):Ronald M. Fairman, MD | |
View Slides in PDF | |
4:18 PM - 4:23 PM | F/B EVAR To Treat Thoracoabdominal Dissections And Post Dissection TAAAs: Indications, Contraindications And Pitfalls |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
4:24 PM - 4:29 PM | Saccular vs. Fusiform Configurations In Thoracic Aortic Aneurysms (TAAs): Does It Matter |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
View Slides in PDF | |
4:30 PM - 4:35 PM | DEBATE: For Arch And Thoracic Aortic Lesions That Are Embolizing, When Anticoagulation, When Bare Stent, When Endograft |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
4:36 PM - 4:41 PM | DEBATE: For Aortic Lesions That Are Embolizing, Endograft Treatment Is Generally The Best And Most Durable Treatment |
Presenter(s):Michel Makaroun, MD | |
View Slides in PDF | |
4:42 PM - 4:48 PM | Panel Discussion |
END OF SESSION 7 | |
SESSION 8 SCHEDULE | |
Tuesday
SESSION 8:
HOW SHOULD MOST PATIENTS WITH UNCOMPLICATED ACUTE TBAD BE TREATED: CONTROVERSY EXISTS AND WILL CONTINUE: THE PROS AND CONS OF EARLY TEVAR
Moderators:Lars G. Svensson, MD, PhD / Santi Trimarchi, MD, PhD
|
|
x | |
FOR EARLY TEVAR | |
4:48 PM - 4:53 PM | Most Patients With Acute/Subacute Uncomplicated TBADs Should Undergo TEVAR: The INSTEAD-XL RCT Shows Better Long-Term Survival With TEVAR Than With Medical Treatment |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
View Slides in PDF | |
4:54 PM - 4:59 PM | Most Patients With Acute Uncomplicated TBAD Should Receive TEVAR Treatment: I Have Said It Before – Now I Know It Is True And No More Trials Are Needed |
Presenter(s):Rodney A. White, MD | |
5:00 PM - 5:05 PM | Most Patients With Uncomplicated Acute TBAD Should Be Treated By TEVAR: Some Immediately And Some After A 6-12 Week Delay: How Can They Be Selected For Each Based On Data From The MOTHER Registry |
Presenter(s):Matt M. Thompson, MD | |
View Slides in PDF | |
5:06 PM - 5:11 PM | With Uncomplicated Acute TBAD There Is A High Risk Group That Should Be Treated By TEVAR: How Can They Be Selected And When Should They Be Treated |
Presenter(s):Michael D. Dake, MD | |
View Slides in PDF | |
5:12 PM - 5:17 PM | Medical Treatment Is Adequate For Most Patients With Uncomplicated TBAD Based On Current Long-Term Results |
Presenter(s):John A. Elefteriades, MD | |
View Slides in PDF | |
5:18 PM - 5:23 PM | The ADSORB Trial Tells Us What We Need To Know About Treating Uncomplicated TBADs: We Don’t Need Further Trials |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
View Slides in PDF | |
5:24 PM - 5:29 PM | We Still Need More Evidence Before We Treat Most Uncomplicated Acute/Subacute TBAD Patients With TEVAR |
Presenter(s):Michel Makaroun, MD | |
View Slides in PDF | |
5:30 PM - 5:35 PM | Why Wider Use Of TEVAR For Uncomplicated TBADs Right Now May Not Be So Good |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
View Slides in PDF | |
5:36 PM - 5:41 PM | The INTACT-AD RCT Comparing TEVAR With Medical Treatment Will Give The Final Answer About The Best Treatment For Uncomplicated Acute/Subacute TBAD Patients: We Need This International Trial And How Will It Be Structured |
Presenter(s):Firas F. Mussa, MD / Christoph A. Nienaber, MD, PhD | |
View Slides in PDF | |
5:42 PM - 5:50 PM | Panel Discussion End of Program A |
END OF SESSION 8 | |
SESSION 9 SCHEDULE | |
Tuesday
SESSION 9:
NEW DEVELOPMENTS IN AAAs AND EVAR
Moderators:Enrico Ascher, MD / Ali F. AbuRahma, MD
|
|
x | |
6:40 AM - 6:44 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
View Slides in PDF | |
6:45 AM - 6:50 AM | Can Anything Besides Smoking Cessation Slow AAA Enlargement |
Presenter(s):Frank A. Lederle, MD | |
View Slides in PDF | |
6:51 AM - 6:56 AM | Redefining Adverse Neck Morphology With Newer EVAR Devices Which Perform Better In Short, Angulated And Large Diameter Necks And Those With A Thrombus Burden: What Are The Limits: From The ENGAGE Registry |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
6:57 AM - 7:02 AM | Parallel Grafts To Revascularize Critical IMAs And Ectopic Renal Arteries When They Must Be Preserved: How To Do It |
Presenter(s):Konstantinos P. Donas, MD | |
View Slides in PDF | |
7:03 AM - 7:08 AM | How Will The Decreased Frequency And Increased Complexity Of Open AAA Repair Affect Vascular Surgery Training: What Can Be Done About It |
Presenter(s):Jeffrey E. Indes, MD | |
View Slides in PDF | |
7:09 AM - 7:14 AM | World’s Largest AAA Repair: All Large AAAs Do Not Rupture |
Presenter(s):Dainis K. Krievins, MD / Christopher K. Zarins, MD | |
View Slides in PDF | |
7:15 AM - 7:20 AM | EVAR For All AAA Patients: We Are Going Too Far: Some Large Aneurysms Should Not Be Fixed: Some Should Be Fixed By Open Repair |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
View Slides in PDF | |
7:21 AM - 7:26 AM | Outcomes Of EVAR For Inflammatory AAAs Are Favorable |
Presenter(s):Furuzan Numan, MD | |
View Slides in PDF | |
7:27 AM - 7:32 AM | Toward 15-Year Results Of The EVAR Trials And Individual Patient Data (IPD) Meta-Analysis With The DREAM, ACE And OVER Trials |
Presenter(s):Roger M. Greenhalgh, MD | |
View Slides in PDF | |
7:33 AM - 7:38 AM | Long-Term Results Of EVAR Are Better Than We Thought – Particularly With The Newer EVAR Devices |
Presenter(s):Timur P. Sarac, MD | |
View Slides in PDF | |
7:39 AM - 7:46 AM | Panel Discussion |
END OF SESSION 9 | |
SESSION 10 SCHEDULE | |
Tuesday
SESSION 10:
NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC BRANCH LESIONS – ESPECIALLY OF THE AORTO-ILIAC SEGMENT - AND TRAUMATIC AORTIC INJURY
Moderators:Kenneth Ouriel, MD, MBA / Barry T. Katzen, MD
|
|
x | |
7:46 AM - 7:51 AM | Iliac Artery Endofibrosis In Hardcore Cyclists: Is Endovascular Treatment Ever Effective If They Won’t Give Up Their Sport Or Is Surgery The Only Effective Treatment: What Should The Operative Treatment Be |
Presenter(s):Kenneth J. Cherry, MD | |
View Slides in PDF | |
7:52 AM - 7:57 AM | Retrograde Open Superior Mesenteric Artery Stenting For Acute Mesenteric Ischemia: Indications, Techniques And Results |
Presenter(s):Richard J. Powell, MD | |
View Slides in PDF | |
7:58 AM - 8:03 AM | Parallel Grafts For Hypogastric Artery Revascularization During EVAR: Techniques, Advantages And Disadvantages |
Presenter(s):Ronald L. Dalman, MD | |
View Slides in PDF | |
8:04 AM - 8:09 AM | What Factors Predict When Treatment Of Blunt Traumatic Aortic Injuries Can Safely Be Delayed |
Presenter(s):Robert S. Crawford, MD / Donald G. Harris, MD | |
View Slides in PDF | |
8:10 AM - 8:14 AM | Panel Discussion |
TREATMENT OF AORTO-ILIAC OCCLUSIVE DISEASE | |
Moderator(s): Barry T. Katzen, MD / Kenneth Ouriel, MD, MBA | |
8:14 AM - 8:19 AM | In Claudication Due To Aorto-Iliac Disease, Supervised Exercise Is As Effective As Stenting When Added To BMRx: What Can Make Exercise Work And Why It Is Good Treatment: The CLEVER RCT Results |
Presenter(s):Alan T. Hirsch, MD | |
View Slides in PDF | |
8:20 AM - 8:25 AM | With Juxtarenal Aorto-Iliac Occlusions Open Surgical Treatment Is Best And Safest: What Precautions May Be Needed |
Presenter(s):Giustino Marcucci, MD | |
View Slides in PDF | |
8:26 AM - 8:31 AM | Most Aorto-Iliac Occlusions Should Be Treated Endovascularly With Stents: But There Are Limits That Require Open Surgery |
Presenter(s):George H. Meier III, MD | |
View Slides in PDF | |
8:32 AM - 8:37 AM | All Aorto-Iliac Occlusions Can Be Treated Endovascularly By Stents – If Certain Precautions Are Taken To Prevent Renal And Visceral Embolization |
Presenter(s):Sonia Ronchey, MD, PhD / Nicola Mangialardi, MD | |
View Slides in PDF | |
8:38 AM - 8:43 AM | Complex Juxtarenal Aorto-Iliac Occlusions Can Be Treated Safely And Effectively With Covered Stents (The CERAB Technique) – However Renal Chimney Endografts May Be Required: Technique For Doing Them Without Risking Renal Or Visceral Embolization |
Presenter(s):Peter C.J. Goverde, MD / Michel M.P. Reijnen, MD, PhD | |
View Slides in PDF | |
8:44 AM - 8:49 AM | The CERAB Technique Using Covered Stents Is Better Treatment For Complex Aorto-Iliac Occlusions Than Bare Stents: Based On Flow Characteristics In An In Vitro Model |
Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
View Slides in PDF | |
8:50 AM - 8:55 AM | Value Of Fusion Imaging To Facilitate Treatment Of Complex Aorto-Iliac Occlusions |
Presenter(s):Klaus M. Overbeck, MD, MPhil | |
View Slides in PDF | |
8:56 AM - 9:01 AM | Treatment Of TASC C And D Aorto-Iliac Occlusions With A Bifurcated Unibody Endograft (AFX – Endologix) Rather Than Kissing Stents Or Stent-Grafts: Technique And Early Results |
Presenter(s):Thomas S. Maldonado, MD / Michel M.P. Reijnen, MD, PhD | |
View Slides in PDF | |
9:02 AM - 9:09 AM | Panel Discussion |
END OF SESSION 10 | |
SESSION 11 SCHEDULE | |
Tuesday
SESSION 11:
VASCULAR LAPAROSCOPY, SOME ROBOTICS AND OPEN SURGERY SKILLS
Moderators:Nicholas J.W. Cheshire, MD / Alan B. Lumsden, MD, FACS
|
|
x | |
9:09 AM - 9:14 AM | The Da Vinci Robot Facilitates Laparoscopic Aorto-Femoral Bypass For Occlusive Disease: Will It Displace Endovascular Techniques |
Presenter(s):Jean-Marc Alsac, MD, PhD / Salma El Batti, MD | |
View Slides in PDF | |
9:15 AM - 9:20 AM | Status Of Retroperitoneoscopic Techniques In Vascular Surgery: They Have Value But Will They Catch On |
Presenter(s):Bernard J. Segers, MD | |
View Slides in PDF | |
9:21 AM - 9:26 AM | A Propensity Score Matched Comparison Of Laparoscopic And Open Repair Of AAAs In Poor Candidates For EVAR: Is Laparoscopic Repair Better And Worth Learning |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
View Slides in PDF | |
9:27 AM - 9:32 AM | DEBATE: Laparoscopy And Articulated Robots For Aortic Surgery Is A Failed Experiment |
Presenter(s):Willem Wisselink, MD | |
View Slides in PDF | |
9:33 AM - 9:38 AM | DEBATE: Laparoscopic Robotic Aortic Surgery Is Not Dead But Has A Bright Future: What Will It Be And What Is The Evidence |
Presenter(s):Fabien Thaveau, MD, PhD | |
View Slides in PDF | |
9:39 AM - 9:44 AM | Open AAA Repair Is Becoming A Lost Art: Why And What Can Be Done About It: Tips And Tricks For Learning It And For Doing It Well |
Presenter(s):Edward Y. Woo, MD | |
View Slides in PDF | |
9:45 AM - 9:51 AM | Panel Discussion |
9:51 AM - 10:05 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Tuesday
SESSION 12:
UPDATE ON OPTIMAL TREATMENT METHODS FOR JUXTARENAL AND PARARENAL AAAs: IT IS STILL CONTROVERSIAL AND OTHER NEW DEVELOPMENTS IN TAAA TREATMENT, TEVAR AND TBAD
Moderators:Giovanni Torsello, MD / Matthew J. Eagleton, MD
|
|
x | |
ADVOCACY FOR SEVERAL METHODS OF JUXTA AND PARARENAL AAA REPAIR | |
10:05 AM - 10:10 AM | Open Repair Is The Procedure Of Choice For Juxta- And Pararenal AAAs: By What Approach |
Presenter(s):Michael S. Conte, MD | |
View Slides in PDF | |
10:11 AM - 10:16 AM | Fenestrated And Branched Grafts With EVAR (F/B EVAR) Is The Best Approach For Juxta- And Pararenal AAAs |
Presenter(s):Timothy A.M. Chuter, DM | |
View Slides in PDF | |
10:17 AM - 10:22 AM | Endografts With Parallel Grafts (Chimneys Or Periscopes) To The Renovisceral Arteries Are The Best Treatment For Juxta- Or Pararenal AAAs: Tips And Tricks For Doing Them Right |
Presenter(s):Zoran Rancic, MD, PhD / Mario L. Lachat, MD | |
View Slides in PDF | |
10:23 AM - 10:28 AM | For Juxta- And Pararenal AAAs Sometimes Chimney EVAR Is Best And When; Sometimes Fenestrated EVAR (F/EVAR With Z-Fen Endograft) Is Best And When: The Two Techniques Are Complementary |
Presenter(s):Jason T. Lee, MD | |
View Slides in PDF | |
10:29 AM - 10:34 AM | Use Of Parallel Grafts With EVAR To Treat Juxta- And Pararenal AAAs: A Simple Safe Technique |
Presenter(s):David J. Minion, MD | |
View Slides in PDF | |
10:35 AM - 10:40 AM | For Juxta- And Pararenal AAAs And Failed Standard EVARs Chimney EVAR Is Effective Midterm: Technical Tips And Tricks For Performing With Endurant Aortic Endografts: From The PROTAGORAS Registry |
Presenter(s):Konstantinos P. Donas, MD / Giovanni Torsello, MD | |
View Slides in PDF | |
10:41 AM - 10:46 AM | Late Results Of Parallel Grafts (Chimneys) For Juxta- And Pararenal AAAs Can Be Good If Done Right: Self-Expanding vs. Balloon-Expanding Branch Stents: Which Is Best |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Slides in PDF | |
OTHER RELATED TOPICS | |
10:47 AM - 10:52 AM | New Concepts And Improvements In Fenestrated Aortic Endografts And Improvements In Imaging For F/BEVAR With Fusion And IVUS |
Presenter(s):Mark A. Farber, MD | |
View Slides in PDF | |
10:53 AM - 10:58 AM | Perils Of The Widespread Use Of FEVAR: All Results Are Not Good |
Presenter(s):Christopher J. Abularrage, MD | |
View Slides in PDF | |
10:59 AM - 11:04 AM | Tips For Decreasing The Learning Curve For Performing F/BEVAR |
Presenter(s):Andres Schanzer, MD | |
View Slides in PDF | |
11:05 AM - 11:10 AM | Value Of Ultrasound (Duplex) In Surveillance Of Renal Artery Branches After B/FEVAR For Juxta- And Pararenal AAAs |
Presenter(s):Martin R. Back, MD | |
View Slides in PDF | |
11:11 AM - 11:19 AM | Panel Discussion |
TAAA TREATMENT, TEVAR AND TBAD RELATED TOPICS | |
Moderator(s): Mark A. Farber, MD / James F. McKinsey, MD | |
11:20 AM - 11:25 AM | Novel Simplified Endograft Device With Off-The-Shelf Potential For Treatment Of TAAAs: The Gore TAMBE Device: How It Works And Early Clinical Results |
Presenter(s):Pierre Galvagni Silveira, MD, PhD | |
View Slides in PDF | |
11:26 AM - 11:31 AM | Avoiding Pitfalls In Sizing The Diameter Of Endografts For TEVAR: The Timing Of Gated CT Scans Matters |
Presenter(s):Juan C. Parodi, MD | |
View Slides in PDF | |
11:32 AM - 11:37 AM | Goals Of Treatment For Complicated And Uncomplicated TBAD: Value Of IVUS And Other Tips And Tricks For Getting Good Outcomes: From A Large Single Center Experience |
Presenter(s):Ali Azizzadeh, MD / Hazim J. Safi, MD | |
View Slides in PDF | |
11:38 AM - 11:43 AM | Value Of Chimney Grafts In Aortic Arch Repairs For Dissections And For Aneurysms: Pros And Cons |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
View Slides in PDF | |
11:44 AM - 11:49 AM | Open And Endovascular Treatment Of Lusorian Artery (Ectopic Right SCA) And Associated Aneurysms (Kommerell’s Diverticulum) |
Presenter(s):Michael J. Jacobs, MD | |
View Slides in PDF | |
11:50 AM - 12:00 PM | Panel Discussion Visit Exhibits And Pavilions (2nd and 3rd Floors) |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Tuesday
SESSION 13:
OUTPATIENT VASCULAR AND BUSINESS ISSUES
Moderators:Richard J. Powell, MD / Enrico Ascher, MD
|
|
x | |
1:00 PM - 1:05 PM | Midterm Results Of Endovascular Treatment Of Common Femoral Artery Occlusive Disease Performed In An Outpatient Setting: It Works And Why |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Advantages And Limitations Of Same Day Discharge For Patients Undergoing EVAR: When Is It Safely Possible And When Not |
Presenter(s):Maciej L. Dryjski , MD, PhD / Linda Harris, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Office Based Lower Extremity Endovascular Treatment Is Safe, Effective And Cost-Saving: How To Prevent Operator Conflict Of Interest And Patient Abuse: The NY Times Is Not Always Right |
Presenter(s):Miguel F. Montero-Baker, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | 4-French Infrainguinal Interventions In An Outpatient Setting Are Safer And Effective: What Equipment Is Needed |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | With Lower Extremity Revascularization Procedures Increased Cost Does Not Improve Outcomes: What Risk Factors Increase Costs And How Should This Influence Treatment |
Presenter(s):Richard J. Powell, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Outpatient Vascular (Angio) Centers: Are They Leading To Unethical Vascular Practices And Harming Patients: What Can Be Done About It |
Presenter(s):Stephen M. Bauer, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Importance Of An Office Based Practice To SVS Members And Vascular Surgeons: How Can The Conflict Of Interest (COI) Issue Be Dealt With Fairly |
Presenter(s):Kim J. Hodgson, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | Assuring Quality Care In An Office Based Setting: Tips And Tricks For Opening An Outpatient Vascular Center And Doing It Right To Avoid Unmonitored And Unnecessary Procedures – As Described In The NY Times |
Presenter(s):Krishna Jain, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | Centers For Amputation Prevention Have Clinical And Financial Advantages And Fill A Need: How To Set One Up And What Is Needed |
Presenter(s):Richard F. Neville, MD | |
View Slides in PDF | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Tuesday
SESSION 14:
NEW TECHNIQUES, CONCEPTS AND UPDATES
Moderators:Kim J. Hodgson, MD / Daniel G. Clair, MD
|
|
x | |
2:00 PM - 2:05 PM | Can Spiral Intermittent Limb Compression Be An Effective Treatment For CLI And Heart Failure |
Presenter(s):Magdiel Trinidad Vasquez, MD | |
View Slides in PDF | |
2:06 PM - 2:11 PM | Role Of Increased Shear Stress In Leading To Thrombosis: Mechanism And Significance For Vascular Devices And Reconstructions |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Telemedicine For Vascular Surgery: Is It Feasible: What Is Its Status And What Are Its Limitations And Risks |
Presenter(s):Clifford M. Sales, MD, MBA, FACS / Jonathan Levison, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | Impact Of Delay In Treatment On Outcomes For CLI: For AAAs |
Presenter(s):Katariina M. Noronen, MD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Pneumatic Compression And Other Tricks For Brachial Access Hemostasis After Large Sheath Insertion |
Presenter(s):Rajiv Parakh, MBBS, MS, FRCS | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Transradial Access For Renal, Visceral And Lower Extremity Interventions: Equipment Needed, Tips And Tricks |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Horizon And Nexus Endografts: A New Concept For Branch Endografting In The Thoracic And Abdominal Aorta |
Presenter(s):Mario L. Lachat, MD | |
View Slides in PDF | |
2:42 PM - 2:47 PM | OCT (Optical Coherence Tomography) To Improve Crossing Of CTOs And Treatment By OCT Directed Atherectomy: The Avinger Pantheris Device And Its Results And How They Correlate With Plaque Histology |
Presenter(s):Patrick E. Muck, MD, FACS / John B. Simpson, MD, PhD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | Status Of Left Atrial Appendage Occlusive Devices To Prevent Strokes: Who Should Get Them |
Presenter(s):Aamir S. Shah, MD / Ali Khoynezhad, MD, PhD | |
View Slides in PDF | |
2:54 PM - 2:59 PM | Arteries And Grafts On Fire: Value And Limitations Of 18F-FDG PET CT In Diagnosing Arteritis And Graft Infections |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Update On Gaining Arterial Access For EVAR And TEVAR With Challenging Aorto-Iliac Anatomy: Tips And Tricks For Conduits And Direct Aortic Or Common Iliac Sheath Placement |
Presenter(s):Jeffrey P. Carpenter, MD | |
View Slides in PDF | |
3:06 PM - 3:20 PM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
Tuesday
SESSION 15:
RENAL AND VISCERAL ARTERY ISSUES
Moderators:Timur P. Sarac, MD / James C. Stanley, MD
|
|
x | |
RENAL ARTERY ISSUES | |
3:20 PM - 3:25 PM | Current Status Of Renal Artery Stenting In Children And Adults: When Is It The Treatment Of Choice And What Is Its Future |
Presenter(s):Thomas A. Sos, MD | |
View Slides in PDF | |
3:26 PM - 3:31 PM | IV DSA Is The Best Way To Assess Occlusive Disease Of The Aorta And Its Branches In Children: Embolization May Be Best Treatment For Segmental Renal Artery Stenosis Causing Hypertension |
Presenter(s):Kyung Cho, MD | |
View Slides in PDF | |
3:32 PM - 3:37 PM | Value Of DEBs To Treat Renal Artery Lesions, Recurrent Lesions And ISR |
Presenter(s):Fabrizio Fanelli, MD, EBIR | |
View Slides in PDF | |
3:38 PM - 3:43 PM | Open Renal Revascularization Can Salvage Failed Renal PTAs And Stents And Do So Durably: Tips And Tricks For These Operations |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
3:44 PM - 3:49 PM | Acute Renal Artery Occlusions: Causes; How To Treat And How Long After An Acute Occlusion Can Kidneys Be Salvaged With Good Function: Mechanism For Such Salvage After Long Delays |
Presenter(s):Samy S. Nitecki, MD | |
View Slides in PDF | |
3:50 PM - 3:55 PM | Renal Artery Aneurysms Rarely Rupture EVEN When >2 cm: How Fast Do They Grow: When And How Should They Be Fixed |
Presenter(s):Peter F. Lawrence, MD | |
View Slides in PDF | |
VISCERAL ARTERY ISSUES | |
3:56 PM - 4:01 PM | 10-Year Natural History Study Of Splanchnic Aneurysms (Splenic, Hepatic, Gastroduodenal And Mesenteric): When Should They Be Fixed And How |
Presenter(s):Mark Conrad, MD, MMSc | |
View Slides in PDF | |
4:02 PM - 4:07 PM | Endovascular Approaches To Treatment Of Giant Visceral Aneurysms (Up To 10 cm) |
Presenter(s):Michele Rossi, MD | |
View Slides in PDF | |
4:08 PM - 4:13 PM | Best Current Treatment For Mesenteric Ischemia: When Endo, When Open, When Hybrid |
Presenter(s):Timur P. Sarac, MD | |
View Slides in PDF | |
4:14 PM - 4:19 PM | Median Arcuate Ligament Syndrome: How To Diagnose And When And How To Treat Open, Laparoscopic Or Endovascularly: Does Treatment Work And How Should The Celiac Axis Be Managed |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS / Keith D. Calligaro, MD | |
View Slides in PDF | |
4:30 PM - 4:26 PM | Panel Discussion |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
Tuesday
SESSION 16:
TOPICS RELATED TO OPEN SURGERY AND THE TREATMENT OF AORTIC COARCTATIONS
Moderators:Richard P. Cambria, MD / Hans-Henning Eckstein, MD, PhD
|
|
x | |
OPEN SURGERY TOPICS | |
4:26 PM - 4:31 PM | New Improved Techniques For Open TAAA Repair: Better Organ Protection And Using Hybrid (Gore) Stent Graft For Faster Branch Revascularization |
Presenter(s):Yamume Tshomba, MD / Roberto Chiesa, MD / Enrico M. Marone, MD | |
View Slides in PDF | |
4:32 PM - 4:37 PM | An Important Role For Open Surgery Exists For AAAs In 2015 And It Will In The Future |
Presenter(s):Arno von Ristow, MD | |
View Slides in PDF | |
4:38 PM - 4:43 PM | Prevention Of Incisional Hernias After Open AAA Repairs Via A Midline Laparotomy Incision By Mesh Augmented Primary Closure (The PRIMAAT Trial): Technique And Material |
Presenter(s):Isabelle van Herzeele, MD, PhD / Frederik Berrevoet, MD / Filip Muysoms, MD | |
View Slides in PDF | |
4:44 PM - 4:49 PM | The Worst Patients For EVAR Are The Best For A Mini-Laparotomy Open Repair: How Is It Done |
Presenter(s):Francesco Spinelli, MD | |
View Slides in PDF | |
4:50 PM - 4:55 PM | Newer Innovations And Technical Tips And Tricks For Anterior Spine Exposure And Large Vessel Mobilization: What Vascular Surgeons Need To Know |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
View Slides in PDF | |
4:56 PM - 5:01 PM | Open Retroperitoneal Exposure Of The Entire Abdominal Aorta And Its Branches Via A Left Retroperitoneal Approach (Video Presentation) |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Slides in PDF | |
5:02 PM - 5:07 PM | Advantages And Disadvantages Of Hybrid Repair For Thoracoabdominal Aortic Aneurysms (TAAAs): Tips And Tricks For Doing It Right |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Slides in PDF | |
5:08 PM - 5:13 PM | Challenges And Results Of Open Repairs Of Residual TAAAs Distal To Prior TEVAR For TBADs |
Presenter(s):Manju Kalra, MBBS | |
View Slides in PDF | |
5:14 PM - 5:19 PM | Some CLI In Hemodialysis Patients Is Best Treated By Open Bypass Rather Than An Endovascular Procedure: Which Patients With What Anatomy |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
5:20 PM - 5:26 PM | Panel Discussion |
AORTIC COARCTATION TOPICS | |
Moderator(s): Hazim J. Safi, MD / Elchanan Bruckheimer, MBBS | |
5:26 PM - 5:31 PM | DEBATE: For Adult Coarctations And Their Complications When Is Endo OK And When Is Open Surgery Needed: What Are The Best And Safest Procedures |
Presenter(s):Joseph E. Bavaria, MD | |
5:32 PM - 5:37 PM | DEBATE: Adult Coarctations And Complications Of Previous Coarctation Repairs Are Best Treated Endovascularly But One Must Be Innovative |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
View Slides in PDF | |
5:38 PM - 5:43 PM | 5-Year Results With Balloon-Expandable Stent-Grafts In The Treatment Of Adult Aortic Coarctations |
Presenter(s):Elchanan Bruckheimer, MBBS | |
View Slides in PDF | |
5:44 PM - 5:49 PM | TEVAR Treatment Of Patch Aneurysms And Other Complications Of Prior Open Repairs: Advantages, Limitations And Precautions |
Presenter(s):Dittmar Boeckler, MD | |
View Slides in PDF | |
5:50 PM - 5:55 PM | New Generation Stent-Grafts For Treating Complications Of Aortic Coarctation Repairs: The Landscape Is Changing |
Presenter(s):Colin D. Bicknell, MD, FRCS | |
View Slides in PDF | |
5:56 PM - 6:03 PM | Panel Discussion End of Program B |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
Tuesday
SESSION 17:
MANAGEMENT OF PULMONARY EMBOLISM: THE MOMENTUM FOR EFFECTIVE TREATMENT IS REAL – PART 1
Moderators:Michael R. Jaff, DO
|
|
x | |
7:00 AM - 7:05 AM | Introduction To The Symposium |
Presenter(s):Frank J. Veith, MD | |
View Slides in PDF | |
7:05 AM - 7:15 AM | Welcome And Introduction |
Presenter(s):Michael R. Jaff, DO | |
7:15 AM - 7:25 AM | The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers? |
Presenter(s):Ido Weinberg, MD, MSc | |
View Slides in PDF | |
7:25 AM - 7:35 AM | The Basics Of Echocardiography For PE: What Must The Vascular Specialist Know, And Is An Emergent Echo Necessary |
Presenter(s):David M. Dudzinski, MD | |
View Slides in PDF | |
7:35 AM - 7:50 AM | What Is State-Of-The-Art Medical Therapy For PE |
Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM | |
View Slides in PDF | |
7:50 AM - 8:00 AM | Intravenous Thrombolytic Therapy For PE: Does It Work Acutely |
Presenter(s):Christopher Kabrhel, MD, MPH | |
View Slides in PDF | |
8:00 AM - 8:10 AM | Catheter-Directed Thrombolysis For PE: What Are The Long-Term Outcomes |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
8:10 AM - 8:25 AM | Percutaneous Pharmacomechanical Intervention For PE: Do We Really Know About The Hows And Whens |
Presenter(s):Nils Kucher, MD | |
View Slides in PDF | |
8:25 AM - 8:35 AM | Lysis For PE - What About The Nuts And Bolts: Heparin, PTT And Fibrinogen Monitoring, And How Do You Know When You Are Done |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
8:35 AM - 8:45 AM | Technical Tips For Pharmacomechanical Intervention For PE: How Do I Do It |
Presenter(s):Jeffrey Y. Wang, MD | |
View Slides in PDF | |
Moderator(s): Michael R. Jaff, DO | |
8:45 AM - 9:15 AM | Case Presentations/Discussion/Questions And Answers |
Panelist(s): Rabih A. Chaer, MD / Christopher Kabrhel, MD, MPH / Raghu Kolluri, MD / Nils Kucher, MD / Geno J. Merli, MD, MACP, FHM, FSVM / Jeffrey Y. Wang, MD / Ido Weinberg, MD, MSc | |
View Slides in PDF | |
9:15 AM - 9:45 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 17 | |
SESSION 18 SCHEDULE | |
Tuesday
SESSION 18:
MANAGEMENT OF PULMONARY EMBOLISM: THE MOMENTUM FOR EFFECTIVE TREATMENT IS REAL – PART 2
Moderators:Michael R. Jaff, DO
|
|
x | |
9:45 AM - 9:55 AM | PE Without DVT: What Does It Mean And Does It Matter |
Presenter(s):Anil P. Hingorani, MD | |
View Slides in PDF | |
9:55 AM - 10:10 AM | Percutaneous Thrombolysis And Thromboaspiration: The Impact Of Combination Therapy |
Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
View Slides in PDF | |
10:10 AM - 10:20 AM | Vortex Strategy For Massive PE |
Presenter(s):Christopher J. Kwolek, MD | |
View Slides in PDF | |
10:20 AM - 10:30 AM | ECMO And Surgical Thromboembolectomy For Massive PE: When, How And Why |
Presenter(s):Nicholas G. Smedira, MD | |
View Slides in PDF | |
10:30 AM - 10:45 AM | What Is The Modern Algorithm For Management Of Massive And Submassive PE |
Presenter(s):Nils Kucher, MD | |
View Slides in PDF | |
10:45 AM - 11:00 AM | Vena Cava Filters In PE Treatment: Do We Need To Do This, And If So, When |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
View Slides in PDF | |
11:00 AM - 11:15 AM | And Now For Something Completely Different: Catheter-Directed Thrombolysis In The Pediatric Population |
Presenter(s):Peter H. Lin, MD | |
View Slides in PDF | |
11:15 AM - 11:30 AM | The Team Approach To PE Management: The Emergence Of National PERT Centers |
Presenter(s):Kenneth Rosenfield, MD | |
View Slides in PDF | |
Moderator(s): Michael R. Jaff, DO | |
11:30 AM - 11:45 AM | Challenging Cases And “PERT” Decisions |
Panelist(s): Anil P. Hingorani, MD / Nils Kucher, MD / Christopher J. Kwolek, MD / Peter H. Lin, MD / Robert A. Lookstein, MD, FSIR, FAHA / Kenneth Rosenfield, MD / Nicholas G. Smedira, MD | |
View Slides in PDF | |
11:45 AM - 12:00 PM | Questions And Answers |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Tuesday
SESSION 19:
RAPID EXPANSION OF OPPORTUNITIES FOR EFFECTIVE TREATMENT OF LARGE VEIN STENOSIS, THROMBOSIS, AND OCCLUSION
Moderators:Kenneth Ouriel, MD, MBA / Peter Gloviczki, MD
|
|
x | |
1:00 PM - 1:05 PM | Lower Extremity Venous Occlusive Disease: A Rapidly Progressing Field With Major Opportunities For Improving Clinical Outcomes |
Presenter(s):Peter Gloviczki, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Large Vein Occlusive Disease: A Global Health Issue In 2015 And Beyond |
Presenter(s):Manj S. Gohel, MD, RCS, FEBVS | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Quality Of Life Surveys In Patients Undergoing Intervention For Chronic Venous Disease: The Good, The Bad, And The Ugly |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Non-Thrombotic May-Thurner Syndrome: Defining Pathology Mandating Treatment From Normal Anatomy |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | When And How Should Pelvic Venous Compression Syndromes Be Treated |
Presenter(s):David L. Gillespie, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Treating Iliofemoral DVT In Pregnancy: Anticoagulation Alone Is No Longer Acceptable In Most Patients |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Role Of Inflammation In DVT: Its Relationship With Thrombosis |
Presenter(s):Thomas W. Wakefield, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | Hemodynamics Of Venous Disease: Toward A Better Understanding And Consensus |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | Third Party Payment For Venous Interventions: Current Deliberations And Gazing Into The Crystal Ball |
Presenter(s):Sean P. Roddy, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | Panel Discussion |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Tuesday
SESSION 20:
ENDOVASCULAR INTERVENTIONS AND PHARMACOLOGIC REGIMENS FOR ACUTE LOWER EXTREMITY DVT: NEW EVIDENCE FOR CLINICAL SAFETY AND EFFECTIVENESS
Moderators:Thomas W. Wakefield, MD / Mark J. Garcia, MD
|
|
x | |
2:00 PM - 2:05 PM | ATTRACT Study Of rt-PA For Acute DVT: Almost 7 Years And Almost 700 Patients, Almost Done: What Will We Find |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
2:06 PM - 2:11 PM | Acute DVT Should Be Managed With An Aggressive Interventional Approach: Large Experience From South Asia |
Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Thrombolysis For DVT: Predictors Of Success |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
2:18 PM - 2:22 PM | BERNUTIFUL: A Beautifully Designed Trial To Evaluate Ultrasound-Assisted Thrombolysis For DVT |
Presenter(s):Nils Kucher, MD / Iris Baumgartner, MD | |
View Slides in PDF | |
2:23 PM - 2:28 PM | How Long To Anticoagulate After DVT: Duplex Imaging Guides Treatment Duration |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
2:29 PM - 2:34 PM | Understanding The Genetics Of Warfarin Dosing And Implications For Safer Anticoagulant Therapy |
Presenter(s):Karthikeshwar Kasirajan, MD | |
View Slides in PDF | |
2:35 PM - 2:40 PM | New Oral Anticoagulants For Extending Treatment Of DVT: Do They Alter The Risk/Benefit Ratio |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
2:41 PM - 2:50 PM | Panel Discussion |
2:51 PM - 3:15 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 20 | |
SESSION 21 SCHEDULE | |
Tuesday
SESSION 21:
NEW DEVICES FOR TREATING LARGE VEIN OCCLUSIVE DISEASE
|
|
x | |
3:16 PM - 3:21 PM | The First Comparative Study Of Four Dedicated Stents For The Venous System |
Presenter(s):Rick De Graaf, MD, PhD | |
View Slides in PDF | |
3:22 PM - 3:27 PM | DEBATE: Marketed Stents Designed For Arteries Are More Than Adequate For Treating Venous Disease |
Presenter(s):Mark J. Garcia, MD | |
View Slides in PDF | |
3:28 PM - 3:33 PM | DEBATE: Arterial Stents Are Suboptimal In Veins: Newer Stents Designed For The Venous Side Are Mandatory |
Presenter(s):Seshadri Raju, MD | |
View Slides in PDF | |
3:34 PM - 3:39 PM | Cutting Balloon Angioplasty For Symptomatic Femoropopliteal Vein Stenoses |
Presenter(s):Thomas O. McNamara, MD | |
View Slides in PDF | |
3:40 PM - 3:45 PM | The Cook Zilver Vena Venous Stent: Update From The VIVO Trial |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
3:46 PM - 3:51 PM | Early Experience With The Veniti VICI Venous Stent And Update On The VIRTUS Trial |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
3:52 PM - 3:57 PM | Rapid Clearance Of Acute Thrombus From The Large Veins: The AngioVac System |
Presenter(s):David J. Dexter, MD | |
View Slides in PDF | |
3:58 PM - 4:03 PM | Ultrasound-Enhanced Thrombolysis For Older DVT: Update From The ACCESS Study |
Presenter(s):Mark J. Garcia, MD | |
View Slides in PDF | |
4:04 PM - 4:09 PM | Panel Discussion |
END OF SESSION 21 | |
SESSION 22 SCHEDULE | |
Tuesday
SESSION 22:
THE INFERIOR VENA CAVA: CHALLENGES AND OPPORTUNITIES
Moderators:Timur P. Sarac, MD / Seshadri Raju, MD
|
|
x | |
4:10 PM - 4:15 PM | Surgical Reconstruction Of The Iliocaval Segment: When And How |
Presenter(s):Peter Gloviczki, MD | |
View Slides in PDF | |
4:16 PM - 4:21 PM | Recanalization Of The Inferior Vena Cava: Technique And Results |
Presenter(s):Erin H. Murphy, MD / Seshadri Raju, MD | |
View Slides in PDF | |
4:22 PM - 4:27 PM | Advantages Of Robotic Vena Cava Surgery Over Traditional Techniques |
Presenter(s):Samuel R. Money, MD, MBA | |
View Slides in PDF | |
4:28 PM - 4:33 PM | Acute And Chronic IVC Occlusion: Why It Occurs And Options For Treatment |
Presenter(s):David L. Gillespie, MD | |
View Slides in PDF | |
4:34 PM - 4:39 PM | Massive DVT And Pulmonary Embolism: Early Institution Of ECMO And Aggressive Anticoagulant Improves Survival |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
4:40 PM - 4:45 PM | Embolic Risk Of Percutaneous Thrombectomy And Thrombolysis For DVT: An IVC Filter Is Not Necessary |
Presenter(s):Peter H. Lin, MD | |
View Slides in PDF | |
4:46 PM - 4:51 PM | Newer, Safer Retrievable IVC Filter Designs Alter Risks And Rewards And Will Expand Applicability Indications |
Presenter(s):Richard G. McWilliams, FRCR, EBIR | |
View Slides in PDF | |
4:52 PM - 5:00 PM | Panel Discussion End of Program C |
END OF SESSION 22 | |
Wednesday, November 18, 2015
Print Entire 2015 Program:
|
|
SESSION 23 SCHEDULE | |
Wednesday
SESSION 23:
LOWER EXTREMITY OCCLUSIVE DISEASE MANAGEMENT – HOT TOPICS AND NEW DEVELOPMENTS
Moderators:Enrico Ascher, MD / Craig M. Walker, MD
|
|
x | |
6:40 AM - 6:45 AM | Prosthetic (PTFE) Grafts Are As Good Or Better Than Non-Greater Saphenous Autologous Vein Grafts For Below The Knee (BTK) Bypasses |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
6:46 AM - 6:51 AM | 12 Commandments To Make BTK Interventions For CLI Succeed |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
6:52 AM - 6:57 AM | What Is The Best Way To Deal Endovascularly With SFA Occlusions To Its Origin |
Presenter(s):George H. Meier III, MD | |
View Slides in PDF | |
6:58 AM - 7:03 AM | 12-Month Results With The Endovascular Tacking Device (Tack-It) For Treating Flow Limiting Post PTA Dissections: The TOBA Trial |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
7:04 AM - 7:09 AM | New Approaches To Limb Salvage In CLI Due To Very Distal Disease: Pedal Loop, Transcollateral And Small Artery Access In The Foot: Techniques, Tips And Tricks |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
7:10 AM - 7:15 AM | Fast, Cheap Way To Cross Tibial CTOs Antegrade And When It Doesn’t Work, Improved Pedal Access Is Available: Techniques And Equipment |
Presenter(s):Gary M. Ansel, MD | |
View Slides in PDF | |
7:16 AM - 7:21 AM | Technical Tips, Pitfalls And Midterm Results With Pedal Access Procedures |
Presenter(s):Hosam F. El Sayed, MD | |
View Slides in PDF | |
7:22 AM - 7:27 AM | How Does Stent Design Influence Results Of SFA Stenting: Advantages And Limitations Of Newer Stents: Supera, Tigris, Biomimics, Etc. |
Presenter(s):Marc Bosiers, MD / Koen Deloose, MD | |
View Slides in PDF | |
7:28 AM - 7:33 AM | DEBATE: Based On 5-Year Results, The Zilver PTX Stent Is The Treatment Of Choice For SFA Occlusive Disease |
Presenter(s):Michael D. Dake, MD | |
View Slides in PDF | |
7:34 AM - 7:39 AM | <>DEBATE: Zilver PTX Stents Are Effective For Long Or Calcified SFA Lesions: But All Other SFA Lesions Should Be Treated With Drug Eluting Balloons (DEBs) |
Presenter(s):Thomas Zeller, MD | |
View Slides in PDF | |
7:40 AM - 7:46 AM | Panel Discussion |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Wednesday
SESSION 24:
MORE LOWER EXTREMITY HOT TOPICS AND NEW DEVELOPMENTS
Moderators:Giancarlo Biamino, MD, PhD / Kenneth Ouriel, MD, MBA
|
|
x | |
7:46 AM - 7:51 AM | Comparison Of Tibial Bypasses With Saphenous Vein vs. Heparin Bonded PTFE (Propaten): Current Indications For Prosthetic Tibial Bypasses And New Developments For Limb Salvage |
Presenter(s):Richard F. Neville, MD | |
View Slides in PDF | |
7:52 AM - 7:57 AM | In Patients With Extensive Gangrene From CLI (Rutherford 5 And 6), Limited Vein And Occlusive Disease Of The SFA And Distal Arteries, Endovascular Treatment Of The SFA And A Short Vein Distal Bypass Is The Best Way To Achieve Limb And Patient Survival |
Presenter(s):Francesco Spinelli, MD | |
View Slides in PDF | |
7:58 AM - 8:03 AM | Below The Ankle And Perimalleolar Occlusive Disease With CLI: Tips And Tricks For Treating It Endovascularly And When They Should Be Used: Hydrodynamic Boost To Re-Enter The Tibial Artery True Lumen And Venous Arterialization |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
8:04 AM - 8:09 AM | New Tips, Tricks And Devices For Pedal And Other Distal Access Procedures |
Presenter(s):Andrej Schmidt, MD | |
View Slides in PDF | |
DRUG ELUTING BALLOONS (DEBS) | |
8:10 AM - 8:15 AM | Importance Of Trial Design And Other Factors In Evaluating The Differing Results With DEBs |
Presenter(s):Kenneth Rosenfield, MD | |
View Slides in PDF | |
8:16 AM - 8:21 AM | Under What Conditions Should DEBs Be Used Preferentially: Diabetics, Calcified Lesions, Extensive Foot Necrosis: What Does It Take To Make DEBs Work Optimally |
Presenter(s):Francesco Liistro, MD | |
View Slides in PDF | |
8:22 AM - 8:27 AM | 2-Year Results With The Lutonix (Bard) DEB vs. Uncoated Balloon Angioplasty (POBA): The LEVANT II Trial In The SFA And BTK Lesions |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / Kenneth Rosenfield, MD / Marianne Brodmann, MD / Thomas Zeller, MD | |
View Slides in PDF | |
8:28 AM - 8:33 AM | In Femoropopliteal Stenting Does Drug Elution Make A Difference vs. Uncoated Stents: New Data From The MAJESTIC Trial |
Presenter(s):Stefan Mueller-Huelsbeck, MD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | Access For BTK Interventions Via Puncture Through Totally Occluded SFAs (With Or Without A Previous Stent): How To Do It |
Presenter(s):Luigi Inglese, MD | |
8:40 AM - 8:45 AM | What The Surgeon Should NOT Do To Preserve Options For Future Endovascular Therapy And Vice Versa |
Presenter(s):Sigrid Nikol, MD | |
View Slides in PDF | |
8:46 AM - 8:52 AM | Panel Discussion |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Wednesday
SESSION 25:
MORE LOWER EXTREMITY NEW DEVELOPMENTS AND HOT TOPICS
Moderators:Giancarlo Biamino, MD, PhD / Frank J. Veith, MD
|
|
x | |
8:52 AM - 8:57 AM | DEBATE: What Percent Of CLI Patients Will Require An Open Surgical Procedure At Some Point In Their Course: An Interventionist's Point Of View |
Presenter(s):Giancarlo Biamino, MD, PhD | |
View Slides in PDF | |
8:58 AM - 9:03 AM | DEBATE: What Percent Of CLI Patients Will Require An Open Procedure At Some Point In Their Course: An Endovascularly Oriented Vascular Surgeon's Point Of View |
Presenter(s):Joseph L. Mills, MD | |
View Slides in PDF | |
9:04 AM - 9:09 AM | 2-Year Positive Results With The In.Pact Admiral DEB To Treat SFA And Popliteal Lesions: The In.Pact SFA RCT Shows Better Patency And Decreased Reintervention Rates Compared To POBA |
Presenter(s):Peter A. Schneider, MD / Gunnar Tepe, MD / John R. Laird, MD | |
View Slides in PDF | |
9:10 AM - 9:15 AM | Value Of The In.Pact DEB To Treat Long TASC C And D Lesions: From The In.Pact SFA Trial Long Lesion Cohort |
Presenter(s):Gunnar Tepe, MD | |
View Slides in PDF | |
9:16 AM - 9:21 AM | Critical Analysis Of The LEVANT II And In.Pact SFA RCTs Of DEBs vs. POBA: What Are The Take Home Messages |
Presenter(s):Thomas Zeller, MD | |
View Slides in PDF | |
9:22 AM - 9:27 AM | Update On The Status Of Drug Eluting Balloons In The US Currently – And What Is Coming |
Presenter(s):Edward Y. Woo, MD | |
View Slides in PDF | |
TREATMENT OF LEG AND FOOT ARTERY OCCLUSIVE DISEASE | |
9:28 AM - 9:33 AM | Foot Artery Disease In CLI: Innocent Bystander Or Leading Villain: When Should It Be Treated; When Should It Not Be Treated; And When Can It Not Be Treated: Some Patent Arteries In Leg And Foot Are Not Seen On DSA: How They Can Be Visualized |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
9:34 AM - 9:39 AM | Future Of Pedal Access And Interventions: What Are Its Limits And Potential: Can It Be Achieved With Duplex Guidance And Can It Be Used For Atherectomy (With The Diamond Back Device): Technical Tips |
Presenter(s):Jihad A. Mustapha, MD | |
View Slides in PDF | |
9:40 AM - 9:45 AM | DEBs And Drug Eluting Stents (DESs) For BTK Arteries: Where Are We And What Is The Future |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Slides in PDF | |
9:46 AM - 9:51 AM | Novel Hybrid Technique For Treating Complex Disease Involving CFA, SFA And Tibial Disease: Distal Access, Retrograde Wire Passage To A Common Femoral Arteriotomy Facilitates Complex Prograde Endovascular Treatments |
Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD | |
View Slides in PDF | |
9:52 AM - 9:59 AM | Panel Discussion |
9:59 AM - 10:12 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Wednesday
SESSION 26:
MORE LOWER EXTREMITY NEW DEVELOPMENTS AND HOT TOPICS
Moderators:Daniel G. Clair, MD / Michael B. Silva, Jr., MD
|
|
x | |
10:12 AM - 10:17 AM | DEBATE: An Endovascular First Approach To All CLI Patients Results In Better Limb Salvage: Based On Long-Term Follow-Up Of A Single Vascular Surgical Center |
Presenter(s):Ramon L. Varcoe, MD | |
View Slides in PDF | |
10:18 AM - 10:23 AM | DEBATE: Not So: Some CLI Patients Are Still Best Treated First By An Open Bypass: Which Ones And An Endovascular First Policy Can Harm Such Patients |
Presenter(s):Michael S. Conte, MD | |
View Slides in PDF | |
10:24 AM - 10:29 AM | Consequences Of An “Endovascular First Policy For All CLI Patients”: They Are Real – Especially With TASC C And D Lesions |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
10:30 AM - 10:35 AM | Consequences Of Failed Tibial Angioplasty: How Often Is The Distal Target Vessel Altered Or Symptoms Increased: Open Bypass As The Initial Treatment Is Better For CLI Patients With TASC D Lesions |
Presenter(s):Marc L. Schermerhorn, MD | |
View Slides in PDF | |
10:36 AM - 10:41 AM | Endovascular Treatments For TASC C And D Lesions Have Improved And Justifies Their Use With Such Lesions: Do Results Support This Use |
Presenter(s):Gary M. Ansel, MD | |
View Slides in PDF | |
10:42 AM - 10:47 AM | 5-Year Results With The Supera Interwoven Stent Are Better Than Other Bare Metal Stents (BMSs) And DEBs In A Propensity Matched Comparison |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / Sabine Steiner, MD | |
View Slides in PDF | |
10:48 AM - 10:53 AM | 3-Year Results From The US IDE Trial With The Supera Stent: How Does The Deployment Technique Influence Midterm Patency |
Presenter(s):Lawrence A. Garcia, MD | |
View Slides in PDF | |
10:54 AM - 10:59 AM | Real World Experience With The Supera Stent For Long Challenging SFA/Pop Lesions: Deployment Tips And Mode Of Failure |
Presenter(s):D. Christopher Metzger, MD | |
View Slides in PDF | |
11:00 AM - 11:05 AM | 1-2-Year Good Results With The Xience Prime Balloon Expandable Everolimus DES For Long BTK Lesions Are Good: From The DESTINY 2 Trial |
Presenter(s):Marc Bosiers, MD / Patrick Peeters, MD | |
View Slides in PDF | |
11:06 AM - 11:12 AM | Panel Discussion |
NEW DEVELOPMENTS IN DEBS | |
Moderator(s): Peter A. Schneider, MD / Darren B. Schneider, MD | |
11:12 AM - 11:17 AM | Role Of DEBs For Infrainguinal Lesions (SFA/Pop/BTK) In 2015 And The Future: What Is It And What Will It Be In Primary And Recurrent Lesions And ISR |
Presenter(s):Giancarlo Biamino, MD, PhD | |
View Slides in PDF | |
11:18 AM - 11:23 AM | DEBATE: Why We Should Stay Away From DEBs For BTK Interventions |
Presenter(s):Erich Minar, MD | |
View Slides in PDF | |
11:24 AM - 11:29 AM | DEBATE: DEBs For BTK Lesions Have A Bright Future: Why The In.Pact Deep Trial Did Not Work And Lessons Learned That Should Make DEBs Effective BTK Including In Crural Arteries |
Presenter(s):Francesco Liistro, MD | |
View Slides in PDF | |
11:30 AM - 11:35 AM | Ongoing Trials Of Drug Delivery Techniques And Improved Stents For BTK Arteries: The Future Is Bright |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
View Slides in PDF | |
11:36 AM - 11:41 AM | Late Patency And Limb Salvage Results After Plantar And Pedal Loop PTAs For CLI: How Do They Differ In Patients With Gangrene And Ulceration And Those With Rest Pain |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
11:42 AM - 11:47 AM | Infrainguinal Artery Calcification In Fem/Pop And Tibial Arteries: What Is Its Location And Nature And How Does It Impact On Endovascular Treatments In The Thigh, Leg And Foot |
Presenter(s):Jihad A. Mustapha, MD | |
View Slides in PDF | |
11:48 AM - 11:53 AM | Meta-Analysis Of Results With Venous Arterialization For Limb Salvage: When Does It Work And Why: Properly Done It Offers A Hope For Limb Salvage In Otherwise Hopeless Circumstances |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Wednesday
SESSION 27:
LOWER EXTREMITY NEW DEVELOPMENTS RELATED TO TREATMENT OF IN STENT RESTENOSIS (ISR)
Moderators:Andrej Schmidt, MD / Marc Bosiers, MD
|
|
x | |
1:00 PM - 1:05 PM | How Can ISR Be Classified And What Is Currently The Best Treatment For Each Class |
Presenter(s):Peter A. Schneider, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | The Spectranetics Excimer Laser Plus Balloon Angioplasty Is The Best Treatment For ISR: Based On The EXCITE-ISR Trial: Should The Balloon Be A DEB |
Presenter(s):Craig M. Walker, MD / D. Christopher Metzger, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Atherectomy (Silverhawk) Plus DEB Is The Best Treatment For ISR And Is Cost Effective: Based On The DEFINITIVE AR Trial |
Presenter(s):Thomas Zeller, MD / Gunnar Tepe, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Viabahn Relining Is Usually The Best Treatment For ISR: Based On Updated 2-Year Results Of The RELINE Trial: When Is It Not The Best |
Presenter(s):Patrick Peeters, MD / Marc Bosiers, MD / Koen Deloose, MD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Viabahn Stent-Grafts Are Good Treatment For ISR: When Are They The Best: What Is The Pattern Of Failure And What Can Be Done To Prevent It |
Presenter(s):Johannes Lammer, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | DEB With The Cotavance Balloon vs. POBA For ISR: Good 1-Year Results: The COPA CABANA Trial |
Presenter(s):Gunnar Tepe, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Panel Discussion |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS, POPLITEAL ANEURYSMS AND OTHER CLI TOPICS OF INTEREST
Moderators:Wesley S. Moore, MD / Craig M. Walker, MD
|
|
x | |
1:42 PM - 1:47 PM | Emergency Treatment Of Vascular Injuries With Stent-Grafts (Covered Stents): Which Stent-Graft For Which Injuries And Other Tips And Tricks In Their Use |
Presenter(s):Maria Antonella Ruffino, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | What Is The Best Current Treatment For Long SFA Occlusions: BMSs, DESs, DEBs, Atherectomy And PTA Or Viabahn Stent-Grafts |
Presenter(s):Johannes Lammer, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | 3-Year Results With Heparin Bonded Viabahn Stent-Grafts To Treat Long SFA Occlusions |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Slides in PDF | |
2:00 PM - 2:05 PM | Heparin Bonding Probably Does Not Improve Results with PTFE Stent-Grafts Or Open PTFE Bypasses |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Slides in PDF | |
POPLITEAL ANEURYSM HOT TOPICS (SEE ALSO SESSION 85) | |
2:06 PM - 2:11 PM | Endoluminal Bypasses With Stent-Grafts For Thrombosed Popliteal Aneurysms: When Can It Work And How To Do It |
Presenter(s):Giovanni Pratesi, MD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | DEBATE: Most Popliteal Aneurysms Should Be Treated Endovascularly: What Are The Exceptions and What Is Their Proportion |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
View Slides in PDF | |
2:18 PM - 2:23 PM | DEBATE: Not So: Endovascular Repair Of Popliteal Aneurysms May Not Be As Good As It’s Cracked Up To Be – Especially In Certain Circumstances: Open Repair Via A Posterior Approach Is Best For Most |
Presenter(s):Martin Bjorck, MD, PhD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Endovascular Stent-Graft Repair Is The Best Treatment For Most Popliteal Aneurysms: What Are The Exceptions |
Presenter(s):Franco Grego, MD | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Open vs. Endo Repair For Popliteal Aneurysms: Which Is Best: From A Real World National Italian Registry |
Presenter(s):Walter Dorigo, MD | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Surveillance Duplex Ultrasound Is Not Reliable For Predicting Stent-Graft Failure After Popliteal Aneurysm Repair But Is Reliable For Predicting Failure Of SFA Stent-Grafts For Occlusive Disease |
Presenter(s):Keith D. Calligaro, MD / Matthew J. Dougherty, MD | |
View Slides in PDF | |
OTHER LOWER EXTREMITY TOPICS OF INTEREST | |
Moderator(s): Joseph L. Mills, MD / Patrick J. Lamparello, MD | |
2:48 PM - 2:53 PM | Value Of Prostaglandins In CLI For Diabetics And Non-Diabetics: Beneficial Effects Can Be Documented By Flow Measurements |
Presenter(s):Afshin Assadian, MD | |
View Slides in PDF | |
2:54 PM - 2:59 PM | Myths Concerning Pedal Bypasses: Their Bad Reputation Is Undeserved: With Them And Pedal Loop Endovascular Techniques No Patient With CLI Should Be Untreatable |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Failure Modes For Pedal Access Endovascular Interventions |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
3:06 PM - 3:11 PM | Impact Of Nitinol Stent Oversizing On Outcomes Of Fempop Interventions: How Should Optimal Stent Size Be Determined |
Presenter(s):Nicolas A. Diehm, MD | |
View Slides in PDF | |
3:12 PM - 3:17 PM | Distal (Pedal) Bypasses vs. PTAs For The Treatment Of Tibial And Pedal Occlusive Lesions: Pros And Cons Of Each |
Presenter(s):Hany Zayed, MD | |
View Slides in PDF | |
3:18 PM - 3:23 PM | Panel Discussion |
3:23 PM - 3:33 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Wednesday
SESSION 29:
ADVANCES IN THE TREATMENT OF ACUTE LIMB ISCHEMIA (ALI) AND INTERMITTENT CLAUDICATION (IC)
Moderators:Keith D. Calligaro, MD / Michael S. Conte, MD
|
|
x | |
ACUTE LIMB ISCHEMIA (SEE ALSO SESSION 62) | |
3:33 PM - 3:38 PM | DEBATE: All Patients With Acute Limb Ischemia (ALI) Should Be Treated Endovascularly: A Strategy For Doing So – Including Mechanical Thrombectomy: Which Device Is Currently Best |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
3:39 PM - 3:44 PM | DEBATE: Some Patients With ALI Need Open Surgical Techniques: Who Are They And Why Are The Open Techniques Needed And Beneficial |
Presenter(s):Joseph L. Mills, MD | |
View Slides in PDF | |
3:45 PM - 3:50 PM | Update On Thrombosuction For ALI: What Are The Best Techniques: How To Do It And What Are The Results |
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
3:51 PM - 3:56 PM | Intraoperative Venous Drainage Through A Hemodialysis System Can Be A Limb And Life Saving Technique For Patients With Late Stage ALI And Reperfusion Injury: How To Do It |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
View Slides in PDF | |
NEW DEVELOPMENTS IN THE MANAGEMENT OF INTERMITTENT CLAUDICATION (IC) AND OTHER CONDITIONS | |
3:57 PM - 4:02 PM | DEBATE: How Should Most Patients With IC Be Treated: An Interventional Cardiologist’s View |
Presenter(s):William A. Gray, MD | |
View Slides in PDF | |
4:03 PM - 4:08 PM | DEBATE: How Should Most Patients With IC Be Treated: A Vascular Surgeon’s View |
Presenter(s):Frank B. Pomposelli, MD | |
View Slides in PDF | |
4:09 PM - 4:14 PM | With Supervised Exercise For IC When Is Stenting Needed: Never? Rarely? |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Slides in PDF | |
4:15 PM - 4:20 PM | Patients With IC Should Have A Trial Of Exercise Treatment And Be Informed About Risks And Benefits Before They Are Treated Interventionally |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Slides in PDF | |
4:21 PM - 4:26 PM | Use Of Electronic Devices Like Fitbits To Improve IC Treatment |
Presenter(s):Robyn A. Macsata, MD | |
View Slides in PDF | |
4:27 PM - 4:32 PM | New Automated Device For Rapid Percutaneous Insertion Of Femoral Artery Sheath In Emergent Situations |
Presenter(s):Rajabrata Sarkar, MD, PhD | |
View Slides in PDF | |
4:33 PM - 4:39 PM | Panel Discussion |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Wednesday
SESSION 30:
CLI AND THE ANGIOSOME CONCEPT; REOPERATIONS AND REINTERVENTION; OTHER NEW CONCEPTS AND TECHNIQUES
Moderators:Timur P. Sarac, MD / Cynthia K. Shortell, MD
|
|
x | |
4:39 PM - 4:44 PM | DEBATE: The Angiosome Concept Has Been Proven Helpful With Open Surgical And Endovascular Treatments Of CLI With Gangrenous Or Ulcerated Lesions |
Presenter(s):Richard F. Neville, MD | |
View Slides in PDF | |
4:45 PM - 4:50 PM | DEBATE: The Angiosome Concept Has Not Been Proven Helpful In The Treatment Of CLI With Gangrenous Or Ulcerated Lesions |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
View Slides in PDF | |
4:51 PM - 4:56 PM | Angiosome Targeted Revascularization Is More Important With Endovascular Repair Than Bypass Surgery |
Presenter(s):Maarit Venermo, MD, PhD | |
View Slides in PDF | |
4:57 PM - 5:02 PM | Critique Of The Angiosome Concept: It Is Not Simple: Outcomes Depend More On The Distribution System In The Foot Than Angiosomes |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
5:03 PM - 5:08 PM | Is The Angiosome Concept Worthwhile And How Should It Be Used |
Presenter(s):Peter A. Schneider, MD | |
View Slides in PDF | |
5:09 PM - 5:14 PM | Update On The Angiosome Concept: It’s Not All It’s Cracked Up To Be: What Other Factors Are More Important |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
View Slides in PDF | |
5:15 PM - 5:20 PM | The Angiosome Concept Is Not Necessary To Achieve Limb Salvage With Ischemic Gangrenous Foot Lesions |
Presenter(s):Ignacio Escotto, MD | |
View Slides in PDF | |
5:21 PM - 5:26 PM | Angiosomes Of The Foot Have Tremendous Variability As Indicated By Laser-Assisted Indocyanine Green Imaging Using The SPY SYSTEM |
Presenter(s):Werner Lang, MD | |
View Slides in PDF | |
5:27 PM - 5:32 PM | The Importance Of Reoperation Or Reintervention When A Primary Procedure For CLI Fails And The Limb Is Rethreatened: 1, 2, 3, 4 And More Procedures Can Be Worthwhile: A Vascular Surgeon’s View |
Presenter(s):Evan C. Lipsitz, MD | |
View Slides in PDF | |
NEW CONCEPTS AND TECHNIQUES | |
5:33 PM - 5:38 PM | Vorapaxar - A New PAR-1 Receptor Blocker, Improves Cardiovascular And Limb Outcomes In PAD Patients: The FDA Agrees |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
5:39 PM - 5:44 PM | When And How Should Distal Embolic Protection Devices Be Used With Lower Extremity Interventions |
Presenter(s):D. Christopher Metzger, MD | |
View Slides in PDF | |
5:45 PM - 5:55 PM | Panel Discussion End of Program D |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Wednesday
SESSION 31:
NATURAL HISTORY, MEDICAL TREATMENTS AND ANTI-ATHEROSCLEROTIC MEDICATIONS
Moderators:Keith D. Calligaro, MD / Hans-Henning Eckstein, MD, PhD
|
|
x | |
6:45 AM - 6:50 AM | Is Metabolic Syndrome A Marker Of Adverse Outcomes After Vascular Procedures: What Can Be Done To Improve The Situation |
Presenter(s):Alan Dardik, MD, PhD | |
View Slides in PDF | |
6:51 AM - 6:56 AM | Cilostazol (Pletal) Is An Underutilized Medication In Vascular Patients: It Can Promote Patency And Decrease Amputations After Arterial Revascularizations: What Is Optimal Timing And Dosing For Its Use |
Presenter(s):Todd R. Vogel, MD, MPH | |
View Slides in PDF | |
6:57 AM - 7:03 AM | How Should Beta Blockers Be Used In Vascular Patients Undergoing Procedures: Use And Overuse Can Harm Patients And Their Use Should Not Be A Quality Metric |
Presenter(s):Michael C. Stoner, MD | |
View Slides in PDF | |
7:04 AM - 7:09 AM | How Do Patient Risk Factors And Antiplatelet Medications Influence Myocardial Ischemia And Infarction In Patients Undergoing Open Arterial Operations: What Can Be Done To Decrease These Adverse Events |
Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Slides in PDF | |
7:10 AM - 7:15 AM | Smoking, Cholesterol, Obesity And BP: The Big 4 Modifiable Causes Of Vascular Disease: Fix Them And Live Forever: What Is Optimal Statin Usage |
Presenter(s):Richard Bulbulia, MA, MD, FRCS | |
View Slides in PDF | |
7:16 AM - 7:21 AM | What Is Happening With The AHA Cholesterol Guidelines: Should We Measure Serum Cholesterol: How Low Should The LDL Be Pushed To And Can It Get There |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Slides in PDF | |
7:22 AM - 7:27 AM | Status Of Cholesterol Lowering Drug Zetia (Ezetimbe) And Its Combination With Statins (Vytorin): Do They Help To Prevent Cardiovascular Events More Than Statins Alone: Who Should Be On Them: The IMPROVE –IT Trial |
Presenter(s):Don Poldermans, MD | |
View Slides in PDF | |
7:28 AM - 7:33 AM | Status Of The New Cholesterol Lowering Drugs: The PCSK 9 Inhibitors (Evolucumab [Amgen] And Alirocumab [Sanofi]): Do They Decrease Cardiovascular Events: How Are They Given; What Are Their Downsides; What Will Their Role Be And When Will They Be Available |
Presenter(s):Ron Waksman, MD | |
View Slides in PDF | |
7:34 AM - 7:39 AM | Statins And Dual Antiplatelet Drugs Reduce Amputations: What Is The Evidence |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Slides in PDF | |
7:40 AM - 7:48 AM | Panel Discussion |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Wednesday
SESSION 32:
RENAL DENERVATION AND OTHER TREATMENTS FOR RESISTANT HYPERTENSION: BLACK BOX WARNINGS; KEY CAROTID TOPIC
Moderators:Ronald L. Dalman, MD / Ali F. AbuRahma, MD
|
|
x | |
7:48 AM - 7:53 AM | Current Status Of Catheter Based Renal Radiofrequency Denervation For Hypertension: Where Is It Going |
Presenter(s):Horst Sievert, MD | |
View Slides in PDF | |
7:54 AM - 7:59 AM | Why The Renal Denervation RCTs Have Not Shown A Positive Effect: Does The Treatment Concept Have A Future |
Presenter(s):Michael R. Jaff, DO / Krishna J. Rocha-Singh, MD | |
View Slides in PDF | |
8:00 AM - 8:05 AM | What Is The Future For Renal Denervation: What Are Its Assets Beyond Lowering BP: Will It Become A Mainstream Treatment |
Presenter(s):Melvin D. Lobo, MBChB, PhD, FRCP | |
View Slides in PDF | |
8:06 AM - 8:11 AM | Does Surgical Renal Denervation Work: Why Does It Fail Long-Term: Is There A Bright Future For Renal Denervation |
Presenter(s):Juan C. Parodi, MD | |
View Slides in PDF | |
8:12 AM - 8:17 AM | Newer Methods To Achieve Renal Denervation: Can Catheter Based Ultrasound (Surround Sound) Be Effective And Safe For Lowering BP, For Treating Heart Failure (The RETREAT Trial): What About Catheter Chemical Denervation With Alcohol And DW 2013: How Are They Delivered |
Presenter(s):Horst Sievert, MD | |
View Slides in PDF | |
OTHER TREATMENTS FOR RESISTANT HYPERTENSION | |
8:18 AM - 8:23 AM | Update On Chronic Carotid Sinus Stimulation With An Implantable Device To Treat Resistant Hypertension |
Presenter(s):Fred A. Weaver, MD | |
View Slides in PDF | |
8:24 AM - 8:29 AM | Treatment Of Resistant Hypertension By The ROX AV Coupling Device: An Endovascular Technique To Create An Iliac A-V Fistula: Technique, Results And Risks |
Presenter(s):David H. Deaton, MD, FACS / Paul A. Sobotka, MD | |
View Slides in PDF | |
8:30 AM - 8:35 AM | Vascular Specialists Ignore Black Box Warnings About Certain Drugs And Their Optimal Usage Resulting In Poor Patient Care: What Can Be Done About It |
Presenter(s):Karthikeshwar Kasirajan, MD | |
View Slides in PDF | |
KEY CAROTID TOPIC | |
8:36 AM - 8:41 AM | What Is Best Medical Treatment (BMRx) For Patients With Carotid Disease |
Presenter(s):J. David Spence, MD | |
View Slides in PDF | |
8:42 AM - 8:49 AM | Panel Discussion |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Wednesday
SESSION 33:
TREATMENT AND PREVENTION OF COMPLICATIONS; ENDOTENSION AND ENDOLEAKS
Moderators:Neal S. Cayne, MD / Timur P. Sarac, MD
|
|
x | |
8:49 AM - 8:54 AM | Value Of Measuring Troponins Before And After Open Vascular Operations: When And How Does It Help In Patient Management |
Presenter(s):Caron B. Rockman, MD / Ramon Berguer, MD, PhD | |
View Slides in PDF | |
8:55 AM - 9:00 AM | Open And Endo Rescue Procedures When The Initial Procedure Goes Awry Or Has A Complication: Tips And Tricks For Getting Out Of Trouble |
Presenter(s):Michael B. Silva, Jr., MD | |
View Slides in PDF | |
9:01 AM - 9:06 AM | Is Endotension Still A Reality With Modern Vascular Imaging: What Conditions Can Mimic It |
Presenter(s):Jacques Busquet, MD | |
View Slides in PDF | |
9:07 AM - 9:12 AM | Strategies For Managing A Patient With A Growing AAA Sac After EVAR But No Apparent Endoleak: Open Or Laparoscopic, Fenestrated Cuff Or Relining Or Observe |
Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
View Slides in PDF | |
ENDOLEAKS | |
9:13 AM - 9:18 AM | Better Imaging Of Endoleaks (Type I) With Contrast MRI Permits Better Diagnosis And Treatment Leading To Better Outcomes |
Presenter(s):Frans L. Moll, MD, PhD | |
View Slides in PDF | |
9:19 AM - 9:24 AM | Aneurysm Sac Filling: A New Endovascular Technique To Eliminate Any Kind Of Endoleak |
Presenter(s):Michael J. Jacobs, MD | |
View Slides in PDF | |
9:25 AM - 9:30 AM | Partial Conversion To Treat Persistent Type 2 Endoleaks: When And How To Do It |
Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD | |
View Slides in PDF | |
9:31 AM - 9:36 AM | Diagnosis And Treatment Of Endoleaks With Nellix Endografts (EVAS): Much Is Different |
Presenter(s):Fabio Verzini, MD, PhD | |
View Slides in PDF | |
9:37 AM - 9:42 AM | Type 2 Endoleak Embolization By Laser-Assisted Transendograft Micropuncture: How To Do It And Results |
Presenter(s):Mark W. Mewissen, MD | |
View Slides in PDF | |
9:43 AM - 9:48 AM | Keys To Success With Embolic Treatment Of Complex Recalcitrant Type 2 Endoleaks After EVAR |
Presenter(s):Martin R. Back, MD | |
View Slides in PDF | |
9:49 AM - 9:54 AM | DEBATE: Fenestrated Cuffs Are The Best Way To Treat Persistent Type 1A Endoleaks After EVAR |
Presenter(s):Timothy A.M. Chuter, DM | |
View Slides in PDF | |
9:55 AM - 10:00 AM | DEBATE: Not So: Chimney Techniques Are The Best Way To Treat Persistent Type 1A Endoleaks After EVAR |
Presenter(s):Konstantinos P. Donas, MD | |
View Slides in PDF | |
10:01 AM - 10:08 AM | Panel Discussion |
10:08 AM - 10:20 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Wednesday
SESSION 34:
HISTORY, MEDICAL/SURGICAL TOPICS AND IMPORTANT ISSUES
Moderators:Herbert Dardik, MD / Bruce A. Perler, MD, MBA
|
|
x | |
10:20 AM - 10:25 AM | What Did Leonardo da Vinci Know About Atherosclerosis Before William Harvey |
Presenter(s):Christopher K. Zarins, MD | |
View Slides in PDF | |
10:26 AM - 10:31 AM | The First Published Report On CAS In 1977: An Interesting Story: How Was It Received |
Presenter(s):Klaus D. Mathias, MD | |
View Slides in PDF | |
MEDICAL/SURGICAL TOPICS | |
10:32 AM - 10:37 AM | Tests For The Hypercoaguable State Are Overused And Unnecessary In Most Vascular Patients: When Are They Needed And Helpful |
Presenter(s):Elna M. Masuda, MD | |
View Slides in PDF | |
10:38 AM - 10:43 AM | Atherosclerotic Plaque Regression: Is It Now A Reality: How Can It Occur: And What Are The Expectations For The Future |
Presenter(s):Ralph G. DePalma, MD | |
View Slides in PDF | |
10:44 AM - 10:49 AM | Value Of Frailty Indices In Vascular Surgical Procedures: What Are They And How Can They Be Helpful |
Presenter(s):Gregory L. Moneta, MD | |
View Slides in PDF | |
10:50 AM - 10:55 AM | Tips And Tricks In The Management Of Pediatric Vascular Trauma |
Presenter(s):Meryl E. Davis, FRCS / George Hamilton, MD, FRCS | |
View Slides in PDF | |
10:56 AM - 11:01 AM | Panel Discussion |
IMPORTANT ISSUES | |
Moderator(s): Ramon Berguer, MD, PhD / Enrico Ascher, MD | |
11:01 AM - 11:06 AM | How Can Vascular Surgeons Reconcile Work And Family Responsibilities And Time Commitments And Succeed With Both |
Presenter(s):Marshall E. Benjamin, MD | |
View Slides in PDF | |
11:07 AM - 11:12 AM | Patient Benefit From Meetings Of The Vascular Community For Education, Innovation And Evidence With Active Collaboration Of CME And Industry Regulatory Bodies |
Presenter(s):Roger M. Greenhalgh, MD | |
View Slides in PDF | |
11:13 AM - 11:18 AM | Current Status Of MOC For Vascular Surgeons: Why Vascular Surgeons Should Join The Cardiologists To Resist The Existing Onerous Requirements |
Presenter(s):John F. Eidt, MD | |
View Slides in PDF | |
11:19 AM - 11:24 AM | Variability In Operating Time For The Same Procedure By Different Vascular Surgeons: How Does It Correlate With Outcomes: Do Slow Surgeons Get Better Or Worse Results |
Presenter(s):Jack L. Cronenwett, MD | |
View Slides in PDF | |
11:25 AM - 11:30 AM | How Should Academic Activity Be Rated And Rewarded: Should There Be Academic RVUs To Define And Quantitate Academic Activity And Productivity: How To Set Up Such A System |
Presenter(s):Mark G. Davies, MD / Alan B. Lumsden, MD, FACS | |
View Slides in PDF | |
11:31 AM - 11:36 AM | Lessons Learned From 2 Disasters: 9-11 And Superstorm Sandy |
Presenter(s):Mark A. Adelman, MD | |
View Slides in PDF | |
11:37 AM - 11:42 AM | Why Should Vascular Surgeons Get An MBA Or Other Advanced Degree |
Presenter(s):Robert B. McLafferty, MD | |
View Slides in PDF | |
11:43 AM - 11:48 AM | What Is The Value Of Vascular And Endovascular Societies: What Should They Do For Us And Our Specialty: Which Ones Should We Join And Why |
Presenter(s):Donald B. Reid, MD | |
View Slides in PDF | |
11:49 AM - 11:59 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor PromenadeVisit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Wednesday
SESSION 35:
ISSUES, ETHICS, HEALTH CARE REFORM AND THE AFFORDABLE CARE ACT (ACA)
Moderators:Robert M. Zwolak, MD, PhD / Ronald L. Dalman, MD
|
|
x | |
1:00 PM - 1:05 PM | The Importance Of Dynasties In Vascular Surgery: Why They Develop And Why They Fall |
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd | |
View Slides in PDF | |
1:06 PM - 1:11 PM | An Ethicist Looks At Overuse Of Procedures And Admissions By Doctors And Hospitals: Why Our Health Care System Incentivizes Such Overuse In Every Institution |
Presenter(s):James W. Jones, MD, PhD, MHA | |
View Slides in PDF | |
1:12 PM - 1:17 PM | The Battle Of Quality vs. Quantity In Hospital Administration: Quantity Wins All Too Often |
Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
View Slides in PDF | |
1:18 PM - 1:23 PM | How Patients (And Their Medical Doctors) Should Be Aware Of Unnecessary Tests And Procedures On Their Veins And Arteries: Such Procedural Overuse Can Harm Patients And Increase Health Care Costs |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | How To Survive In An ACO-ACA Environment: Is Our Health Care System Crumbling |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Slides in PDF | |
1:30 PM - 1:35 PM | What Is Happening With The Device Tax Component Of The ACA: What Are The Detrimental Effects Of The ACA On Industry |
Presenter(s):Nicky James / Pete R. Yonkman / Kem Hawkins, MBA | |
View Slides in PDF | |
1:36 PM - 1:41 PM | The Negative Impact Of The ACA On The Country And Health Care Is Worse Than We Thought It Would Be |
Presenter(s):Clifford J. Buckley, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | There Are Some Good Parts To The ACA That Should Be Preserved: How Can That Be Done |
Presenter(s):Timothy F. Kresowik, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | Perils Of The ACA For Patients: Health Care Exchanges Or Short Changes |
Presenter(s):James H. Black, III, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | Perspectives On Consolidation In The Health Care Industry: What Is Good And What Is Bad: How Can We Physicians Cope |
Presenter(s):Michael R. Jaff, DO | |
View Slides in PDF | |
2:00 PM - 2:05 PM | Medical Decision Making Should Be Shared With The Patient Especially With Vascular Patients: It Can Improve Care |
Presenter(s):Dirk T. Ubbink, MD, PhD | |
View Slides in PDF | |
2:06 PM - 2:11 PM | It Is An Imperfect World For Everyone – But Especially For Physicians And Super-Especially For Vascular Surgeons/Specialists |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
2:12 PM - 2:20 PM | Panel Discussion |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Wednesday
SESSION 36:
ACOs, GOVERNING BODIES (BOARDS/RRC), INDEPENDENCE, EDUCATION, REIMBURSEMENTS, TRAINING, SIMULATION
Moderators:Peter F. Lawrence, MD / Michel Makaroun, MD
|
|
x | |
2:20 PM - 2:25 PM | Strategies To Allow Us To Confront The Changing Health Care System And ACOs |
Presenter(s):John H. Furtek, BS, RT(r) | |
View Slides in PDF | |
2:26 PM - 2:31 PM | Why ACOs Have Not And Will Not Decrease Health Spending In Cardiovascular Care |
Presenter(s):Philip P. Goodney, MD, MS | |
View Slides in PDF | |
2:32 PM - 2:37 PM | Is The RRC-S (Residency Review Committee-Surgery) Working Well For Vascular Surgery: Should We Have An Independent RRC-VS |
Presenter(s):Ronald L. Dalman, MD | |
View Slides in PDF | |
2:38 PM - 2:43 PM | Current Impact Of The 0+5 Vascular Surgery Residency Programs: Should Vascular Surgery Now Become An Independent Specialty As It Is In Most Other Civilized Countries |
Presenter(s):John F. Eidt, MD | |
View Slides in PDF | |
2:44 PM - 2:49 PM | The Need For Continuing Evolution And Recognition Of Vascular Surgery As An Independent Specialty |
Presenter(s):James C. Stanley, MD | |
View Slides in PDF | |
2:50 PM - 2:55 PM | Role Of Our Vascular Journals In Dealing With Political, Training And Governance Issues Facing Vascular Surgery |
Presenter(s):Timothy M. Sullivan, MD | |
View Slides in PDF | |
2:56 PM - 3:01 PM | Update On 0+5 Vascular Residencies: Numbers, Levels Of Resident Satisfaction And Incidence Of Dropouts |
Presenter(s):Murray L. Shames, MD | |
View Slides in PDF | |
3:02 PM - 3:07 PM | Comparison Of Knowledge Base, Surgical Skills And Other Characteristics Of 5+2 And 0+5 Vascular Surgery Residents |
Presenter(s):Robyn A. Macsata, MD | |
View Slides in PDF | |
3:08 PM - 3:13 PM | Importance Of Promoting The Careers Of Junior Faculty Vascular Surgeons (As Well As Residents And Fellows): A System For Doing It |
Presenter(s):Karl A. Illig, MD / John F. Eidt, MD | |
View Slides in PDF | |
3:14 PM - 3:19 PM | Panel Discussion |
REIMBURSEMENT ISSUES | |
Moderator(s): Ramon Berguer, MD, PhD / Kim J. Hodgson, MD | |
3:19 PM - 3:24 PM | Update On Coding And Reimbursement Issues For Vascular Surgery: Now, In 2016 And Beyond |
Presenter(s):Sean P. Roddy, MD | |
View Slides in PDF | |
3:25 PM - 3:30 PM | Financial Impact Of The ACA To Date And In The Future: What Will It Mean To Vascular Surgeons |
Presenter(s):Robert M. Zwolak, MD, PhD | |
View Slides in PDF | |
SIMULATION ISSUES | |
3:31 PM - 3:36 PM | How To Shift The Learning Curve For Vascular Surgery From The Patient To A Model: The Vascular International Training Course Helps To Do This |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
3:37 PM - 3:42 PM | Advantages In Patient Specific Simulation For EVAR For Elective And Ruptured AAAs |
Presenter(s):Isabelle van Herzeele, MD, PhD / Mario L. Lachat, MD | |
View Slides in PDF | |
3:43 PM - 3:48 PM | The Introduction Of New Technology For Treating Vascular Lesions May Lead To Unnecessary Adverse Events: Many Of These Can Be Avoided By Simulation And Team Training |
Presenter(s):Colin D. Bicknell, MD, FRCS | |
View Slides in PDF | |
3:49 PM - 4:00 PM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Wednesday
SESSION 37:
VASCULAR CARE, MALPRACTICE LAW, CONTRACTS, COSTS, REIMBURSEMENT AND THE FDA
Moderators:Russell H. Samson, MD, RVT, FACS / Sean P. Roddy, MD
|
|
x | |
4:00 PM - 4:05 PM | The Indications And Results For EVAR Differ Widely In Different Regions: What Is The Reason |
Presenter(s):Barend M.E. Mees, MD, PhD | |
View Slides in PDF | |
4:06 PM - 4:11 PM | Health Care Literacy In Vascular Patients Is Inadequate: Do We Need Better Ways To Inform Patients |
Presenter(s):Olivier H.J. Koning, MD, PhD | |
View Slides in PDF | |
4:12 PM - 4:17 PM | What Is The Patient’s Compensation System Law: Where Is It In Effect; How Will It Help End The Malpractice Problem, Help Patients And Doctors To Be Treated Fairly And Cut Health Care Costs |
Presenter(s):O. William Brown, MD, JD | |
View Slides in PDF | |
4:18 PM - 4:23 PM | How Vascular Surgeons And Specialists Should Negotiate Contracts With Hospitals, Employers Or Partners: Tips And Tricks |
Presenter(s):Hillel Presser, Esq., MBA | |
View Slides in PDF | |
4:24 PM - 4:29 PM | Vascular Surgery Patients Readmissions: What Can And Cannot Be Modified And Why Financial Penalties For Many Of Them Are Unfair |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
4:30 PM - 4:35 PM | How To Make EVAR More Cost Effective And Profitable For Hospitals In Today’s Health Care Environment |
Presenter(s):W. Charles Sternbergh III, MD | |
View Slides in PDF | |
4:36 PM - 4:41 PM | Tips And Tricks On How Vascular Surgeons Can Fairly Maximize Collections And Income In A Practice Or An Academic Setting |
Presenter(s):Alan M. Graham, MD | |
View Slides in PDF | |
4:42 PM - 4:47 PM | What The FDA Is Doing To Facilitate Access To New Devices Rapidly And With Assured Safety And Effectiveness – In Both The Civilian And Military Spheres |
Presenter(s):Kenneth J. Cavanaugh, Jr., PhD / J. Pablo Morales, MD / Brian Pullin, MD | |
View Slides in PDF | |
4:48 PM - 4:53 PM | When Do I Need A Physician Sponsored Investigative Device Exemption (PSIDE) And How Do I Get It |
Presenter(s):Dorothy B. Abel, BSBME | |
View Slides in PDF | |
4:54 PM - 4:59 PM | Tips And Tricks To Make A PSIDE Affordable |
Presenter(s):Carlos H. Timaran, MD | |
View Slides in PDF | |
5:00 PM - 5:06 PM | Panel Discussion |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Wednesday
SESSION 38:
ISSUES: PUBLISHING MDs’ RESULTS; RESEARCH TIPS; EVIDENCE BASED MEDICINE; RCTs; GUIDELINES; ACA; DISHONEST WITNESSES; VQIs AND SOCIETIES
Moderators:Anton N. Sidawy, MD, MPH / Ronald M. Fairman, MD
|
|
x | |
5:06 PM - 5:11 PM | Preferential Funding For Primary Care vs. Specialty Care And Penalties For Readmissions (As Promoted In The ACA) Are Bad For Patients And Society And Will Not Decrease Costs |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Slides in PDF | |
5:12 PM - 5:17 PM | Publishing Vascular Surgeons’ Mortality Results In The Public Press Can Be A Disaster For The Surgeon And Bad For Patient Care: The UK Experience |
Presenter(s):Ian Loftus, MD | |
View Slides in PDF | |
5:18 PM - 5:23 PM | Issues In Planning And Interpreting Small Trials: How To Make Their Data Meaningful |
Presenter(s):Charles C. Miller, PhD | |
View Slides in PDF | |
5:24 PM - 5:29 PM | How To Get Access To Population Based Datasets |
Presenter(s):Todd R. Vogel, MD, MPH | |
View Slides in PDF | |
5:30 PM - 5:35 PM | The Tyranny Of p Values: The Importance Of Knowing The Details And Flaws In The Holy Grail Of RCTs |
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd | |
View Slides in PDF | |
5:36 PM - 5:41 PM | The New SVS Practice Guidelines For Lower Extremity Occlusive Disease: Key Take Home Messages And How They Prevent Over Usage Of SFA Stents |
Presenter(s):Frank B. Pomposelli, MD / Michael S. Conte, MD | |
View Slides in PDF | |
5:42 PM - 5:47 PM | Validity Of The New SVS Lower Extremity Threatened Limb Classification System: The WIFI System (Wound Ischemia And Foot Infection): It Allows Prediction Of Poor Outcomes With CLI Treatment |
Presenter(s):Marc L. Schermerhorn, MD / Joseph L. Mills, MD | |
View Slides in PDF | |
5:48 PM - 5:53 PM | What To Do When Physician Expert Witnesses Provide False Testimony Against You |
Presenter(s):O. William Brown, MD, JD | |
View Slides in PDF | |
5:54 PM - 5:59 PM | VQI In A Community Hospital: How It Succeeded In Improving Vascular Care And Resolving Harmful Turf Issues |
Presenter(s):Tej M. Singh, MD, MBA | |
View Slides in PDF | |
6:00 PM - 6:05 PM | DEBATE: Positive Value Of VQI Initiatives |
Presenter(s):Larry W. Kraiss, MD | |
View Slides in PDF | |
6:06 PM - 6:11 PM | DEBATE: Limitations And Possible Downsides Of VQI Initiatives |
Presenter(s):Kenneth Ouriel, MD, MBA | |
View Slides in PDF | |
6:12 PM - 6:17 PM | How Vascular Societies Should Prevent Risk Averse Behavior Of Surgeons And Gaming The System For The Benefit Of Surgeons And To The Detriment Of Patients: Do The Societies Do It Well |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Slides in PDF | |
6:18 PM - 6:25 PM | Panel Discussion End of Program E |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Wednesday
SESSION 39:
MORE NEW DEVELOPMENTS RELATING TO THORACIC AORTA AND AORTIC DISSECTIONS
Moderators:Germano Melissano, MD / Michael J. Jacobs, MD
|
|
x | |
6:45 AM - 6:50 AM | How Often Are Additional Procedures (Open Or Endo) Required After An Open Ascending Aortic Repair Of A Type A Aortic Dissection (TAAD) |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
6:57 AM - 7:02 AM | Open Retrograde Access To Branch Arteries As A Bailout For Failed Antegrade Access During F/BEVAR |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
7:03 AM - 7:08 AM | Total Arch Replacement For Aortic Dissections: Value Of Frozen Elephant Trunk Procedures With EVITA, Jotec Or Thoraflex Hybrid (Vascutek) Grafts |
Presenter(s):Aamir S. Shah, MD / Ali Khoynezhad, MD, PhD | |
View Slides in PDF | |
7:15 AM - 7:20 AM | DEBATE: Branched Grafts Are The Best Endovascular Method To Treat Arch Aneurysms And TAAAs: Parallel Grafts Have Disadvantages |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
7:21 AM - 7:26 AM | DEBATE: Disadvantages Of Off-The-Shelf And Patient Specific Branched Grafts: Parallel Grafts Are Better Solutions |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Slides in PDF | |
7:27 AM - 7:32 AM | Pitfalls In F/BEVAR And How To Deal With Them |
Presenter(s):Götz M. Richter, MD, PhD | |
View Slides in PDF | |
7:33 AM - 7:38 AM | PET CT With 18F-FDG Can Predict Late Aortic Complications After TEVAR For TBADs |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
View Slides in PDF | |
7:39 AM - 7:44 AM | Influence Of Respiratory And Cardiac Induced Movement On Precise Aortic Arch Endograft Deployment |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
View Slides in PDF | |
7:45 AM - 7:51 AM | Panel Discussion |
6:51 PM - 6:56 AM | Clinical Outcomes Of TBADs In Patients With Connective Tissue Diseases (Marfans, Loeys-Dietz, Etc.) Are Worse Than In Those Without |
Presenter(s):Richard G.J. Gibbs, FRCS | |
View Slides in PDF | |
7:09 PM - 7:14 PM | MR Elastography To Characterize The Aortic Wall: Implications For The Design And Sizing Of Ascending Aortic Devices |
Presenter(s):Rachel E. Clough, MD, PhD | |
View Slides in PDF | |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Wednesday
SESSION 40:
MORE TOPICS RELATING TO THE ASCENDING AORTA, THE ARCH AND PARALLEL GRAFTS
Moderators:Rodney A. White, MD / Mario L. Lachat, MD
|
|
x | |
7:52 AM - 7:57 AM | Further Experience With Longer Follow-Up On Arch Chimney Grafts: When Do They Work And Pitfalls To Avoid So They Do Not Fail |
Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD | |
View Slides in PDF | |
7:58 AM - 8:03 AM | In Vitro Analysis Of Parallel Grafts: How They Work And Why They Fail: New Lessons Learned |
Presenter(s):Jan D. Blankensteijn, MD | |
View Slides in PDF | |
8:04 AM - 8:09 AM | Tips And Tricks To Facilitate Successful Use Of Branched Endografts And Pitfalls To Avoid |
Presenter(s):Martin J. Austermann, MD | |
View Slides in PDF | |
8:10 AM - 8:15 AM | Use Of The VORTEC Technique – A Clampless, Sutureless Anastomosis Using An Endograft Connector To Revascularize The Supra-Aortic Branches Simplifies Hybrid Arch Repairs: Technique And Results |
Presenter(s):Zoran Rancic, MD, PhD / Mario L. Lachat, MD | |
View Slides in PDF | |
8:16 AM - 8:21 AM | Single Innominate Chimney Grafts: When Is It A Good Choice And When Is It Not |
Presenter(s):Boonprasit Kritpracha, MD | |
View Slides in PDF | |
8:22 AM - 8:27 AM | Various Cardiac Access Routes To Treat Ascending Aortic And Arch Lesions: Advantages And Limitations |
Presenter(s):Tilo Kölbel, MD, PhD | |
View Slides in PDF | |
8:28 AM - 8:33 AM | Redo Procedures After TEVAR: Why Needed; Tips, Tricks And Results; Value Of A Self-Expanding Extra Large Stent (Jotec E-XL) |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | Retrograde Aortic Dissection After TEVAR: Incidence, Risk Factors, Precautions And Treatment |
Presenter(s):Joseph S. Coselli, MD / Ourania Preventza, MD | |
View Slides in PDF | |
8:40 AM - 8:46 AM | Panel Discussion |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Wednesday
SESSION 41:
MORE TOPICS RELATED TO FENESTRATED, BRANCHED AND PARALLEL GRAFTS; JUXTARENAL AAAs AND TAAAs
Moderators:Eric L.G. Verhoeven, MD, PhD / Timothy A.M. Chuter, DM
|
|
x | |
8:46 AM - 8:51 AM | Optimal Choice Of Bridging Stent-Grafts For F/BEVAR: What Is Available And Which Is Best |
Presenter(s):Richard G. McWilliams, FRCR, EBIR | |
View Slides in PDF | |
8:52 AM - 8:57 AM | 3 Or 4 FEVAR vs. Standard FEVAR With 2 Fenestrations And A Scallop For The SMA: Advantages, Limitations And Differing Results |
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
8:58 AM - 9:03 AM | How To Avoid Brachial Or Axillary Access With Complex AAA Repairs: Tips And Tricks |
Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD | |
View Slides in PDF | |
9:04 AM - 9:09 AM | DEBATE: EVAR With Short (8-15 mm) Necks Are Best Treated With Standard EVAR Using Newer Endograft Devices |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
9:10 AM - 9:15 AM | DEBATE: EVAR With Short (8-15 mm) Necks Are Best Treated By FEVAR |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
9:16 AM - 9:21 AM | Strategies And Techniques To Treat Short Proximal Neck AAAs |
Presenter(s):Giovanni Torsello, MD | |
View Slides in PDF | |
9:22 AM - 9:28 AM | Panel Discussion |
Moderator(s): Jason T. Lee, MD / Stephan Haulon, MD | |
9:28 AM - 9:33 AM | DEBATE: Endovascular Methods Are Now The Best Treatment For Most TAAAs |
Presenter(s):Timothy A.M. Chuter, DM | |
View Slides in PDF | |
9:34 AM - 9:39 AM | DEBATE: Not So: Open Repair Is Still The Best Treatment For Many (Possibly Most) TAAAs |
Presenter(s):Hazim J. Safi, MD | |
View Slides in PDF | |
9:40 AM - 9:45 AM | Eight Simple Markers That Can Suggest The Presence Of A Thoracic Aneurysm |
Presenter(s):John A. Elefteriades, MD | |
View Slides in PDF | |
9:46 AM - 9:51 AM | With complicated TBADs, Are The Hard Indications For Treatment (Rupture And Malperfusion) Associated With Higher Mortality And Morbidity Than The Soft Indications (Pain And Persistent Hypertension) |
Presenter(s):Matt M. Thompson, MD | |
View Slides in PDF | |
9:52 AM - 9:57 AM | Update On Tips And Tricks For Treating Arterial Complications Of Ehlers-Danlos Syndrome, Marfan’s And Other Connective tissue Disorders: Endografts Can Be Valuable |
Presenter(s):James H. Black, III, MD | |
View Slides in PDF | |
9:58 AM - 10:03 AM | Accurate Placement Of Thoracic Endografts Parallel To The Aortic Arch By Controlling Device Angulation Improves Outcomes: Techniques For Doing So |
Presenter(s):Ali Azizzadeh, MD | |
View Slides in PDF | |
10:04 AM - 10:09 AM | Purse-String Temporary Closure Of Femoral Access Sites During Complex EVARs (B/FEVAR) To Decrease Limb And Spinal Cord Ischemia |
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
10:10 AM - 10:15 AM | How To Identify Healthy Aorta To Land The Ends Of Aortic Endografts With Complex AAAs: Is It Always Necessary To Do So |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
10:16 AM - 10:23 AM | Panel Discussion |
10:23 AM - 10:38 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Wednesday
SESSION 42:
UPDATE ON THE STATUS OF MULTILAYER FLOW MODULATING (MLFM) STENTS FOR THE TREATMENT OF AORTIC ANEURYSMS AND DISSECTIONS
Moderators:Frank J. Veith, MD / Clifford J. Buckley, MD
|
|
x | |
10:38 AM - 10:43 AM | The MLFM Stent Is A Better Treatment For TAAAs Than F/BEVAR, Parallel Grafts, Hybrid Repairs And Full Open Repair And Here Is The Data |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Slides in PDF | |
10:44 AM - 10:49 AM | 4-Year Experience With MLFM Stents For The Treatment Of Complex Aortic Aneurysms: When They Do Not Work |
Presenter(s):Thomas Larzon, MD, PhD | |
View Slides in PDF | |
10:50 AM - 10:55 AM | 4-Year Results Of The MLFM Stent For The Treatment Of Complex Aortic Aneurysms: From The French Registry |
Presenter(s):Claude D. Vaislic, MD | |
View Slides in PDF | |
10:56 AM - 11:01 AM | Why I Am Still Somewhat Skeptical |
Presenter(s):Mark F. Fillinger, MD | |
View Slides in PDF | |
11:02 AM - 11:07 AM | For What Aortic Lesions Is The MLFM Stent An Effective Treatment: Tips And Tricks To Make It Work |
Presenter(s):Erno Remsey-Semmelweis, MD | |
View Slides in PDF | |
11:08 AM - 11:13 AM | When Is The MLFM Stent An Effective Treatment Of Arch And Ascending Aortic Aneurysms And When Is It Not: A Partly Positive View And Experience |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Slides in PDF | |
11:14 AM - 11:19 AM | Treatment Of Aortic Dissection And Complex TAAAs With The MLFM Stent: Experience In More Than 30 Patients |
Presenter(s):Victor S. Costache, MD, PhD | |
View Slides in PDF | |
11:20 AM - 11:25 AM | Update On The MLFM Stent For Treatment Of Complex Aortic Aneurysms: Is Its Star Rising |
Presenter(s):Frans L. Moll, MD, PhD | |
View Slides in PDF | |
11:26 AM - 11:31 AM | Role Of Multilayer Uncovered Stents For The Successful Treatment Of TAAAs: The Concept Works: When And How |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
View Slides in PDF | |
11:32 AM - 11:37 AM | Is The MLFM Stent A Valid Treatment In High Risk 80- And 90-Year Olds With Paravisceral And TAAAs |
Presenter(s):Arno von Ristow, MD | |
View Slides in PDF | |
11:38 AM - 11:43 AM | The MLFM Stent Has A Role In The Treatment Of Complex Aortic Aneurysms: What Is It And What More Do We Need To Know |
Presenter(s):Christos D. Liapis, MD | |
View Slides in PDF | |
11:44 AM - 11:49 AM | Histopathological Findings In Patients And Animals After Implantation Of MLFM Stents: Characteristics Of Endothelialization And Thrombus Formation |
Presenter(s):Antoine Alves, Dr. | |
View Slides in PDF | |
11:50 AM - 12:00 PM | Panel Discussion Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Wednesday
SESSION 43:
MORE TOPICS RELATED TO AAAs, THE ABDOMINAL AORTA AND EVAR
Moderators:Roger M. Greenhalgh, MD / Kenneth Ouriel, MD, MBA
|
|
x | |
1:00 PM - 1:05 PM | Comparative Changes In Aortic Neck Morphology After EVAR And Open AAA Repair: Is Open Repair Really That Good: From The DREAM Trial |
Presenter(s):Jan D. Blankensteijn, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | EVAR Strategy To Deal With A Proximal Neck Over 35 mm In Diameter |
Presenter(s):Jacques Busquet, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Patterns Of Rupture Of AAAs After EVAR: How Does It Differ From Rupture Patterns In Untreated AAAs |
Presenter(s):Markus K. Furrer, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Differences In AAA Size At Rupture Between Patients Treated By EVAR And Those Not So Treated |
Presenter(s):James May, MD, MS, FRACS, FACS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Progress In 18F-FDG Uptake On PET CT And Other Markers In Predicting AAA Rupture Risk |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Current Indications For Repairing Small AAAs (<5 cm) By EVAR; By Open Repair: Has Anything Changed |
Presenter(s):Ronald M. Fairman, MD | |
View Slides in PDF | |
1:36 PM - 1:42 PM | Panel Discussion |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Wednesday
SESSION 44:
RECORDED LIVE COMPLEX ENDOVASCULAR CASES: COMPLICATIONS WITH SOLUTIONS
|
|
x | |
1:42 PM - 1:54 PM | Single Session Pharmacomechanical Venous Thrombolysis |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Slides in PDF | |
1:54 PM - 2:06 PM | Stent Graft-Induced New Entry (SINE) After TEVAR For Stanford Type B Aortic Dissection |
Presenter(s):Donald D. Lee, MD | |
View Slides in PDF | |
2:06 PM - 2:18 PM | Extensive Aorto-Iliac Occlusive Disease: A Modified CERAB Technique |
Presenter(s):Andrew Holden, MBChB | |
View Slides in PDF | |
2:18 PM - 2:30 PM | Hydrodynamic Boost: A Novel Re-Entry Technique In Distal BTK Vessel: When And How To Do It |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
2:30 PM - 2:42 PM | CLI Patient Following 2 Failed Bypass Surgery Procedures Who Was Told The Next Step Would Be Amputation |
Presenter(s):Thomas Zeller, MD | |
View Slides in PDF | |
2:42 PM - 2:54 PM | Endovascular Techniques To Restore The Femoral Artery After Failed Bypass |
Presenter(s):Andrej Schmidt, MD | |
View Slides in PDF | |
2:54 PM - 3:02 PM | General Discussion |
3:02 PM - 3:17 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Wednesday
SESSION 45:
INNOVATIVE TECHNIQUES FOR CHALLENGING PERIPHERAL LESIONS
|
|
x | |
3:17 PM - 3:25 PM | Latest Techniques For Aortoiliac Reconstruction Of TASC C And D Lesions: Are Covered Stents The Solution |
Presenter(s):Koen Deloose, MD | |
View Slides in PDF | |
3:25 PM - 3:37 PM | Recorded Case: Chimney Reconstruction Of A Complete Aortoiliac Occlusion (Leriche Syndrome) |
Presenter(s):Peter C.J. Goverde, MD / Andrej Schmidt, MD | |
View Slides in PDF | |
3:37 PM - 3:45 PM | Patient Specific Approaches For Femoropopliteal Lesions: Stents, Atherectomy And Drug-Eluting Devices |
Presenter(s):D. Christopher Metzger, MD | |
View Slides in PDF | |
3:45 PM - 3:57 PM | Recorded Case: Recanalization Of A Severely Calcified SFA Occlusion With Interwoven Nitinol Stents |
Presenter(s):Andrej Schmidt, MD / M. Ulrich, MD | |
3:57 PM - 4:05 PM | The Angiosome Concept For BTK Interventions: How to Translate It Into Clinical Practice |
Presenter(s):Giancarlo Biamino, MD, PhD | |
View Slides in PDF | |
4:05 PM - 4:17 PM | Recorded Case: Recanalization Of A Tibioperoneal Trunc Occlusion With DES Via Retrograde Peroneal Access |
Presenter(s):Andrej Schmidt, MD / C. Piorkowski, MD | |
4:17 PM - 4:25 PM | Current And Future Concepts To Improve Outcome Of BTK-Interventions In CLI |
Presenter(s):Ramon L. Varcoe, MD | |
View Slides in PDF | |
4:25 PM - 4:37 PM | Panel Discussion |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Wednesday
SESSION 46:
MORE TOPICS RELATED TO AAAs, THE AORTA AND EVAR
Moderators:James May, MD, MS, FRACS, FACS / Enrico Ascher, MD
|
|
x | |
4:37 PM - 4:42 PM | How To Manage EVAR With Small Distal Aortas: When Are Bifurcated Grafts OK And When Is An Aorto-Uni-Iliac Device Needed |
Presenter(s):David J. Minion, MD | |
View Slides in PDF | |
4:43 PM - 4:48 PM | Screening For AAAs In Women: When Should They Be Screened And When Should They Not Be |
Presenter(s):Andrew N. Nicolaides, MS, FRCS / Mohsen Chabok, MD, MSc | |
View Slides in PDF | |
4:49 PM - 4:54 PM | Is EVAR Good Treatment For Young (<60) AAA Patients: When Is Open Repair The Best Option |
Presenter(s):Thomas L. Forbes, MD | |
View Slides in PDF | |
4:55 PM - 5:00 PM | DEBATE: Off-Label Use Of EVAR Devices May Have Satisfactory Early Outcomes, But Long-Term Outcomes Are Guarded |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
5:01 PM - 5:06 PM | DEBATE: Not So: Off-Label Use Of EVAR Devices Is Sometimes Justified And Does Not Yield Higher Long-Term Failure Rates If Certain Requirements Are Fulfilled |
Presenter(s):B. Patrice Mwipatayi, FRACS | |
View Slides in PDF | |
5:07 PM - 5:12 PM | What Has Changed Since Our Oft Quoted 2011 Circulation Article: I Now Believe Some Off-Label Use Of EVAR Devices Is Justified And Safe |
Presenter(s):Andres Schanzer, MD | |
View Slides in PDF | |
5:13 PM - 5:19 PM | Panel Discussion |
Moderator(s): Thomas L. Forbes, MD / Ali F. AbuRahma, MD | |
5:19 PM - 5:24 PM | Has EVAR Led To A Decrease In AAA Rupture Over The Last 2 Decades Or Has It Just Led To More Unnecessary AAA Repairs |
Presenter(s):James May, MD, MS, FRACS, FACS | |
View Slides in PDF | |
5:25 PM - 5:30 PM | The Iliac Seal Zone In EVAR: Its Dynamics And Clinical Consequences |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
5:31 PM - 5:36 PM | Diminished Sexual Function In AAA Patients Occurs After EVAR As Well As Open Repair |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
View Slides in PDF | |
5:37 PM - 5:42 PM | Are Newer EVAR Devices Better Than The Previous Ones: Do They Produce Better Results Or Are They Just Easier To Use |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Slides in PDF | |
5:43 PM - 5:48 PM | Patient Reported Quality Of Life (QOL) Measures After Open And Endo AAA Repair: Which Is Better |
Presenter(s):Robert J. Hinchliffe, MD | |
View Slides in PDF | |
5:49 PM - 5:55 PM | Panel Discussion End of Program F |
END OF SESSION 46 | |
Thursday, November 19, 2015
Print Entire 2015 Program:
|
|
SESSION 47 SCHEDULE | |
Thursday
SESSION 47:
NEW TECHNIQUES, TECHNOLOGY AND CONCEPTS
Moderators:Keith D. Calligaro, MD / Nicholas J.W. Cheshire, MD
|
|
x | |
6:45 AM - 6:50 AM | Implantable Microtechnology To Remotely Monitor Bypass Function |
Presenter(s):Richard F. Neville, MD | |
View Slides in PDF | |
6:51 AM - 6:56 AM | MR Based 3D Imaging In Peripheral Vascular Interventions: A Way To Reduce Radiation Exposure |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Slides in PDF | |
6:57 AM - 7:02 AM | Innovative Approaches To Cell Therapy For CLI And Bold MRI To Measure Calf Perfusion To Monitor Its Effects |
Presenter(s):Bijan Modarai, PhD, FRCS | |
View Slides in PDF | |
7:03 AM - 7:08 AM | Percussion Crossing Device (The Piculet Hammer) To Facilitate Crossing Heavily Calcified CTOs |
Presenter(s):Max Amor, MD | |
View Slides in PDF | |
7:09 AM - 7:14 AM | Shockwave Lithoplasty: A Balloon That Transmits Shockwaves To Crack Heavily Calcified Lesions And Then Dilate Them (PTA) |
Presenter(s):Andrew Holden, MBChB / Marianne Brodmann, MD | |
View Slides in PDF | |
7:15 AM - 7:20 AM | Variable Curve Directable Guide Sheath From Aptus To Facilitate Other Challenging Endovascular Procedures |
Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD | |
View Slides in PDF | |
7:21 AM - 7:26 AM | What Has Anatomy And Pathology Taught Us About Renal Denervation: Where Are The Nerves That Need To Be Destroyed And What Damage Can Radiofrequency Do To The Renal Artery |
Presenter(s):Renu Virmani, MD | |
View Slides in PDF | |
7:27 AM - 7:32 AM | Human Tissue Engineered Arterial Grafts Are Finally Working As Lower Extremity Bypasses And Dialysis Access: Why And Prospects For The Future |
Presenter(s):Jeffrey H. Lawson, MD, PhD | |
View Slides in PDF | |
7:33 AM - 7:38 AM | What Is New In Better Balloon Angioplasty Catheters: Can They Inflate In A Curved Configuration |
Presenter(s):Timothy A.M. Chuter, DM | |
View Slides in PDF | |
7:39 AM - 7:44 AM | Value Of 3D Printing To Create A Vascular Phantom To Facilitate And Improve Complex AAA Repairs |
Presenter(s):Benjamin W. Starnes, MD | |
View Slides in PDF | |
7:45 AM - 7:50 AM | How To Non-Invasively Measure Blood Flow And Lesion Significance In Coronary Arteries With CTA: Fractional Flow Reserve (FFR) Is Valuable There: Will It Be In Other Arterial Beds And How Will It Work |
Presenter(s):Christopher K. Zarins, MD | |
View Slides in PDF | |
7:51 AM - 7:58 AM | Panel Discussion |
END OF SESSION 47 | |
SESSION 48 SCHEDULE | |
Thursday
SESSION 48:
ADVANCES IN BRANCHED AND FENESTRATED EVAR (F/BEVAR) AND PARALLEL GRAFTS FOR LESIONS NEAR TO OR IN THE VISCERAL AORTA
Moderators:Timothy A.M. Chuter, DM / Frank J. Veith, MD
|
|
x | |
7:58 AM - 8:03 AM | How Durable Are F/B Endografts For Various Aortic Lesions Including TAAAs |
Presenter(s):Tara M. Mastracci, MD | |
View Slides in PDF | |
8:04 AM - 8:09 AM | How Durable Are Parallel Grafts (Chimney And Periscope Grafts) For Various Aortic Lesions Including TAAAs |
Presenter(s):Mario L. Lachat, MD | |
View Slides in PDF | |
8:10 AM - 8:15 AM | Parallel Grafts (Chimneys, Etc.) Do Work As Proven By The PERICLES Registry: Midterm Results With A Variety Of Devices |
Presenter(s):Konstantinos P. Donas, MD / Jason T. Lee, MD | |
View Slides in PDF | |
8:16 AM - 8:21 AM | Parallel Grafts Are Valuable Even If F/BEVAR Is Available |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
View Slides in PDF | |
8:22 AM - 8:27 AM | Status Of Sandwich Grafts For Aneurysms Involving The Visceral Segment: What Are The Midterm Results – Single Center And Multicenter |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Slides in PDF | |
8:28 AM - 8:33 AM | Sandwich (Parallel) Grafts Work For TAAAs: How Much Oversizing Of The Main Endograft And Overlap Of The Branch Grafts Are Required |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | Failure Modes Of Chimney And Other Parallel Grafts And How They May Be Overcome |
Presenter(s):Claude Mialhe, MD | |
View Slides in PDF | |
8:40 AM - 8:45 AM | Inner Branched Endografts: A Better Solution For F/BEVAR Than Other Configurations For Treating Visceral Aortic Segment Lesions |
Presenter(s):Marcelo Ferreira, MD | |
View Slides in PDF | |
8:46 AM - 8:51 AM | Role Of Off-The-Shelf Fenestrated And Branched Grafts For Treating AAAs Involving The Visceral Segment Of The Aorta (Cook P-Branch And T-Branch) Devices: What Percent Of Patients Are Suitable |
Presenter(s):Mark A. Farber, MD | |
View Slides in PDF | |
8:52 AM - 8:57 AM | Patient Specific And Off-The-Shelf Devices Will Not Suffice For Many Patients With AAAs Involving The Visceral Aortic Segment: What Is The Solution |
Presenter(s):David J. Minion, MD | |
View Slides in PDF | |
8:58 AM - 9:05 AM | Panel Discussion |
9:05 AM - 9:20 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 48 | |
SESSION 49 SCHEDULE | |
Thursday
SESSION 49:
MORE TOPICS RELATED TO F/BEVAR AND PARALLEL GRAFTS FOR TREATMENT OF AAAs AND TAAAs
Moderators:Mark A. Adelman, MD / Frans L. Moll, MD, PhD
|
|
x | |
MORE ON THORACOABDOMINAL ANEURYSMS (TAAAS) | |
9:20 AM - 9:25 AM | For Which TAAA Patient Is No Repair The Best Option: Better Than A B/FEVAR |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
9:26 AM - 9:31 AM | For Which TAAA Patient Is An Open Repair The Right Option: In What Type Of Institution |
Presenter(s):Richard P. Cambria, MD | |
View Slides in PDF | |
9:32 AM - 9:37 AM | For Which TAAA Patient Is A F/BEVAR The Best Option: In What Type Of Institution |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
9:38 AM - 9:43 AM | In Which TAAA Patient Is A Parallel Graft Procedure With All Chimney And Periscope Grafts Or A Partially Hybrid Procedure The Best Treatment: What Are The Disadvantages Or Limitations |
Presenter(s):Mario L. Lachat, MD | |
View Slides in PDF | |
9:44 AM - 9:49 AM | In Which TAAA Patient Is A Sandwich Graft The Best Option: Advantages, Disadvantages And Limitations |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Slides in PDF | |
9:50 AM - 9:55 AM | How To Detect And Best Manage Complications Of F/BEVAR: They Are Part Of The Game |
Presenter(s):Luis A. Sanchez, MD | |
View Slides in PDF | |
9:56 AM - 10:01 AM | Update On The French Countrywide Comparison Of Open Repair vs. F/BEVAR For The Treatment Of AAAs Involving The Visceral Aortic Segment: New 4-Year Results |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
View Slides in PDF | |
10:02 AM - 10:10 AM | Panel Discussion |
Moderator(s): Evan C. Lipsitz, MD / ShenMing Wang, MD, PhD | |
10:11 AM - 10:16 AM | Staged Hybrid Repair Of Extensive TAAA Especially Those Associated With Aortic Dissections: Another Option With Advantages |
Presenter(s):Gilbert R. Upchurch, Jr., MD | |
View Slides in PDF | |
10:17 AM - 10:22 AM | A New Manifold Branched Endograft Device For Treating TAAAs And Other Complex Aortic Lesions: Concept, Advantages, Initial Clinical Experience Under A PSIDE |
Presenter(s):Patrick W. Kelly, MD | |
View Slides in PDF | |
10:23 AM - 10:28 AM | Tips And Tricks To Facilitate Upper Extremity Access For F/BEVAR And Parallel Graft Insertion And How To Avoid Complications |
Presenter(s):Carlos H. Timaran, MD | |
View Slides in PDF | |
10:29 AM - 10:34 AM | How Physicians Can Modify Gore C3 Devices To Facilitate F/BEVAR In Urgent TAAAs And Pararenal AAAs: Midterm Clinical Results |
Presenter(s):Wayne W. Zhang, MD | |
View Slides in PDF | |
10:35 AM - 10:40 AM | Can Parallel Graft EVAR Work In A Community Hospital Setting: Advantages And Limitations |
Presenter(s):Jeffrey Y. Wang, MD | |
View Slides in PDF | |
10:41 AM - 10:46 AM | Advances In Fenestrated And Branched Endografts To Simplify Their Use And Improve Results Including Methods To Minimize Lower Extremity Ischemia With Prolonged Sheath Insertion |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
10:47 AM - 10:52 AM | Midterm Results Following Hybrid (Octopus) Repair Of Complex TAAAs With And Without CT Disorders: It Is Still An Option In Experienced Centers |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Slides in PDF | |
10:53 AM - 11:00 AM | Panel Discussion |
END OF SESSION 49 | |
SESSION 50 SCHEDULE | |
Thursday
SESSION 50:
IN TRIBUTE TO OUR MILITARY: TOPICS RELATED TO MILITARY TRAUMA AND VASCULAR SURGERY (7 And 10-MINUTE TALKS)
Moderators:Norman M. Rich, MD, FACS, DMCC / Eric Elster, MD
|
|
x | |
11:00 AM - 11:07 AM | Long-Term Results Of Vascular Injuries And Repairs After The Lebanon-Israel War |
Presenter(s):Samy S. Nitecki, MD | |
View Slides in PDF | |
11:08 AM - 11:15 AM | Implementation Of A Vascular Trauma Course For Military And Civilian Surgeons In Germany: Important For Dealing With Combat And Terror Situations |
Presenter(s):Michael Engelhardt, MD / Afshin Assadian, MD | |
View Slides in PDF | |
11:16 AM - 11:23 AM | Novel Off-The-Shelf Conduits For Use With Military Vascular Injuries: The Humacyte Graft |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
View Slides in PDF | |
11:24 AM - 11:34 AM | Medical Lessons From War: Turning Past Data Into Future Decisions And Guidelines |
Presenter(s):Eric Elster, MD | |
View Slides in PDF | |
11:35 AM - 11:50 AM | A Serious And Possible Limiting Problem With Visual Impairment From Protracted Space Flights: Increased Intracranial Pressure As A Possible Cause And What Can Be Done About It |
Presenter(s):Lee M. Morin, MD, PhD | |
View Slides in PDF | |
11:50 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 50 | |
SESSION 51 SCHEDULE | |
Thursday
SESSION 51:
NEW DEVELOPMENTS IN THE MANAGEMENT OF RUPTURED AAAs (RAAAs): IT’S STILL CONTROVERSIAL
Moderators:Benjamin W. Starnes, MD / Jean-Pierre Becquemin, MD, FRCS
|
|
x | |
THE RAAA CONTROVERSY | |
1:00 PM - 1:05 PM | Level 1 Evidence (IMPROVE Trial, Etc.) Shows That EVAR Has No Survival Advantage Over Open Repair For RAAAs: The Outcome Of Treatment Depends On Bad Neck Anatomy More Than Treatment Method |
Presenter(s):Janet T. Powell, MD, PhD / Robert J. Hinchliffe, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Open Repair Is As Good As EVAR For RAAAs: The AJAX Trial Proves It |
Presenter(s):Willem Wisselink, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | The IMPROVE And Other RCTs Reach A Misleading Main Conclusion – EVAR Has A Lower Mortality Than Open Repair For RAAAs If It Can Be Done |
Presenter(s):Frank J. Veith, MD / Martin Malina, MD, PhD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | The Main Conclusions Of IMPROVE AJAX And ECAR - RCTs Comparing EVAR And Open Repair For RAAAs Are Incorrect: The Proof: 100% Of RAAAs Can Be Treated By EVAR Or Chimney EVAR With Low Early Mortality And Turn Down Rates |
Presenter(s):Thomas Larzon, MD, PhD / Dieter O. Mayer, MD / Mario L. Lachat, MD / Johnny Steuer, MD, PhD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | With RAAAs, Patients With Hostile Neck Anatomy Do Not Have Worse Outcomes Than Those With Favorable Anatomy: Our Data Differs From Those In The IMPROVE Trial |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | DEBATE: Midterm Re-Interventions And Survival Is No Better After EVAR For RAAAs Than After Open Repair |
Presenter(s):Willem Wisselink, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | DEBATE: Midterm And Late Survival And Quality Of Life After EVAR For RAAAs Are Better Than After Open Repair |
Presenter(s):Dieter O. Mayer, MD / Zoran Rancic, MD, PhD / Mario L. Lachat, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | Improving Nationwide Care For RAAAs: Lessons From The US And The UK: The Proportion Of Patients Reaching The Hospital But Not Treated Invasively (The Turn Down Rate) Is Shocking! |
Presenter(s):Matt M. Thompson, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | Late Breaking (1-Year) Results From The IMPROVE Trial Shows That An EVAR Strategy May Be Better In Some Ways Than Open Repair For RAAAs |
Presenter(s):Robert J. Hinchliffe, MD / Janet T. Powell, MD, PhD | |
View Slides in PDF | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 51 | |
SESSION 52 SCHEDULE | |
Thursday
SESSION 52:
MORE TOPICS RELATED TO RAAAs AND TAAAs
Moderators:Gregg S. Landis, MD / Alan B. Lumsden, MD, FACS
|
|
x | |
RAAA RELATED TOPICS | |
2:00 PM - 2:05 PM | Asthma And The Drugs Used In Its Treatment Increases The Rupture Risk Of AAAs |
Presenter(s):Jes S. Lindholt, MD | |
View Slides in PDF | |
2:06 PM - 2:11 PM | What Are The Risk Factors For AAA Expansion And Rupture: Do Statins Help |
Presenter(s):Janet T. Powell, MD, PhD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Which Patients With RAAAs Benefit The Most From EVAR: Tips And Tricks For Doing It Well |
Presenter(s):Manish Mehta, MD, MPH | |
View Slides in PDF | |
2:18 PM - 2:23 PM | Acute Renal Failure Is More Common After Open Repair For RAAAs Than After EVAR |
Presenter(s):Jonathan R. Boyle, MD, FRCS | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Nellix Endografts Can Be Used Effectively To Treat RAAAs: Tips, Tricks, Advantages And Limitations |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Emergency EVAR Should Be The New And Best Standard Of Care For RAAAs: Why |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Open Repair Of RAAAs Is A Bad Option And Here Is Why |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Slides in PDF | |
TAAA RELATED TOPICS | |
2:42 PM - 2:47 PM | A New Preloaded Wire System To Simplify TAAA Branched Endograft Repairs |
Presenter(s):Timothy A. Resch, MD, PhD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | What Is The Role Of Open Surgery For TAAAs And Thoracic Aneurysms In 2015 And Beyond |
Presenter(s):Michael J. Jacobs, MD | |
View Slides in PDF | |
2:54 PM - 3:00 PM | Panel Discussion |
3:00 PM - 3:10 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 52 | |
SESSION 53 SCHEDULE | |
Thursday
SESSION 53:
VASCULAR ROBOTICS AND GUIDANCE SYSTEMS
Moderators:Frans L. Moll, MD, PhD / Vicente Riambau, MD, PhD
|
|
x | |
3:10 PM - 3:15 PM | Progress In The Hansen Magellan Robot Technology For Catheter/Sheath Guidance: Results And How It Improves Procedural Success And Safety To The Patient And Operator |
Presenter(s):Nicholas J.W. Cheshire, MD | |
View Slides in PDF | |
3:16 PM - 3:21 PM | The Magellan Robot System Is Valuable For FEVAR, Carotid And Embolization Procedures |
Presenter(s):Miss Celia Riga, BSc, MBBS, MD, FRCS / Colin D. Bicknell, MD, FRCS | |
View Slides in PDF | |
3:22 PM - 3:27 PM | Benefits From The Magellan Robotic Navigation With 3D Imaging: It Really Helps With Complex Endovascular Procedures |
Presenter(s):Alan B. Lumsden, MD, FACS | |
3:28 PM - 3:33 PM | Lessons Learned From The Magellan Robot Catheter/Sheath Guidance System: Advantages And Limitation: When Is It Valuable And When Is It Essential |
Presenter(s):Barry T. Katzen, MD | |
View Slides in PDF | |
3:34 PM - 3:39 PM | What The ROVER Registry Tells Us About The Magellan Robot System And How It Has Facilitated Endo Procedures That Have Failed Standard Manual Attempts |
Presenter(s):Jean Bismuth, MD | |
View Slides in PDF | |
3:40 PM - 3:45 PM | How The Magellan Robotic System Helps In A Vascular Practice: And How It Improves Results And Efficiency |
Presenter(s):Joseph J. Ricotta II, MD, MS | |
View Slides in PDF | |
3:46 PM - 3:51 PM | The Magellan Robotic System Has Distinct Advantages In Performing Difficult Embolization Procedures: What Are They |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Slides in PDF | |
3:52 PM - 3:57 PM | Robotic Aortic Surgery May Be A Failed Experiment But Robotically Directed Catheters Have A Bright Future In Vascular Surgery: Why |
Presenter(s):Hans M.E. Coveliers, MD, MBA | |
View Slides in PDF | |
3:58 PM - 4:03 PM | Duplex Guidance For Endovascular Interventions In Patients With Renal Insufficiency: Tips And Tricks To Make It Work |
Presenter(s):Natalie A. Marks, MD, RPVI, RVT / Enrico Ascher, MD / Anil P. Hingorani, MD | |
View Slides in PDF | |
4:04 PM - 4:10 PM | Panel Discussion |
END OF SESSION 53 | |
SESSION 54 SCHEDULE | |
Thursday
SESSION 54:
MORE CONTROVERSIES, UPDATES AND NEW CONCEPTS – FENESTRATION IN TBADs; EVAS FOR EVAR; PRE-EVAR EMBOLIZATION; TRAINING TRAUMA SURGEONS, ETC.
Moderators:Luis A. Sanchez, MD / Firas F. Mussa, MD
|
|
x | |
FENESTRATION IN TBAD | |
4:10 PM - 4:15 PM | A New Concept For Treating TBAD After TEVAR By Extensive Fenestration To Equalize True And False Lumen Pressures: And A special New Instrument To Do It Endovascularly: Theory, Technique, Results |
Presenter(s):Juan C. Parodi, MD / Ramon Berguer, MD, PhD | |
View Slides in PDF | |
4:16 PM - 4:21 PM | Role Of Fenestration For TBAD In The TEVAR Era: Management Of TBAD Patients Is Not Simple: Fenestration Is An Important Option For Some Patients: When And How To Do It |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
4:22 PM - 4:27 PM | Cheese Wire Technique To Eliminate An Aortic Dissection Flap In Chronic TBAD Patient: When Needed; Advantages And Limitations |
Presenter(s):Ronald L. Dalman, MD | |
View Slides in PDF | |
4:28 PM - 4:33 PM | An Endovascular Flap Cutting Device To Fenestrate Chronic TBADs: When Is It Needed |
Presenter(s):Jean-Marc Alsac, MD, PhD | |
View Slides in PDF | |
4:34 PM - 4:39 PM | Possible Long-Term Disadvantages Of A Suprarenal Bare Stent With AAA EVAR Endografts |
Presenter(s):Claude Mialhe, MD | |
View Slides in PDF | |
4:40 PM - 4:45 PM | DEBATE: EVAS (Endovascular Aneurysm Sealing) With The Nellix Device Is A Game Changer For Endo AAA Repair |
Presenter(s):Matt M. Thompson, MD | |
View Slides in PDF | |
4:46 PM - 4:51 PM | DEBATE: EVAS With The Nellix Device Is Not A Game Changer For Endo AAA Repair |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
4:52 PM - 4:58 PM | Panel Discussion |
Moderator(s): Michel Makaroun, MD / John B. Chang, MD | |
4:59 PM - 5:04 PM | Clinical Significance In Macrophage Types And Changes In Macrophage Types With Vascular Disease |
Presenter(s):John P. Fletcher, MD | |
View Slides in PDF | |
5:05 PM - 5:10 PM | New Approach To Median Arcuate Ligament Syndrome: Transthoracic Ligament Release And Mesenteric Revascularization: When Should It Be Done (Diagnosis), Technique And Results |
Presenter(s):Enrique Criado, MD, FACS | |
View Slides in PDF | |
VALUE OF PRE-EVAR BRANCH EMBOLIZATION | |
5:11 PM - 5:16 PM | DEBATE: AAA Branch (Lumbar And IMA) Before EVAR Is Seldom Worth The Effort And Has Downsides |
Presenter(s):Richard G. McWilliams, FRCR, EBIR | |
View Slides in PDF | |
5:17 PM - 5:22 PM | DEBATE: Branch Coil Embolization During EVAR Is Worthwhile And Decreases Type 2 Endoleaks: When Should It Be Done |
Presenter(s):Dominique Fabre, MD | |
View Slides in PDF | |
5:23 PM - 5:28 PM | AAA Branch Embolization Before EVAR: Does It Have Value And When Should It Be Done |
Presenter(s):Franco Grego, MD | |
View Slides in PDF | |
TRAINING TRAUMA SURGEONS | |
5:29 PM - 5:34 PM | DEBATE: Why Trauma Surgeons Should Be Trained In Vascular And Endovascular Techniques |
Presenter(s):Charles J. Fox, MD, FACS | |
View Slides in PDF | |
5:35 PM - 5:40 PM | DEBATE: Nonsense: We Don’t Train Trauma Surgeons To Do Procedures For Head Trauma And Should Not Train Them To Do Vascular And Endovascular Procedures |
Presenter(s):Mark A. Adelman, MD | |
View Slides in PDF | |
5:41 PM - 5:46 PM | I Have Changed My Mind: Chimney Grafts And Other Parallel Grafts Have A Role In The Era Of Fenestrated And Branched Endografts: What Is This Role |
Presenter(s):Martin Malina, MD, PhD | |
View Slides in PDF | |
5:47 PM - 5:55 PM | Panel Discussion End of Program G |
END OF SESSION 54 | |
SESSION 55 SCHEDULE | |
Thursday
SESSION 55:
NEW OR IMPROVED DEVICES FOR EVAR AND JUXTARENAL AAA REPAIR (4 1/2-MINUTE TALKS
Moderators:Michel Makaroun, MD / Gilbert R. Upchurch, Jr., MD
|
|
x | |
6:45 AM - 6:50 AM | Aorfix Endograft With The New IntelliFlex Delivery System For EVAR: Technique And Advantages |
Presenter(s):Andrew Holden, MBChB | |
View Slides in PDF | |
6:50 AM - 6:55 AM | Aorfix Endograft For EVAR: Interim Results Of The ARCHYTAS Post Market Registry Experience With On-Label And Off-Label Use Of The Graft With Unfavorable Anatomy |
Presenter(s):Vicente Riambau, MD, PhD | |
View Slides in PDF | |
6:55 AM - 7:00 AM | Aorfix Endograft For EVAR: 3-Year Results Of PYTHAGORAS Pivotal PMA Trial In Standard And Angulated Neck AAAs |
Presenter(s):Mark F. Fillinger, MD | |
View Slides in PDF | |
7:00 AM - 7:05 AM | Gore C3 Excluder Endograft With C3 Delivery System Which Allows Graft Repositioning: Advantages And Experience In >200 AAA Patients |
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
7:05 AM - 7:10 AM | Gore Excluder Endograft For EVAR: 10-Year Experience Demonstrates Endograft Durability |
Presenter(s):Giovanni Pratesi, MD | |
View Slides in PDF | |
7:10 AM - 7:15 AM | Gore Conformable CEXC Excluder Endograft For EVAR: The Angle Of The Proximal Graft Body Can Be Actively Changed To Conform To AAA Neck Angulation: How Does It Work And Early Results |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD / Dittmar Boeckler, MD / Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
7:15 AM - 7:20 AM | Cordis Incraft Endograft For EVAR 4-Year Experience: Advantages And European Trial Results |
Presenter(s):Giovanni Torsello, MD | |
View Slides in PDF | |
7:20 AM - 7:31 AM | Panel Discussion |
Moderator(s): ShenMing Wang, MD, PhD / James F. McKinsey, MD | |
7:31 AM - 7:36 AM | Fenestrated Anaconda Endograft (Vascutek) For Juxtarenal AAA Repairs And Type 1A Endoleaks: Advantages And European Multicenter Results To Date |
Presenter(s):Donald B. Reid, MD / Clark J. Zeebregts, MD, PhD / Afshin Assadian, MD | |
View Slides in PDF | |
7:36 AM - 7:41 AM | Anaconda ONE-LOK Endograft (Vascutek) For EVAR: Technical Advantages And 1 Year US Results |
Presenter(s):Christopher J. Kwolek, MD | |
View Slides in PDF | |
7:41 AM - 7:46 AM | Newly Modified Medtronic Endurant (EVO) Endograft: Initial Clinical Experience And Advantages |
Presenter(s):Gilbert R. Upchurch, Jr., MD | |
View Slides in PDF | |
7:46 AM - 7:51 AM | Ovation Endograft From TriVascular For EVAR: Advantages And Tips And Tricks For Use |
Presenter(s):David J. Minion, MD | |
View Slides in PDF | |
7:51 AM - 7:56 AM | Ovation Endograft From TriVascular: The Real World European Experience And Advantages |
Presenter(s):Patrick Peeters, MD | |
View Slides in PDF | |
7:56 AM - 8:01 AM | Ovation Prime Endograft From TriVascular: Midterm Results And Advantages |
Presenter(s):Carlo Setacci, MD / Francesco Setacci, MD | |
View Slides in PDF | |
8:01 AM - 8:12 AM | Panel Discussion |
END OF SESSION 55 | |
SESSION 56 SCHEDULE | |
Thursday
SESSION 56:
MORE NEW OR IMPROVED DEVICES FOR EVAR
Moderators:Peter L. Faries, MD, FACS / Gary Giangola, MD
|
|
x | |
8:12 AM - 8:17 AM | Aorfix Endograft Can Be Effective In Badly Angled AAA Necks: Tips And Tricks To Make It Work And When It Will Not |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Slides in PDF | |
8:18 AM - 8:23 AM | Treovance Endograft (Bolton Medical) For EVAR: Experience To Date And Advantages |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
8:24 AM - 8:29 AM | New Cook Zenith Alpha Endograft System For EVAR: Why It Is Better |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
8:30 AM - 8:35 AM | Nellix Endograft System From Endologix For Endovascular Aneurysm Sealing (EVAS): Clinical Experience To Date: Type 1A Endoleaks Can Occur And Can Cause Rupture But They Can Be Detected And Fixed: How To Do So |
Presenter(s):Dittmar Boeckler, MD | |
View Slides in PDF | |
8:36 AM - 8:41 AM | Nellix Endograft System For EVAS: Key Points From The Global Registry And How To Prevent, Diagnose And Treat Type IA Endoleaks |
Presenter(s):Andrew Holden, MBChB / Jean-Paul de Vries, MD, PhD | |
View Slides in PDF | |
8:42 AM - 8:47 AM | Nellix Endograft System For EVAS: What Are The Anatomic Restrictions: Can Chimney Grafts Be Used With It: How To Detect And Fix Gutter Endoleaks |
Presenter(s):Ian Loftus, MD | |
View Slides in PDF | |
8:48 AM - 8:53 AM | In Vitro Model Shows That Sac And Gutter Sealing Is Achieved With Chimney Graft And The Nellix Device If Certain Conditions Are Fulfilled |
Presenter(s):Jan D. Blankensteijn, MD | |
View Slides in PDF | |
8:54 AM - 8:59 AM | How The Nellix Device Can Be Used To Treat AAAs With Iliac Aneurysms: Tips And Tricks |
Presenter(s):Dainis K. Krievins, MD | |
View Slides in PDF | |
9:00 AM - 9:05 AM | Gore Excluder Iliac Branched Endograft Device For Hypogastric Revascularization: The Initial European Experience: Advantages And Limitations |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Slides in PDF | |
9:06 AM - 9:11 AM | 1-Year US Results Of Gore Iliac Branched Endograft: Advantages And Limitations |
Presenter(s):Darren B. Schneider, MD | |
View Slides in PDF | |
9:12 AM - 9:17 AM | Cook Iliac Branched Device For Hypogastric Revascularization: Advantages And Long-Term Durability: Failure Rates And Contraindications |
Presenter(s):Fabio Verzini, MD, PhD | |
View Slides in PDF | |
9:18 AM - 9:25 AM | Panel Discussion |
9:25 AM - 9:40 AM | Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 56 | |
SESSION 57 SCHEDULE | |
Thursday
SESSION 57:
NEW OR IMPROVED DEVICES FOR TEVAR OR BRANCHED EVAR FOR TAAAs
Moderators:Michael L. Marin, MD / Palma M. Shaw, MD
|
|
x | |
9:40 AM - 9:45 AM | The Bolton Ascending Aortic Endovascular Endograft Device: Technical Aspects, Advantages And Limitations |
Presenter(s):Carlos E. Donayre, MD / Rodney A. White, MD | |
View Slides in PDF | |
9:46 AM - 9:51 AM | Bolton Relay Endograft System For TEVAR: Technical Description, Unique Advantages And Clinical Experience To Date |
Presenter(s):Vicente Riambau, MD, PhD | |
View Slides in PDF | |
9:52 AM - 9:57 AM | Bolton Aortic Arch Endograft Device: Technical Description, Advantages And Clinical Results |
Presenter(s):W. Anthony Lee, MD | |
View Slides in PDF | |
9:58 AM - 10:03 AM | Proximal Scalloped Endografts (Bolton) For TEVAR To Maintain Left Subclavian Flow: Advantages, Limitations And Midterm Results |
Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
View Slides in PDF | |
10:04 AM - 10:09 AM | Advantages Of The Bolton Relay TEVAR Device With A Proximal Scallop: Can It Serve As An Off-The-Shelf Device |
Presenter(s):Jean-Marc Alsac, MD, PhD | |
View Slides in PDF | |
10:10 AM - 10:15 AM | Gore Conformable TAG (CTAG) Device For TEVAR: 2-Year Multicenter Trial Results |
Presenter(s):William D. Jordan, Jr., MD | |
View Slides in PDF | |
10:16 AM - 10:21 AM | Value Of Hybrid Repairs Of Aortic Arch Lesions With And Without The Gore Hybrid Graft: Its Advantages |
Presenter(s):Grayson H. Wheatley, MD | |
View Slides in PDF | |
10:22 AM - 10:27 AM | Cook Zenith Low Profile Alpha Endograft System For TEVAR: Advantages And Clinical Results |
Presenter(s):Germano Melissano, MD | |
View Slides in PDF | |
10:28 AM - 10:33 AM | Cook Zenith Alpha Endograft Device For TEVAR: Advantages And Clinical Experience |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
View Slides in PDF | |
10:34 AM - 10:39 AM | Cook T-Branch Off-The-Shelf Branched Endograft System For TAAAs: Extending Its Applicability |
Presenter(s):Marcelo Ferreira, MD | |
View Slides in PDF | |
10:40 AM - 10:49 AM | Panel Discussion |
END OF SESSION 57 | |
SESSION 58 SCHEDULE | |
Thursday
SESSION 58:
NEW THORACIC AORTIC AND TAAA DEVICES
Moderators:Eric E. Roselli, MD / Luis A. Sanchez, MD
|
|
x | |
10:50 AM - 10:55 AM | Are New Endograft Devices For TEVAR Solving The Problems That Occurred With The Older Systems: What Does The Future Hold |
Presenter(s):Clifford J. Buckley, MD | |
View Slides in PDF | |
10:56 AM - 11:01 AM | The Value And Limitations Of The New Lower Profile Devices For TEVAR |
Presenter(s):Giovanni Torsello, MD | |
View Slides in PDF | |
11:02 AM - 11:07 AM | A New Simplified Endovascular Graft For TAAAs: It Needs Only A Single Measurement: Neck Diameter For Planning And Graft Selection |
Presenter(s):Juan C. Parodi, MD | |
View Slides in PDF | |
11:08 AM - 11:13 AM | Update On The Zenith TX2-LP Endograft System For Treatment Of Blunt Thoracic Aortic Injuries: Advantages, Limitations And Results |
Presenter(s):Benjamin W. Starnes, MD | |
View Slides in PDF | |
11:14 AM - 11:19 AM | For Treating Ischemic Complications Of TBADs, The Petticoat Concept Using A Proximal Bolton Relay Or E-Vita (Jotec) TEVAR And Distal Jotec E-XL Bare Stent Is Valuable |
Presenter(s):Burkhart Zipfel, MD, PhD | |
View Slides in PDF | |
LEFT SUBCLAVIAN ARTERY REVASCULARIZATION | |
11:20 AM - 11:25 AM | Laser In Situ Fenestration Is The Best Way To Preserve LSA Flow When Its Origin Must Be Covered: Techniques, Limitations And Midterm Results |
Presenter(s):Jean M. Panneton, MD | |
View Slides in PDF | |
BRANCHED TEVAR | |
11:26 AM - 11:31 AM | The Medtronic Branched TEVAR Endograft – The Valiant Mona LSA System: Technique, Advantages And Results |
Presenter(s):Frank R. Arko, MD / Eric E. Roselli, MD | |
View Slides in PDF | |
11:32 AM - 11:37 AM | Gore Branched Endograft For Treating Arch Lesions: Technique, Early Results With The LSA And Future Potential For Treating Other Arch Branches |
Presenter(s):Michael D. Dake, MD | |
View Slides in PDF | |
11:38 AM - 11:43 AM | Will The Benefits Of LSA Branched TEVAR Devices Justify The Costs |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
View Slides in PDF | |
11:44 AM - 11:49 AM | New Developments In In Situ Fenestration: How Can It Be Made To Work In Complex Aortic And Arch Endografting |
Presenter(s):Bjőrn Sonesson, MD, PhD | |
View Slides in PDF | |
11:50 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 58 | |
SESSION 59 SCHEDULE | |
Thursday
SESSION 59:
NEW DEVICES FOR TREATMENT OF LOWER EXTREMITY DISEASE
Moderators:Gregory L. Moneta, MD / Palma M. Shaw, MD
|
|
x | |
PROSTHETIC ARTERIAL GRAFTS | |
1:00 PM - 1:05 PM | 1-Year Results Of The FINAST RCT Comparing The Fusion Bioline Heparin Coated Prosthetic Graft vs. A Standard PTFE Graft For Femoropopliteal Bypasses: The Fusion Graft Had Better Patency And Less Suture Line Bleeding |
Presenter(s):Alan B. Lumsden, MD, FACS | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Update On The Advantages Of Spiral Flow Prosthetic Grafts In Decreasing Intimal Hyperplasia After Bypasses |
Presenter(s):Sebastian E. Debus, MD, PhD / Christian A. Behrendt, MD / Hosam F. El Sayed, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Are Propaten-Bonded PTFE Arterial Fempop Grafts Cost Effective: How Well Does Their Improved Patency Persist |
Presenter(s):Jes S. Lindholt, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Interesting Uses For The Gore Hybrid PTFE Graft Which Combines A Covered Self-Expanding Stent At One End With A Standard Vascular Graft At The Other End: Advantages And Limitations |
Presenter(s):Edward Y. Woo, MD | |
View Slides in PDF | |
ENDOVASCULAR INNOVATIONS | |
1:24 PM - 1:29 PM | Present Status Of Drug Eluting Devices In Tibial Artery Endovascular Treatments |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | The Value Of DEBs In Infrapopliteal Arteries Is Promising: Why The In.Pact Deep Trial Failed To Show A Benefit And What Is Being Done To Make DEBs Work Better In Leg Arteries |
Presenter(s):Andrej Schmidt, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | A New Concept For Local Drug Delivery To Arteries Using The Bullfrog Catheter Technology From Mercator |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | Update On The Chocolate PTA Balloon: Mode Of Action, Advantages And Clinical Results |
Presenter(s):Jihad A. Mustapha, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | Value Of Bioabsorbable Antibiotic Impregnated Beads In Treating Vascular Graft Infections |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 59 | |
SESSION 60 SCHEDULE | |
Thursday
SESSION 60:
NEW STENT AND STENT-GRAFT DEVICES AND CONCEPTS
Moderators:Peter A. Schneider, MD / Timur P. Sarac, MD
|
|
x | |
BIODEGRADABLE STENTS | |
2:00 PM - 2:05 PM | The ABSORB III Trial Results: The Pivotal US Approval Randomized Trial Of Bioabsorbable Scaffolds vs. Metallic Drug-Eluting Stents In Coronary Artery Disease |
Presenter(s):Gregg W. Stone, MD | |
View Slides in PDF | |
2:06 PM - 2:11 PM | How Well Do Biodegradable Stents Work In The Coronary Arteries: Where Are They Going In Other Arteries – Especially Smaller Ones |
Presenter(s):Ron Waksman, MD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | 1-Year Experience With Drug Eluting (Everolimus) Bioabsorbable Stents (ABSORB BVS From Abbott) In The BTK Arteries Including The Tibials |
Presenter(s):Ramon L. Varcoe, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | The ESPRIT Bioabsorbable DES In The SFA: 2-Year Results Are Promising |
Presenter(s):Johannes Lammer, MD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Rethinking Stent Designs And Techniques For Use In The SFA: What Does The Future Hold |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
2:30 PM - 2:42 PM | Panel Discussion |
Moderator(s): Giancarlo Biamino, MD, PhD / Firas F. Mussa, MD | |
2:43 PM - 2:48 PM | New Nitinol Stents (Like SMART CONTROL From Cordis) In The SFA: Are They Better Than The Old Ones For Patency And Effectiveness – Especially For More Complex Lesions |
Presenter(s):Daniel G. Clair, MD | |
View Slides in PDF | |
2:49 PM - 2:54 PM | Pulsar Nitinol Stent In Combination With Other Adjunctive Techniques (DEBs, Scoring Balloons, Debulking Devices): 12-Month Results Of The BIOFLEX Registry Are Promising |
Presenter(s):Michael K.W. Lichtenberg, MD | |
View Slides in PDF | |
2:55 PM - 3:00 PM | >1 Year Experience With The Unique Two Component Gore Tigris Stent In The SFA And Popliteal Artery: What Are Its Unique Advantages And Limitations |
Presenter(s):Andrej Schmidt, MD | |
View Slides in PDF | |
3:01 PM - 3:06 PM | Self-Expanding Thin Strut Nitinol Stents (Pulsar) Plus DEBs: 2-Year Results From The DEBAS Trial Are Promising |
Presenter(s):B. Patrice Mwipatayi, FRACS | |
View Slides in PDF | |
3:07 PM - 3:12 PM | A Long Self-Expanding Bare Metal Stent (EverFlex From Covidien) Can Be Effective In Treating Complex Fempop Lesions: 3-Year Results From The DURABILITY II Trial |
Presenter(s):Jon S. Matsumura, MD / Krishna J. Rocha-Singh, MD | |
View Slides in PDF | |
3:13 PM - 3:18 PM | Silent Infection Of Endografts: How Can It Be Detected And What Is Its Significance |
Presenter(s):Werner Lang, MD | |
View Slides in PDF | |
3:19 PM - 3:26 PM | Panel Discussion |
3:26 PM - 3:40 PM | Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 60 | |
SESSION 61 SCHEDULE | |
Thursday
SESSION 61:
PREVENTING AND TREATING MIGRATION AND ENDOLEAKS: UPDATE ON HELI-FX ENDOANCHORS
Moderators:Mark A. Farber, MD / Gregg S. Landis, MD
|
|
x | |
3:40 PM - 3:45 PM | How Effective Is Embolization (With Coils And Onyx) For Otherwise Untreatable Proximal Type 1 Endoleaks After EVAR: Techniques, Midterm Outcomes, Pitfalls And Patient Selection |
Presenter(s):Robert A. Morgan, MD | |
View Slides in PDF | |
3:46 PM - 3:51 PM | When Do Aptus EndoAnchors Work In EVAR And When Don’t They: Update On ANCHOR Registry: Do EndoAnchors Prevent Type 1A Endoleaks |
Presenter(s):William D. Jordan, Jr., MD | |
View Slides in PDF | |
3:52 PM - 3:57 PM | Can EndoAnchors Fix Early And Late Type 1A Endoleaks: Do They Prevent Migration |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Slides in PDF | |
3:58 PM - 4:03 PM | Treatment Of Endograft Migration With Type 1A Endoleak With Chimney Grafts: Technical Tips And Results |
Presenter(s):Ignacio Escotto, MD | |
View Slides in PDF | |
4:04 PM - 4:09 PM | EndoAnchors Can Increase EVAR Durability: Comparison Of Matched Patients With And Without EndoAnchors |
Presenter(s):Bart E. Muhs, MD, PhD | |
View Slides in PDF | |
4:10 PM - 4:15 PM | Do EndoAnchors Stop Or Delay AAA Neck Dilatation After EVAR |
Presenter(s):Apostolos K. Tassiopoulos, MD | |
View Slides in PDF | |
WITH TEVAR | |
4:16 PM - 4:21 PM | Tips And Tricks For EndoAnchor Use During TEVAR: When Are They Indicated |
Presenter(s):Grayson H. Wheatley, MD | |
View Slides in PDF | |
4:22 PM - 4:27 PM | Technique Of EndoAnchor Placement During TEVAR: Indications And Results |
Presenter(s):Jean M. Panneton, MD | |
View Slides in PDF | |
4:28 PM - 4:33 PM | Use Of EndoAnchors To Seal Gutter Endoleaks After Parallel Grafts With TEVAR And EVAR: Technical Consideration And How To Place Them |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
View Slides in PDF | |
4:34 PM - 4:39 PM | Value Of EndoAnchors In Complex TEVARs And F/B EVARs: Indications And Technical Tips |
Presenter(s):Piotr M. Kasprzak, MD | |
View Slides in PDF | |
4:40 PM - 4:47 PM | Panel Discussion |
END OF SESSION 61 | |
SESSION 62 SCHEDULE | |
Thursday
SESSION 62:
NEW DEVICES AND CONCEPTS FOR EMBOLIZATION, THROMBECTOMY AND THROMBOLYSIS
Moderators:Christopher J. Kwolek, MD / Nicholas J. Morrissey, MD
|
|
x | |
4:48 PM - 4:53 PM | POD Coils From Penumbra: A New Better Coil Embolization Device Which Fixes Coils To Vessel Wall And Permits Tighter Packing: Technical Aspects And Clinical Experience |
Presenter(s):Frank R. Arko, MD | |
View Slides in PDF | |
4:54 PM - 4:59 PM | Clinical Experience With PODCOIL Embolization In The ACE Multicenter Study |
Presenter(s):Claudio J. Schonholz, MD | |
View Slides in PDF | |
CATHETER THROMBECTOMY AND THROMBOLYSIS (SEE ALSO SESSION 29) | |
5:00 PM - 5:05 PM | Indigo Catheter Thrombectomy System From Penumbra: A Novel Endovascular Way To Remove Clot From Medium-Sized And Small Arteries: What Makes It Different And Better And Multicenter Clinical Results From The PRISM Trial |
Presenter(s):James F. Benenati, MD | |
View Slides in PDF | |
5:06 PM - 5:11 PM | Advantages Of The Indigo Thrombectomy Device For Treating ALI: How Does It Work And Why Does It Get Fresh And Old Clot Out More Effectively Than Other Systems |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Slides in PDF | |
5:12 PM - 5:17 PM | The Indigo Thrombectomy System Reduces The Need For Thrombolytics And Decreases The Risk And Cost Of Treatment For ALI |
Presenter(s):Frank R. Arko, MD | |
View Slides in PDF | |
5:18 PM - 5:23 PM | When Thrombosis Complicates Retrograde Access For Complex Lower Extremity Interventions, Intra-Thrombus Bolus ReoPro And Catheter Aspiration Can Be Helpful: Technical Tips And Tricks |
Presenter(s):Thomas O. McNamara, MD | |
5:24 PM - 5:29 PM | How To Decrease Bleeding Associated With Catheter Directed Thrombolysis And Improve Clot Lysis And Safety With A Microbubble Technique: Technical Aspects And Results |
Presenter(s):Kak Khee Yeung, MD, PhD | |
View Slides in PDF | |
5:30 PM - 5:35 PM | There Is No Advantage To Giving Heparin With Intra-arterial Thrombolysis: How To Prevent Clot Formation On Catheters And Sheaths |
Presenter(s):Martin Bjorck, MD, PhD | |
View Slides in PDF | |
5:36 PM - 5:44 PM | Panel Discussion End of Program H |
END OF SESSION 62 | |
SESSION 63 SCHEDULE | |
Thursday
SESSION 63:
VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
|
|
x | |
7:30 AM - 7:31 AM | Introduction To Veins At VEITH |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
7:31 AM - 7:36 AM | Establishing The Treatment Plan With CEAP & VCSS |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
7:37 AM - 7:42 AM | Outcome Assessment Of CVD |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
7:43 AM - 7:48 AM | Identifying Reflux Pathways With Duplex Ultrasound Mapping |
Presenter(s):Neil M. Khilnani, MD | |
View Slides in PDF | |
7:49 AM - 7:54 AM | Symptoms Of Chronic Venous Disease: Definition And Significance |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
7:55 AM - 8:00 AM | Veins: Beginning Or End Of Circulation: Differences In Physiology And Pathology |
Presenter(s):Seshadri Raju, MD | |
View Slides in PDF | |
8:01 AM - 8:06 AM | Air Plethysmography For Beginners |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Slides in PDF | |
8:07 AM - 8:12 AM | Hemodynamic Approach On Superficial Venous Reflux (ASVAL): Does It Work |
Presenter(s):Sylvain Chastanet, MD | |
View Slides in PDF | |
8:13 AM - 8:18 AM | Hemodynamic Approach On Superficial Venous Reflux (CHIVA): Does It Work |
Presenter(s):Paolo Zamboni, MD | |
View Slides in PDF | |
8:19 AM - 8:24 AM | A New Look At Venous Hemodynamics: Measuring Reflux And Venous Outflow Obstruction |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Slides in PDF | |
8:25 AM - 8:30 AM | Panel Discussion |
END OF SESSION 63 | |
SESSION 64 SCHEDULE | |
Thursday
SESSION 64:
VENOUS IMAGING TECHNIQUES
Moderators:Jose I. Almeida, MD, RVT, RPVI, FACS / Mark H. Meissner, MD
|
|
x | |
8:31 AM - 8:36 AM | Duplex Mapping: Tweaking The Buttons For Image Optimization |
Presenter(s):Jan M. Sloves, RVT | |
View Slides in PDF | |
8:37 AM - 8:42 AM | How To Recognize Variants On The Venous Duplex Exam |
Presenter(s):Neil M. Khilnani, MD | |
View Slides in PDF | |
8:43 AM - 8:48 AM | Reflux Exam In The Standing Position: Why Is This Still Controversial |
Presenter(s):Mark H. Meissner, MD | |
View Slides in PDF | |
8:49 AM - 8:54 AM | The Argument Against Routine Duplex Ultrasound After Truncal Ablation: An Evidence-Based Cost-Benefit Analysis |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
8:55 AM - 9:00 AM | Vein Diameter Is Not The Key For Stratifying Interventional Strategies For Superficial Venous Disease |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
View Slides in PDF | |
9:01 AM - 9:06 AM | The Use Of Wound Planimetry To Guide Decisions About Superficial And Perforator Ablations |
Presenter(s):Peter F. Lawrence, MD | |
View Slides in PDF | |
9:07 AM - 9:12 AM | C1 Disease And Truncal Incompetence: To Ablate Or Not To Ablate |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
9:13 AM - 9:18 AM | Panel Discussion |
END OF SESSION 64 | |
SESSION 65 SCHEDULE | |
Thursday
SESSION 65:
SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
|
|
x | |
9:19 AM - 9:24 AM | Staged Phlebectomy: Why |
Presenter(s):Jean Luc Gerard, MD | |
View Slides in PDF | |
9:25 AM - 9:30 AM | Concomitant Treatment Of Truncal Reflux And Varicosed Tributaries Is The Gold Standard |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
View Slides in PDF | |
9:31 AM - 9:36 AM | Lessons Learned: RF Ablation |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Slides in PDF | |
9:37 AM - 9:42 AM | Lessons Learned: Laser Ablation |
Presenter(s):Jean Luc Gerard, MD | |
View Slides in PDF | |
9:43 AM - 9:48 AM | Lessons Learned: MOCA Ablation |
Presenter(s):Steve Elias, MD | |
View Slides in PDF | |
9:49 AM - 9:54 AM | Step By Step: Cyanoacrylate Embolic Adhesive |
Presenter(s):Ian J. Franklin, Mr, MS, FRCS (Gen Surg) | |
View Slides in PDF | |
9:55 AM - 10:00 AM | Step By Step: Proprietary Foam |
Presenter(s):Kathleen D. Gibson, MD | |
View Slides in PDF | |
10:01 AM - 10:06 AM | Step By Step: Phlebectomy |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
10:07 AM - 10:12 AM | Cyanocrylate Adhesive: More Than One Product Available: Is There A Difference |
Presenter(s):Ian J. Franklin, Mr, MS, FRCS (Gen Surg) | |
View Slides in PDF | |
10:13 AM - 10:18 AM | A Strategy For Treatment Of Complex And Extensive Venous Burden |
Presenter(s):Barrie A. Price, Mr, MD, MS, FRCS | |
View Slides in PDF | |
10:19 AM - 10:24 AM | Superficial Reflux With Obstructed Deep Veins: When And When Not To Treat |
Presenter(s):Manj S. Gohel, MD, RCS, FEBVS | |
View Slides in PDF | |
10:25 AM - 10:30 AM | Incidence, Causes, And Treatment Of Recurrent Varicose Veins Following Endovenous Thermal Ablation |
Presenter(s):Edward G. Mackay, MD | |
View Slides in PDF | |
10:31 AM - 10:36 AM | Will The 1920nm Laser Be The Best |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
10:37 AM - 10:42 AM | Concomitant Truncal Venous Incompetence And Lymphedema: To Ablate Or Not To Ablate |
Presenter(s):Paul Pittaluga, MD | |
View Slides in PDF | |
10:43 AM - 10:48 AM | Reflux Extending To The Ankle: When And How To Treat |
Presenter(s):Steve Elias, MD | |
View Slides in PDF | |
10:49 AM - 10:54 AM | Panel Discussion |
END OF SESSION 65 | |
SESSION 66 SCHEDULE | |
Thursday
SESSION 66:
VENOUS SOCIETAL AND GOVERNANCE
|
|
x | |
10:55 AM - 11:00 AM | 25 Years Of IAC-VL And Still No Link To Reimbursement: Should I Continue Spending Money To Re-Accredit |
Presenter(s):Mark H. Meissner, MD | |
View Slides in PDF | |
11:01 AM - 11:06 AM | IAC Vein Center: Importance And Update |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
View Slides in PDF | |
11:07 AM - 11:12 AM | How To Deal With LCDs |
Presenter(s):Harold J. Welch, MD | |
View Slides in PDF | |
11:13 AM - 11:18 AM | Medicare Policy, Payments And Pitfalls |
Presenter(s):Harold J. Welch, MD | |
View Slides in PDF | |
11:19 AM - 11:24 AM | How Should Reflux Testing Be Performed According To IAC-VL |
Presenter(s):Ellen D. Dillavou, MD | |
View Slides in PDF | |
11:25 AM - 11:30 AM | Outpatient Interventions: Are Controls Needed |
Presenter(s):Paul J. Gagne, MD, FSIR, FACR | |
View Slides in PDF | |
11:31 AM - 11:36 AM | Update On The SVS-PSO VQI Venous Registry |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
11:37 AM - 11:42 AM | What Is The Future Of Venous Reimbursement |
Presenter(s):Glenn Jacobowitz, MD | |
View Slides in PDF | |
11:43 AM - 11:48 AM | Non-Thermal Devices Are Available For Truncal Ablation: How To Implement In Practice Without Dedicated CPT Codes |
Presenter(s):Steve Elias, MD | |
View Slides in PDF | |
11:49 AM - 11:54 AM | A National Coverage Determination Policy Is Needed |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
11:55 AM - 12:00 PM | Economic Forecast And Recommendations For Venous Intervention |
Presenter(s):Peter F. Lawrence, MD | |
View Slides in PDF | |
12:00 PM - 12:59 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 66 | |
SESSION 67 SCHEDULE | |
Thursday
SESSION 67:
EXAMINING THE EVIDENCE
Moderators:Thomas W. Wakefield, MD / Bo G. Eklof, MD, PhD
|
|
x | |
1:00 PM - 1:05 PM | C6 Disease: Is Superficial Surgery A Cost Benefit |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | C6 Disease: When To Ablate A Refluxing Saphenous Vein |
Presenter(s):Brajesh K. Lal, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | C5 Or C6 With Arterial Claudication: Which Comes First |
Presenter(s):Marc A. Passman, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | C6: Treat Central Venous Occlusion First |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Perforator Ablation For C3 Or C4 |
Presenter(s):John Blebea, MD, MBA | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Is Accessory Saphenous Vein Ablation Experimental |
Presenter(s):Elna M. Masuda, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Is C2 Disease Progressive |
Presenter(s):Mark H. Meissner, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | Why Graduated Compression Is An Insurance Requirement |
Presenter(s):Fedor Lurie, MD, PhD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | Panel Discussion |
END OF SESSION 67 | |
SESSION 68 SCHEDULE | |
Thursday
SESSION 68:
MORE USEFUL SUPERFICAL VEIN INFORMATION
|
|
x | |
1:54 PM - 1:59 PM | Is The Saphenous Vein Sacred |
Presenter(s):Paul Pittaluga, MD | |
View Slides in PDF | |
2:00 PM - 2:05 PM | Sclerotherapy Pearls |
Presenter(s):Neil M. Khilnani, MD | |
View Slides in PDF | |
2:06 PM - 2:11 PM | Should You Use Foam For Telangiectasia Or Reticular Veins: Where Is The Evidence |
Presenter(s):Ellen D. Dillavou, MD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Neurological Complications Of Sclerotherapy For Varicose Veins |
Presenter(s):Edward G. Mackay, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | Why Not Use Homemade Foam For The GSV |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Laser Or Ohmic Devices For Telangiectasia: When And Why |
Presenter(s):Ian J. Franklin, Mr, MS, FRCS (Gen Surg) | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Superficial Vein Thrombophlebitis: To Treat Or Not To Treat |
Presenter(s):Dawn M. Coleman, MD | |
View Slides in PDF | |
2:36 PM - 2:41 PM | SVT In The Pregnant Patient |
Presenter(s):Joann Lohr, MD | |
View Slides in PDF | |
2:42 PM - 2:47 PM | Panel Discussion |
END OF SESSION 68 | |
SESSION 69 SCHEDULE | |
Thursday
SESSION 69:
SUPERFICIAL VENOUS ABLATION, COMPRESSION AND RESEARCH
Moderators:John Blebea, MD, MBA / Mark A. Adelman, MD
|
|
x | |
2:48 PM - 2:53 PM | How To Properly Design And Interpret Clinical Trials |
Presenter(s):Thomas W. Wakefield, MD | |
View Slides in PDF | |
2:54 PM - 2:59 PM | Thermal Ablation On Anticoagulated Patients: Is It Safe And Effective |
Presenter(s):Glenn Jacobowitz, MD | |
View Slides in PDF | |
3:00 PM - 3:05 PM | VeClose Randomized Clinical Trial: 12-Month Follow-Up Results - VenaSeal vs. RFT (ClosureFast) |
Presenter(s):Kathleen D. Gibson, MD | |
View Slides in PDF | |
3:06 PM - 3:12 PM | Complete Varicose Vein Surgery Improves VCSS: Advantages Of Ablation Plus Transilluminated Powered Phlebectomy (TIPP) |
Presenter(s):Thomas W. Wakefield, MD | |
View Slides in PDF | |
3:13 PM - 3:18 PM | Biological Differences And Similarities Between 147nm And 1920nm On The Vein Wall: Using Immunocytochemistry |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Slides in PDF | |
3:19 PM - 3:24 PM | Varithena: Summary Phase 3 Trials |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
3:25 PM - 3:30 PM | The SECURE Trial: Update On Perforator Ablation |
Presenter(s):Mark A. Adelman, MD | |
View Slides in PDF | |
3:31 PM - 3:36 PM | Endovenous Thermal Ablation RCTs: Do We Know Enough |
Presenter(s):Peter Gloviczki, MD | |
View Slides in PDF | |
3:37 PM - 3:42 PM | Can Real World Experience Contradict RCTs (e.g., ESCHAR Trial) |
Presenter(s):Alfred M. Obermayer, MD | |
View Slides in PDF | |
3:43 PM - 3:48 PM | Shocking: All Companies' Graduated Compression Measurements Are Not The Same |
Presenter(s):John Blebea, MD, MBA | |
View Slides in PDF | |
3:49 PM - 3:54 PM | What To Do When Stockings Fail To Control Swelling |
Presenter(s):Mark H. Meissner, MD | |
View Slides in PDF | |
3:55 PM - 4:00 PM | What Does Compression Add To Thermal Ablation |
Presenter(s):Todd Berland, MD | |
View Slides in PDF | |
4:01 PM - 4:06 PM | What Is Short-Stretch Compression And Why Is That Important For Vascular Surgeons |
Presenter(s):Fedor Lurie, MD, PhD | |
View Slides in PDF | |
4:07 PM - 4:12 PM | Panel Discussion |
END OF SESSION 69 | |
SESSION 70 SCHEDULE | |
Thursday
SESSION 70:
VENOUS PRACTICE MANAGEMENT
|
|
x | |
4:13 PM - 4:18 PM | Five Things Your Office Manager Should Be Doing |
Presenter(s):Barrie A. Price, Mr, MD, MS, FRCS | |
View Slides in PDF | |
4:19 PM - 4:24 PM | Venous EMR Trials And Tribulations |
Presenter(s):Edward G. Mackay, MD | |
View Slides in PDF | |
4:25 PM - 4:30 PM | Marketing Your Vein Practice |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Slides in PDF | |
4:31 PM - 4:36 PM | Optimizing Patient Throughput And Increasing Patient Satisfaction: Lean Six Sigma |
Presenter(s):Christopher M. Banoub, MPA | |
View Slides in PDF | |
4:37 PM - 4:42 PM | Practice Building Tips For Venous Specialists |
Presenter(s):Edward G. Mackay, MD | |
View Slides in PDF | |
4:43 PM - 4:48 PM | How To Get Vascular Surgeons Engaged In Venous Disease |
Presenter(s):Peter F. Lawrence, MD | |
View Slides in PDF | |
4:49 PM - 5:00 PM | Panel Discussion End of Program I |
END OF SESSION 70 | |
SESSION 71 SCHEDULE | |
Thursday
SESSION 71:
THE OPENING OF A NEW ERA: STROKE TRIALS AND EVIDENCE
Moderators:TBD / TBD
|
|
x | |
8:00 AM - 8:05 AM | Introduction |
8:06 AM - 8:16 AM | Stroke Demographics And Epidemiology |
8:17 AM - 8:27 AM | Recent Negative NEJM Trials: What Did We Learn |
8:28 AM - 8:38 AM | MR CLEAN |
8:39 AM - 8:49 AM | ESCAPE |
8:50 AM - 9:00 AM | SWIFT PRIME |
9:01 AM - 9:11 AM | Innovative Endovascular Therapy: From Trials To Practice |
9:12 AM - 9:22 AM | REVASCAT |
9:23 AM - 9:33 AM | THERAPY |
9:34 AM - 9:44 AM | Evidence Shared By Trials |
9:45 AM - 9:55 AM | Important Differences In Trials |
9:56 AM - 10:05 AM | Panel Discussion |
10:05 AM - 10:25 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 71 | |
SESSION 72 SCHEDULE | |
Thursday
SESSION 72:
TRIAGE STRATEGIES THAT NEED TO BE ADDRESSED
Moderators:TBD / TBD
|
|
x | |
10:26 AM - 10:36 AM | Prior To The ER And Transport Issues |
10:37 AM - 10:47 AM | Emergency Room Issues And Solutions |
10:48 AM - 10:58 AM | Telestroke Implementation And Problems |
10:59 AM - 11:09 AM | Data: We Should Require Documenting Time Points: AKA Cardiology |
11:10 AM - 11:20 AM | DEBATE: Cardiologists Can Do This: Why I Agree |
Presenter(s):L. Nelson Hopkins, MD | |
11:21 AM - 11:31 AM | DEBATE: Interventional Neuro Specialists Are Plentiful And The Appropriate Standard Of Care |
11:32 AM - 11:42 AM | Stroke Care Organization: Rural vs. City |
11:43 AM - 11:53 AM | Wake Up Strokes: Do We Have Any Data Or Not |
11:54 AM - 12:04 PM | Panel Discussion |
LUNCHEON PROGRAM: NEW FRONTIERS IN BRAIN HEMORRHAGE EVACUATION | |
Moderator(s): TBD / TBD | |
12:05 PM - 12:17 PM | The Rationale For Minimally Invasive Surgery For The Evacuation Of Intracranial Hemorrhage |
12:18 PM - 12:30 PM | Minimally Invasive Access Surgery For Intracerebral Hemorrhage: Early Results And Future Directions |
12:31 PM - 12:43 PM | Minimally Invasive Surgery With Apollo: Experience To Date And Next Steps |
12:44 PM - 12:59 PM | Panel Discussion |
END OF SESSION 72 | |
SESSION 73 SCHEDULE | |
Thursday
SESSION 73:
LUNCHEON PROGRAM: NEW FRONTIERS IN BRAIN HEMORRHAGE EVACUATION
Moderators:TBD
|
|
x | |
12:05 PM - 1:00 PM | Please see the bottom of Session 72 for the Multidisciplinary Acute Stroke Management at AIMsymposium Luncheon Program. |
END OF SESSION 73 | |
SESSION 74 SCHEDULE | |
Thursday
SESSION 74:
PATIENT SELECTION AND STATE-OF-THE-ART IMAGING
Moderators:TBD / TBD
|
|
x | |
1:00 PM - 1:10 PM | Basics Of Imaging For Stroke And The Latest Tools |
1:11 PM - 1:21 PM | Clinical Triage Basics |
1:22 PM - 1:33 PM | CT/CTA Is The Standard And All I Need |
1:33 PM - 1:43 PM | Perfusion Is A Necessity For Best Practice And I Can Prove It |
1:44 PM - 1:54 PM | Size Of The Core And The Physiology Of Progression: My Pearls |
1:55 PM - 2:05 PM | Collateral Imaging At Its Best |
END OF SESSION 74 | |
SESSION 75 SCHEDULE | |
Thursday
SESSION 75:
HEMORRHAGIC STROKE
Moderators:TBD / TBD
|
|
x | |
2:06 PM - 2:16 PM | Intraparenchymal Hemorrhage: When To Decompress |
2:17 PM - 2:27 PM | Imaging Of Parenchymal Clots: Signs That Make You Worry |
2:28 PM - 2:38 PM | Aneurysm Therapy: Is There A Science Behind Which Aneurysms Will Grow And Rupture |
2:39 PM - 2:49 PM | Small Aneurysms: Coil Or Stent – Theory And Logic Behind My Decisions |
Presenter(s):Philip M. Meyers, MD | |
2:50 PM - 3:00 PM | Wide Neck Aneurysms: New Devices And Strategies |
3:01 PM - 3:11 PM | Flow Diversion: Next Generation Ideas |
3:12 PM - 3:22 PM | Managing Complications Of Aneurysm Therapy |
3:23 PM - 3:33 PM | AVM Treatment Options And Why |
3:34 PM - 3:44 PM | Dural Fistula: Venous Approaches |
Presenter(s):Guilherme Dabus, MD | |
3:45 PM - 3:55 PM | Dural Sinus Stenosis: When And Why I Treat |
3:56 PM - 4:06 PM | Direct Radial, Carotid And Venous Access |
END OF SESSION 75 | |
SESSION 76 SCHEDULE | |
Thursday
SESSION 76:
LATEST SCIENCE, LITERATURE AND NEWEST DEVICES
Moderators:TBD / TBD
|
|
x | |
4:07 PM - 4:17 PM | Suction Thrombectomy: Lessons Learned |
4:18 PM - 4:28 PM | Stent Retrievers Are The Standard Of Care: The Evidence |
4:29 PM - 4:39 PM | Treating Stroke After The Time Window Closes: Physiology And Practical Issues |
Presenter(s):Colin P. Derdeyn, MD | |
4:40 PM - 4:50 PM | Posterior Circulation Ischemia: Is There A Role For Thrombectomy |
4:51 PM - 5:01 PM | Posterior Circulation Stroke: Strategies |
5:02 PM - 5:12 PM | Economics Of Stroke Therapy |
5:13 PM - 5:23 PM | Comprehensive Stroke Centers: Is It Going To Be Required For Treatment |
5:24 PM - 5:30 PM | Panel Discussion End of Program J |
END OF SESSION 76 | |
Friday, November 20, 2015
Print Entire 2015 Program:
|
|
SESSION 77 SCHEDULE | |
Friday
SESSION 77:
NEW TECHNIQUES, TECHNOLOGIES, CONCEPTS – CAROTID RELATED
Moderators:Claudio J. Schonholz, MD / Sriram S. Iyer, MD, FACC
|
|
x | |
6:39 AM - 6:45 AM | Atherosclerotic Plaque Regression: Is It Now A Reality: How Can It Occur: And What Are The Expectations For The Future |
Presenter(s):Kosmas I. Paraskevas, MD | |
6:46 AM - 6:51 AM | Current Optimal Methods To Evaluate Plaque Instability With Asymptomatic Carotid Stenosis (ACS) |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
View Slides in PDF | |
6:52 AM - 6:57 AM | Juxtaluminal Black Area (JBA) On Duplex Determines Stroke Risk In ACS Patients: How To Determine And Quantitate It: Can It Be Changed: What Other Factors Quantitate Risk |
Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD | |
View Slides in PDF | |
6:58 AM - 7:03 AM | DEBATE: Patch Closure After CEA Should Be Used Most Of The Time: The Level 1 Evidence Shows It |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
7:04 AM - 7:09 AM | DEBATE: Patch Closure After CEA Is Usually Not Needed Despite The Level 1 Evidence |
Presenter(s):Nicholas J. Gargiulo III, MD, FACS, RPVI, RVT, RDMS | |
View Slides in PDF | |
7:10 AM - 7:15 AM | DEBATE: If Certain Techniques Are Employed, Patch Closure After CEA Is Not Always Needed And Patch Closures Have Complications: What Are They |
Presenter(s):Glenn M. LaMuraglia, MD | |
View Slides in PDF | |
7:16 AM - 7:21 AM | Is Preop Coronary Angiography Before CEA Beneficial Over The Long-Term: Based On A RCT |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
View Slides in PDF | |
MESH COVERED CAROTID STENTS | |
7:22 AM - 7:27 AM | Midterm Results With A Micromesh Covered Stent For CAS (The Roadsaver Stent From Terumo); What Are The Differences Between The 3 Available Mesh Covered Stents |
Presenter(s):Max Amor, MD | |
View Slides in PDF | |
7:28 AM - 7:33 AM | Technical Aspects And Results With The Gore Scaffold Mesh Covered Stent For CAS: Are Any Of These Mesh Covered Stents Ready For Prime Time |
Presenter(s):Peter A. Schneider, MD / Claudio J. Schonholz, MD | |
View Slides in PDF | |
7:34 AM - 7:39 AM | MicroNet Covered Embolic Prevention Carotid Stent System: From CARENET And PARADIGM Studies To Routine Clinical Practice |
Presenter(s):Piotr Musialek, MD, DPhil | |
View Slides in PDF | |
7:40 AM - 7:45 AM | Update On Value Of Contrast Enhanced 3D Duplex And Carotid Artery Flow Dynamics To Detect Plaque Changes And Identify High Risk ACS Patients For Invasive Treatment |
Presenter(s):Brajesh K. Lal, MD | |
View Slides in PDF | |
7:46 AM - 7:51 AM | MRI Can Determine Carotid Plaque Characteristics And Embolic Risk Prospectively: These MRI Findings Correlate With Symptoms, TCD Hits And Cognitive Changes |
Presenter(s):Peter L. Faries, MD, FACS | |
View Slides in PDF | |
7:52 AM - 8:00 AM | Panel Discussion |
END OF SESSION 77 | |
SESSION 78 SCHEDULE | |
Friday
SESSION 78:
MORE ABOUT COMPLEX ANEURYSM TREATMENT AND SPINAL CORD ISCHEMIA (SCI)
Moderators:Gustavo S. Oderich, MD, FACS / Christian D. Etz, MD, PhD
|
|
x | |
SPINAL CORD ISCHEMIA (SCI) AND ITS PREVENTION | |
8:00 AM - 8:05 AM | Mechanisms Of Neuronal Death In SCI With Aortic Repairs And What Can Be Done To Minimize It: CSF Drainage And High BP Will Not Stop All SCI: An Anesthesiologist’s Perspective |
Presenter(s):Hamdy Awad, MD | |
View Slides in PDF | |
8:06 AM - 8:11 AM | Pitfalls And Safeguards In Spinal Cord Protection During And After TEVAR |
Presenter(s):Vicente Riambau, MD, PhD | |
View Slides in PDF | |
8:12 AM - 8:17 AM | Institutional And Administrative Barriers To Adequate Spinal Cord Protection Treatment After TAAA Repair – Open And Endo |
Presenter(s):Charles W. Acher, MD | |
View Slides in PDF | |
8:18 AM - 8:23 AM | New Concepts In Causes And Treatment Of SCI With TAAA Repairs – Open And Endo: Why Preemptive Ischemic Preconditioning With Coil Embolization Of Intercostals May Help Prevent SCI |
Presenter(s):Christian D. Etz, MD, PhD | |
View Slides in PDF | |
8:24 AM - 8:29 AM | Optimal Approaches To Decrease SCI After TEVAR And Open TAAA Repair |
Presenter(s):Michael J. Jacobs, MD | |
View Slides in PDF | |
8:30 AM - 8:35 AM | 2 Staging B/FEVAR Procedures For Complex TAAAs Is A Better Way Than Leaving A Patent Branch To Prevent SCI: Why |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
8:36 AM - 8:41 AM | Selective Staging Based On Spinal Cord Function Monitoring Is The Best Way To Prevent SCI With TAAA F/BEVAR Repairs: Intrasac Pressure Measurements And Leaving A Patent Branch May Be Appropriate For Some Cases |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
View Slides in PDF | |
8:42 AM - 8:47 AM | Impact Of Early Pelvic And Lower Extremity Reperfusion In Preventing SCI During TAAA Endovascular Repairs: Techniques To Achieve It |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
8:48 AM - 8:53 AM | Predictors Of SCI During TEVAR For TBAD And Strategies To Prevent It |
Presenter(s):Xin Li, MD / Chang Shu, MD | |
View Slides in PDF | |
8:54 AM - 8:59 AM | Paraplegia After TEVAR: Etiology And Strategies To Prevent It |
Presenter(s):Germano Melissano, MD / Yamume Tshomba, MD / Roberto Chiesa, MD | |
View Slides in PDF | |
9:00 AM - 9:07 AM | Panel Discussion |
9:07 AM - 9:23 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 78 | |
SESSION 79 SCHEDULE | |
x | |
9:23 AM - 9:28 AM | Safety And Effectiveness Of CAS With Radiation Induced Carotid Stenosis: Review Of A Multicenter Experience |
Presenter(s):Peter L. Faries, MD, FACS | |
View Slides in PDF | |
9:29 AM - 9:34 AM | Pathogenesis Of Carotid Radiation Arteritis: What Is Its Impact On How It Should Be Treated |
Presenter(s):Beatrice R. Amann-Vesti, MD | |
View Slides in PDF | |
9:35 AM - 9:40 AM | Carotid Artery Aneurysms: Is Open Surgery The Best Treatment For Most: When Are Endovascular Techniques Indicated |
Presenter(s):Gregg S. Landis, MD | |
View Slides in PDF | |
9:41 AM - 9:46 AM | How To Increase Intelligence By Increasing Cerebral Blood Flow: Can A Pill Do It |
Presenter(s):Juan C. Parodi, MD | |
View Slides in PDF | |
9:47 AM - 9:52 AM | Asymptomatic Carotid Stenosis (ACS) Is Associated With Cognitive Impairment: Does Correction Of The Stenosis With CEA Or CAS Reverse The Cognitive Defect |
Presenter(s):Brajesh K. Lal, MD | |
View Slides in PDF | |
9:53 AM - 9:58 AM | Implications Of The 2014 Revisions Of The AHA Carotid Guidelines For Symptomatic Patients: What Was Changed And What Should Have Been Changed |
Presenter(s):Kosmas I. Paraskevas, MD | |
View Slides in PDF | |
9:59 AM - 10:05 AM | Panel Discussion |
PROGRESS IN EMBOLIC BRAIN PROTECTION DURING CAS | |
Moderator(s): Peter L. Faries, MD, FACS / Juan C. Parodi, MD | |
10:05 AM - 10:10 AM | What Is New In Cerebral Embolic Protection Devices |
Presenter(s):Mark H. Wholey, MD | |
View Slides in PDF | |
10:11 AM - 10:16 AM | Some Form Of Proximal Brain Protection Should Be The Method Of Choice With CAS And Why |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD / Horst Sievert, MD | |
View Slides in PDF | |
10:17 AM - 10:22 AM | CAS In High Risk Patients Has A Lower Embolic Stroke Risk With The Silk Road Cervical Access And Reversal Of Flow System: Outcomes Can Be As Good As With CEA (From The PROOF Trial) |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Slides in PDF | |
10:23 AM - 10:28 AM | Transcervical Carotid Open Exposure And CAS With The Silk Road System And Flow Reversal: Favorable Results Of The ROADSTER Trial In High Risk Patients |
Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD | |
View Slides in PDF | |
10:29 AM - 10:34 AM | DEBATE: A Surgeon’s View Of The Silk Road System Of Cervical Access And Reversal Of Flow For CAS |
Presenter(s):L. Nelson Hopkins, MD | |
View Slides in PDF | |
10:35 AM - 10:40 AM | DEBATE: An Interventionalist’s View Of The Silk Road System Of Cervical Access And Reversal Of Flow For CAS |
Presenter(s):Klaus D. Mathias, MD | |
View Slides in PDF | |
10:41 AM - 10:47 AM | Panel Discussiion |
END OF SESSION 79 | |
SESSION 80 SCHEDULE | |
Friday
SESSION 80:
MORE CAROTID RELATED TOPICS: CAS Vs. CEA
Moderators:L. Nelson Hopkins, MD / Frank J. Veith, MD
|
|
x | |
10:47 AM - 10:52 AM | Double Filtration Embolic Brain Protection During CAS Improves Outcomes: A Novel PTA Balloon With An Integrated Filter Helps To Do This: The Paladin Balloon |
Presenter(s):Ravish Sachar, MD | |
10:53 AM - 10:58 AM | Effect Of Statins On Restenosis And Late Patient Survival After CEA |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
10:59 AM - 11:04 AM | How Enlightened Surgeons Should Select Asymptomatic Carotid Stenosis (ACS) Patients For CEA; For CAS; For BMRx Alone: All ACS Patients Should Get BMRx |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
11:05 AM - 11:10 AM | Striking Variability In Preop Carotid Imaging Before Invasive Treatment In Different Locations And Why It’s Bad For Patient Care |
Presenter(s):Andres Schanzer, MD | |
View Slides in PDF | |
11:11 AM - 11:16 AM | DEBATE: Early CEA In Symptomatic Carotid Stenosis Patients Within <2 Weeks Of The First Symptom Carries No Increased Risk Even If The Patient Is On Dual Antiplatelet Agents |
Presenter(s):Ross Naylor, MD, FRCS | |
View Slides in PDF | |
11:17 AM - 11:22 AM | DEBATE: Not So: Early CEA After Symptom Onset Has A Higher Risk Of Adverse Events (Death/Stroke) Than Delayed Operation: How Long Should CEA Be Delayed |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
11:23 AM - 11:28 AM | Current Optimal Ways To Manage Infected Carotid Patches When There Is No False Aneurysm And When There Is One |
Presenter(s):Ali F. AbuRahma, MD / Patrick A. Stone, MD | |
View Slides in PDF | |
11:29 AM - 11:34 AM | DEBATE: CMS Data Based Studies Tell Us Correctly About CEA And CAS Results In Real World Practice |
Presenter(s):Thomas G. Brott, MD | |
View Slides in PDF | |
11:35 AM - 11:40 AM | DEBATE: Not So: CMS Data Based Studies Are Flawed Models Sinking In The Quicksand Of Pseudo-Data |
Presenter(s):Richard P. Cambria, MD | |
View Slides in PDF | |
11:41 AM - 11:46 AM | Update On The Status Of ACST-2 Comparing CEA And CAS In ACS Patients: Devices Used, Medical Treatments: Is CEA/CAS Equipoise For ACS Being Supported |
Presenter(s):Alison Halliday, MS, FRCS | |
View Slides in PDF | |
11:47 AM - 11:55 AM | Panel Discussion |
11:55 AM - 12:00 PM | Associate Faculty Awards Presentation |
Presenter(s):Enrico Ascher, MD / Alan Dardik, MD, PhD | |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 80 | |
SESSION 81 SCHEDULE | |
Friday
SESSION 81:
MORE NEW DEVELOPMENTS IN CAROTID DISEASE, ONGOING TRIALS AND CONTROVERSIES
Moderators:Brajesh K. Lal, MD / Frank J. Veith, MD
|
|
x | |
1:00 PM - 1:05 PM | Predictors Of Stroke And Death After CAS: Post-Stent Ballooning Is Bad And Proper Use Of Beta Blockers Is Good: Data From The SVS VQI |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Guidelines For Management Of Carotid Stenosis Are Outdated, Inconsistent And Flawed: It Is Time For An Overhaul And Update |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
View Slides in PDF | |
1:12 PM - 1:17 PM | How Do The SVS Guidelines For Management Of Extracranial Carotid Disease Impact On Clinical Practice: Do They Need To Be Updated |
Presenter(s):Enrico Ascher, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | What Are The Ongoing Carotid Trials (CREST-2, SPACE-2, ACST-2, ACT-1, ECST-2) Telling Us And Going To Tell Us |
Presenter(s):Alison Halliday, MS, FRCS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Status Of The SPACE-2 Trial: Although Patient Enrollment Has Been Stopped, What Useful Information Will It Provide |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | What Is Happening With CREST-2: When Will We Have Answers |
Presenter(s):Thomas G. Brott, MD / Brajesh K. Lal, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Why CREST-2 May Be A Bad Deal For CAS |
Presenter(s):Mark H. Wholey, MD | |
1:42 PM - 1:47 PM | Double Filtration Embolic Brain Protection During CAS Improves Outcomes: A Novel PTA Balloon With An Integrated Filter Helps To Do This: The Paladin Balloon |
Presenter(s):Ravish Sachar, MD | |
View Slides in PDF | |
Moderator(s): Thomas G. Brott, MD / Mark H. Wholey, MD | |
1:48 PM - 1:53 PM | DEBATE: Which Carotid Stenosis Patients Are Candidates For CAS In 2015: An Interventionist’s View |
Presenter(s):Klaus D. Mathias, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | DEBATE: Which Carotid Stenosis Patients Are Appropriate Candidates For CAS In 2015: A Vascular Surgeon’s View |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Slides in PDF | |
2:00 PM - 2:05 PM | What Lesion Characteristics Are Higher Risk For CAS Than CEA: How Should They Influence The Choice Of Treatment In Symptomatic And Asymptomatic Patients: Data From CREST |
Presenter(s):Wesley S. Moore, MD | |
View Slides in PDF | |
2:06 PM - 2:11 PM | DEBATE: Screening For Asymptomatic Carotid Stenosis (ACS) Is Justified In Some Patients: Which Ones And For What Reason |
Presenter(s):Glenn Jacobowitz, MD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | DEBATE: Screening For ACS Is |
Presenter(s):Erich Minar, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | CEA, CAS And Best Medical Treatment (BMRx) Alone: Which Treatment For Which Patient |
Presenter(s):R. Clement Darling III, MD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Early Intervention After Symptom Onset Is Safe With CEA But Not With CAS |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
2:30 PM - 2:36 PM | Panel Discussion |
END OF SESSION 81 | |
SESSION 82 SCHEDULE | |
Friday
SESSION 82:
LATE BREAKING IMPORTANT INFORMATION, KEY UPDATES AND PEVAR
Moderators:Pedro P. Komlos, MD / Mark A. Adelman, MD
|
|
x | |
2:36 PM - 2:41 PM | Statins Are Safe, Cheap And Effective And Should Be Used More Widely: Late Breaking Long-Term Results Of The MRC/BHF HEART PROTECTION Study Of Statins vs. Placebo |
Presenter(s):Richard Bulbulia, MA, MD, FRCS | |
View Slides in PDF | |
2:42 PM - 2:47 PM | Do ACE Inhibitors Slow AAA Growth: The AARDVARK Trial |
Presenter(s):Janet T. Powell, MD, PhD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | What’s New With Stem Cell Treatment For Unfixable CLI: What About For Myocardial Ischemia |
Presenter(s):Alan Dardik, MD, PhD | |
View Slides in PDF | |
2:54 PM - 2:59 PM | Active Smoking Increases The Risk Of Limb Loss After Infrainguinal Bypass For Intermittent Claudication |
Presenter(s):Raghuveer Vallabhaneni, MD | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Dual Antiplatelet Drugs Are Better Than One Drug For All Lower Extremity Arterial Interventions – Endo And Open |
Presenter(s):Marc L. Schermerhorn, MD | |
View Slides in PDF | |
UPDATE ON PEVAR | |
3:06 PM - 3:11 PM | Update On The Status Of Percutaneous EVAR And TEVAR: What Device Is Best, Who Should Not Have It, Precautions And What Improved Devices Are On The Horizon |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
View Slides in PDF | |
3:12 PM - 3:17 PM | Benefits Of PEVAR In More Than 3000 EVAR Cases: Technical Tips And How Can Costs Be Minimized |
Presenter(s):Giovanni Pratesi, MD / Bruno Freitas, MD / Dierk Scheinert, MD | |
View Slides in PDF | |
3:18 PM - 3:23 PM | Real World Results With PEVAR vs. Open Femoral Approaches For EVAR: They Are Not What Might Be Expected |
Presenter(s):Dipankar Mukherjee, MD | |
View Slides in PDF | |
3:24 PM - 3:29 PM | Do Closure Devices Accelerate Femoral Artery Atherosclerosis |
Presenter(s):Luis R. Leon, MD, RVT, FACS | |
View Slides in PDF | |
3:30 PM - 3:35 PM | Update On Facial Suture Technique For Minimally Invasive Sheath Insertion: Is It Better Than PEVAR: Tips And Tricks For Doing It Right |
Presenter(s):Thomas Larzon, MD, PhD | |
View Slides in PDF | |
3:36 PM - 3:41 PM | Endovascular AV Fistula Creation For Hemodialysis Access: Technique And Early Trial (NEAT) Results |
Presenter(s):Charmaine Lok, MD | |
View Slides in PDF | |
3:42 PM - 3:55 PM | Panel Discussion And Break Visits Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 82 | |
SESSION 83 SCHEDULE | |
Friday
SESSION 83:
NEW CONCEPTS AND UPDATES RELATED TO CAROTID DISEASE AND ITS TREATMENT
Moderators:Gregory L. Moneta, MD / Klaus D. Mathias, MD
|
|
x | |
3:55 PM - 4:00 PM | Current Optimal Management Of Infected Carotid Patches Without And With Pseudoaneurysms |
Presenter(s):Joseph S. Giglia, MD | |
View Slides in PDF | |
4:01 PM - 4:06 PM | Radial Or Brachial Access As A Primary Choice For CAS With A Bovine Arch: Technical Tips |
Presenter(s):Luigi Inglese, MD | |
View Slides in PDF | |
4:07 PM - 4:12 PM | Screening For ACS Is Important: Not To Increase Invasive Treatments But To Lead To Better Medical Treatment: Which Patients Should Be Screened |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Slides in PDF | |
4:13 PM - 4:18 PM | Cranial Nerve Injuries With CEA: What Are The Risk Factors: How Serious Are They: What Can Be Done To Prevent Them |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
4:19 PM - 4:24 PM | FDA Regulation Of CAS Devices: What Is Happening And What Does The Future Hold |
Presenter(s):Thomas G. Brott, MD | |
View Slides in PDF | |
4:25 PM - 4:30 PM | Carotid Artery Replacement With Resection Of Recurrent Neck Cancer: When Yes And When No Based On A RCT: Tips And Tricks |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
View Slides in PDF | |
4:31 PM - 4:36 PM | Is There A Current Role For EC-IC Bypasses Despite The Negative Level 1 Evidence: What Is Its This Role |
Presenter(s):Mark A. Adelman, MD | |
View Slides in PDF | |
4:37 PM - 4:42 PM | Will Transcarotid Approaches For CAS Be A Game Changer Even Without Any Specialized Devices And Why |
Presenter(s):Patrice F. Bergeron, MD | |
View Slides in PDF | |
4:43 PM - 4:49 PM | Panel Discussion |
END OF SESSION 83 | |
SESSION 84 SCHEDULE | |
Friday
SESSION 84:
NEW CONCEPTS AND UPDATES IN AORTIC DISEASE AND ITS TREATMENT
Moderators:Evan C. Lipsitz, MD / Benjamin W. Starnes, MD
|
|
x | |
4:49 PM - 4:54 PM | Recognition And Surgical Management Of Non-Aortic Pediatric Arterial Aneurysms |
Presenter(s):James C. Stanley, MD / Frank M. Davis, MD / Dawn M. Coleman, MD / Jonathan L. Eliason, MD | |
View Slides in PDF | |
4:55 PM - 5:00 PM | Comparative Performance Of FEVAR, Open Repair And Off-Label EVAR For Juxtarenal AAAs Not Suitable For Standard On-Label EVAR: Beyond A Single Center Experience |
Presenter(s):S. Rao Vallabhaneni, MD, FRCS | |
View Slides in PDF | |
5:01 PM - 5:06 PM | Chimney EVAR For Juxtarenal AAAs Has A Less Deleterious Effect On Renal Function Than Open Repair |
Presenter(s):Zoran Rancic, MD, PhD | |
5:07 PM - 5:12 PM | When Do Parallel Grafts Work And When Don’t They And Why |
Presenter(s):William D. Jordan, Jr., MD | |
View Slides in PDF | |
5:13 PM - 5:18 PM | Surgical Infrarenal Aortic Graft Replacement As An Adjunct To Other Procedures: It Can Be A Useful Part Of A Hybrid Approach To Complex Aortic Pathology |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Slides in PDF | |
5:19 PM - 5:24 PM | Status Of The LEOPARD Trial To Compare Outcomes Of On-The-Bifurcation Fixation With The Endologix AFX EVAR Device To Current Proximally-Fixed EVAR Endografts |
Presenter(s):Christopher J. Kwolek, MD / Benjamin W. Starnes, MD | |
View Slides in PDF | |
5:25 PM - 5:30 PM | Why Is The Right Axillary Approach The Best For Inserting Chimney Grafts: Tips And Tricks For Inserting Multiple Chimneys Safely |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
5:31 PM - 5:36 PM | DEBATE: Severely Angled Aortic Necks May Remodel Beneficially After EVAR, Minimizing The Need For Open Repair |
Presenter(s):Boonprasit Kritpracha, MD | |
View Slides in PDF | |
5:37 PM - 5:42 PM | DEBATE: No They Do Not: Minilap Open Repair Is Usually A Better Choice Than Off-Label Use Of EVAR Devices For AAAs |
Presenter(s):Francesco Spinelli, MD | |
View Slides in PDF | |
5:43 PM - 5:48 PM | For Aortic Operations On Scarred Or Heavily Calcified Aortas An Anastomotic Technique Using An Endograft Connector Avoids The Need For Difficult Aortic Dissection, Clamping And Suturing: The VORTEC Technique |
Presenter(s):Mario L. Lachat, MD | |
View Slides in PDF | |
5:49 PM - 5:55 PM | Panel Discussion End of Program K |
END OF SESSION 84 | |
SESSION 85 SCHEDULE | |
Friday
SESSION 85:
NEW DEVELOPMENTS IN DISEASES OF THE POPLITEAL ARTERY; ANEURYSMS, OCCLUSIONS AND ENTRAPMENT
Moderators:Cynthia K. Shortell, MD / Ali F. AbuRahma, MD
|
|
x | |
POPLITEAL ANEURYSM RELATED TOPICS (SEE ALSO SESSION 28) | |
6:45 AM - 6:50 AM | Is Totally Endovascular Treatment A Good Option For Ruptured Popliteal Artery Aneurysms: Tips And Tricks |
Presenter(s):Francesco Setacci, MD | |
View Slides in PDF | |
6:51 AM - 6:56 AM | Is Totally Endovascular Treatment A Good Option For A Thrombosed Popliteal Aneurysm: Tips On How To Do It |
Presenter(s):Giovanni Pratesi, MD | |
View Slides in PDF | |
6:57 AM - 7:02 AM | Open Repair Of Asymptomatic Popliteal Aneurysm Is Associated With Better Outcomes Than Endo Repair: When Should Endo Repair Be Used |
Presenter(s):Mohammad H. Eslami, MD, RVT | |
View Slides in PDF | |
7:03 AM - 7:08 AM | DEBATE: What Have I Learned About Repairing Popliteal Aneurysms Since Peter Gloviczki And I Treated A Famous Popliteal Aneurysm Patient Almost 10 Years Ago |
Presenter(s):Barry T. Katzen, MD | |
View Slides in PDF | |
7:09 AM - 7:14 AM | DEBATE: What Have I Learned About Popliteal Aneurysms Since Barry Katzen And I Treated A Famous Popliteal Aneurysm Patient Almost 10 Years Ago |
Presenter(s):Peter Gloviczki, MD | |
View Slides in PDF | |
POPLITEAL OCCLUSIVE DISEASE | |
7:15 AM - 7:20 AM | What Is The Best Treatment For Treating Popliteal Occlusive Disease: PTA With Plain Balloons Or DEBs, When Stenting (Bare Or DES), When Atherectomy Or When Bypass |
Presenter(s):Jörn O. Balzer, MD, PhD | |
View Slides in PDF | |
7:21 AM - 7:26 AM | Effectiveness Of Zilver PTX DESs Placed Across The Knee Joint For Occlusive Disease: Long-Term Results |
Presenter(s):Marcelo Ferreira, MD | |
View Slides in PDF | |
POPLITEAL ENTRAPMENT SYNDROMES | |
7:27 AM - 7:32 AM | Popliteal Entrapment Syndromes: Optimizing Diagnosis And Treatment In 2015 And Beyond |
Presenter(s):Niten Singh, MD | |
View Slides in PDF | |
7:33 AM - 7:38 AM | Functional Popliteal Entrapment In High Performance Athletes: How To Diagnose It And How To Treat It By Partial Medial Gastrocnemius Resection: Why Does It Work |
Presenter(s):Jason T. Lee, MD | |
View Slides in PDF | |
7:39 AM - 7:45 AM | Panel Discussion |
END OF SESSION 85 | |
SESSION 86 SCHEDULE | |
Friday
SESSION 86:
NEW DEVELOPMENTS IN THE MANAGEMENT OF INFECTED ARTERIAL GRAFTS, EVARs, TEVARs AND MYCOTIC AAAs; USE OF ENDOGRAFTS TO TREAT AORTIC INFECTION AND AORTO-ENTERIC FISTULAS
Moderators:R. James Valentine, MD / Timur P. Sarac, MD
|
|
x | |
TREATMENT OF INFECTED EVARS AND TEVARS | |
7:45 AM - 7:50 AM | Surgical Treatment Of Infected Abdominal Endografts (EVARs): Techniques And Results From A Multicenter Study |
Presenter(s):Samuel R. Money, MD, MBA | |
View Slides in PDF | |
7:51 AM - 7:56 AM | DEBATE: Management Of Infectious Complications Of EVARs And Aortic Graft Infections: The Graft Must Come Out |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
7:57 AM - 8:02 AM | DEBATE: Not So: New Concepts For Treating Infected EVARs And Aortic Grafts Less Invasively Can Work: Leaving The Graft In Place But Treating The Infected AAA Sac With Drainage/Irrigation Or Excision Can Be Effective And Less Morbid |
Presenter(s):Martin Malina, MD, PhD | |
View Slides in PDF | |
8:03 AM - 8:08 AM | How To Treat Infected FEVARs And TEVARs: What Strategies Work |
Presenter(s):Piotr M. Kasprzak, MD | |
View Slides in PDF | |
8:09 AM - 8:14 AM | Treatment Strategies For Infected Thoracic Endografts: The Graft Must Come Out: What If It Can’t |
Presenter(s):Christos D. Liapis, MD | |
View Slides in PDF | |
TREATMENT OF MYCOTIC AAAS WITH EVAR | |
8:15 AM - 8:20 AM | EVAR Is Durable Treatment For Mycotic AAAs – Sometimes: Other Adjuncts And Surveillance Are Vital: Results Of European Multicenter Study |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Slides in PDF | |
8:21 AM - 8:26 AM | With Infected AAAs, EVAR Should Be The First Choice Treatment: Based On Over 80 Patients – Some Followed Over 10 Years: What Problems Can Arise And How Can They Be Managed |
Presenter(s):Boonprasit Kritpracha, MD | |
View Slides in PDF | |
8:27 AM - 8:33 AM | Panel Discussion |
MANAGEMENT OF AORTO-ENTERIC FISTULAS | |
Moderator(s): Thomas C. Bower, MD / Samuel R. Money, MD, MBA | |
8:33 AM - 8:38 AM | EVAR And TEVAR Can Be Definitive Treatment For Aorto-Enteric Fistulas: What Is Required |
Presenter(s):Furuzan Numan, MD | |
View Slides in PDF | |
8:39 AM - 8:44 AM | Successful Radical And Semi-Radical Treatment Of Aortobronchial And Aortoesophageal Fistulas After TEVAR: What Is Required For Survival – Which Is Possible |
Presenter(s):Ludovic Canaud, MD, PhD | |
View Slides in PDF | |
MORE ON INFECTED GRAFTS AND MYCOTIC AAAS | |
8:45 AM - 8:50 AM | New Developments In The Treatment Of Infected Aortic Grafts And Mycotic AAAs: What Strategies Work |
Presenter(s):Kamphol Laohapensang, MD | |
View Slides in PDF | |
8:51 AM - 8:56 AM | New Developments In The Treatment Of Aortic Graft Infection: How Do Silver Impregnated Grafts And Negative Wound Pressure Help To Preserve Infected Grafts And When Won’t These Measures Work |
Presenter(s):Max Zegelman, MD | |
View Slides in PDF | |
8:57 AM - 9:02 AM | Tips And Tricks To Deal With Infected Groin Wounds Containing Infected Grafts |
Presenter(s):Joseph S. Giglia, MD | |
View Slides in PDF | |
9:03 AM - 9:08 AM | How To Recognize Complications Of Femoral Vein Grafts Used To Treat Aortic Graft Infections And How To Manage These Complications |
Presenter(s):R. James Valentine, MD | |
View Slides in PDF | |
9:09 AM - 9:16 AM | Panel Discussion |
9:17 AM - 9:37 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 86 | |
SESSION 87 SCHEDULE | |
Friday
SESSION 87:
NEW DEVELOPMENTS IN HYBRID OPERATING SUITES AND IMPROVEMENTS IN IMAGING
Moderators:Daniel G. Clair, MD / Frans L. Moll, MD, PhD
|
|
x | |
9:37 AM - 9:42 AM | Advantages Of Fusion And How It Reduces Contrast And X-ray Dosage For Complex AAA Repairs: How To Eliminate Registration Errors Due To Changes In Anatomy From Vascular Devices, Sheaths And Wires |
Presenter(s):Neal S. Cayne, MD | |
View Slides in PDF | |
9:43 AM - 9:48 AM | Advances In Fusion Techniques To Make Them More Accurate: Use Of Vascular Calcium To Correct For Aortic Distortion From Sheaths And Wires And Automatic Fusion Registration And Re-Registration |
Presenter(s):Alan B. Lumsden, MD, FACS | |
9:49 AM - 9:54 AM | A New System For Automated 3D Fusion Overlay Which Works With All Digital Fluoroscopes – Fixed And MOBILE From All Manufacturers And Which Re-Registers With Patient And Table Movement |
Presenter(s):Tom Carrell, MD, MChir | |
View Slides in PDF | |
9:55 AM - 10:00 AM | A Modern Hybrid Room Will Reduce Radiation Dose And Protect Patients' Kidneys: Tips And Tricks To Use Such Rooms Optimally |
Presenter(s):Lieven F. Maene, MD | |
View Slides in PDF | |
10:01 AM - 10:06 AM | Rotation Angio-CT: What Is It And How Can It Improve Complex Endovascular Treatments Compared To Standard DSA And Pressure Measurements |
Presenter(s):Timothy A. Resch, MD, PhD | |
View Slides in PDF | |
10:07 AM - 10:12 AM | Update On New Assets In Hybrid Suites And How They Help Get Better Results |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
10:13 AM - 10:18 AM | How To Train Hybrid Suite Staff Optimally For Complex Aortic Procedures: It’s Essential They Know About All Equipment |
Presenter(s):Rodney A. White, MD | |
View Slides in PDF | |
10:19 AM - 10:27 AM | Panel Discussion |
Moderator(s): Rodney A. White, MD / Alan B. Lumsden, MD, FACS | |
10:27 AM - 10:32 AM | Mobile C-Arm (Ziehm Vision RFT Hybrid) And Stille Mobile Floating Table Has Many Of The Advantages Of A Hybrid Room At A Lower Cost And They Can Function In Multiple ORs |
Presenter(s):Peter C.J. Goverde, MD | |
View Slides in PDF | |
10:33 AM - 10:38 AM | Intra-arterial Arteriography Does Not Always Accurately Reflect The Anatomy: What Can Be Done To Fix This Problem |
Presenter(s):Nicolas A. Diehm, MD | |
View Slides in PDF | |
10:39 AM - 10:44 AM | Can Optical Techniques Replace X-ray For Interventional Guidance: Some Specifics |
Presenter(s):Frans L. Moll, MD, PhD | |
View Slides in PDF | |
10:45 AM - 10:50 AM | Value Of Optical Coherence Tomography (OCT) In The Treatment Of Lower Extremity And Other Arteries: How Does It Work And What Are The Limitations |
Presenter(s):Vikram S. Kashyap, MD | |
View Slides in PDF | |
10:51 AM - 10:56 AM | Value Of IVUS To Evaluate Residual Stenoses After SFA Interventions And SPY To Evaluate Foot Tissue Perfusion To Assess Procedure Effectiveness: How Do They Work |
Presenter(s):Wei Zhou, MD | |
View Slides in PDF | |
10:57 AM - 11:11 AM | Panel Discussion |
END OF SESSION 87 | |
SESSION 88 SCHEDULE | |
Friday
SESSION 88:
NEW DEVELOPMENTS IN THORACIC OUTLET SYNDROME (TOS)
Moderators:Karl A. Illig, MD / Robert W. Thompson, MD
|
|
x | |
11:11 AM - 11:16 AM | What’s New In The Treatment Of TOS |
Presenter(s):Robert W. Thompson, MD | |
View Slides in PDF | |
11:17 AM - 11:22 AM | New SVS Reporting Standards For TOS: Highlights And What Is New And Different |
Presenter(s):Karl A. Illig, MD | |
View Slides in PDF | |
11:23 AM - 11:28 AM | Value Of Supraclavicular Approach To TOS And First Rib Resection: Technical Tips And Tricks To Simplify The Approach |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
11:29 AM - 11:34 AM | Robot Assisted Thoroscopic First Rib Resection Is The Approach Of Choice For TOS: Why And What Equipment And Skills Are Required |
Presenter(s):Hans M.E. Coveliers, MD, MBA | |
View Slides in PDF | |
11:35 AM - 11:40 AM | Treatment Of TOS In Competitive Athletes: When Is Surgical Treatment Indicated: Technical Tips And Tricks |
Presenter(s):Jason T. Lee, MD | |
View Slides in PDF | |
11:41 AM - 11:46 AM | How Can Cervical Ribs Cause A Stroke: What Is The Best Treatment If They Do |
Presenter(s):Fred A. Weaver, MD | |
View Slides in PDF | |
11:47 AM - 11:52 AM | Outpatient Surgery For TOS Is Safe And Effective: Technical Details, Precautions, And Requirements |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
View Slides in PDF | |
11:53 AM - 0:00 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 88 | |
SESSION 89 SCHEDULE | |
Friday
SESSION 89:
NEW OR UPDATED CONCEPTS REGARDING VASCULAR TRAUMA, TAKAYASU’S DISEASE; AND MEDICAL TOPICS
Moderators:Richard J. Powell, MD / Vivian Gahtan, MD
|
|
x | |
1:00 PM - 1:05 PM | Improving Outcomes Of Treatment For Major Trauma (Vascular And Other) With Aortic Balloon Control And Other Over The Wire Endovascular Techniques: The REBOA Registry And How Aortic Balloon Control Should Work |
Presenter(s):Tal M. Hörer, MD, PhD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA) With A Low Profile Not Over-A-Guide Wire: How Does It Work And Value In Military And Civilian Injuries |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Update On A Simplified Aortic Occlusion Balloon System For RAAAs, Major Vascular Or Other Hemorrhagic Trauma: Does It Require Fluoro And Who Can Use It |
Presenter(s):Benjamin W. Starnes, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | What Is The Role Of Endovascular Treatments In Takayasu’s Disease Of The Aorta And Its Branches |
Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Pitfalls In The Endovascular Treatment Of Takayasu’s Disease: Should They Ever Be Used And When |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | DEBATE: Endovascular Treatments Should Be Used In Many Patients With Intermittent Claudication |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
1:36 PM - 1:41 PM | DEBATE: Not So: Exercise And Medical Therapy Are The Best Treatment For Almost All Patients With Intermittent Claudication |
Presenter(s):Erich Minar, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | How To Predict Groin Wound Infections After Open Vascular Surgery: What Can Be Done To Prevent Them |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | DEBATE: Statins Are Disruptive Safe Miracle Drugs And Should Be Used More Widely: Which Drug, What Dose And For Whom |
Presenter(s):Don Poldermans, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | DEBATE: Not So: Statin Benefits Are Overblown And They Are Dangerous: They Should Be Used Less |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Slides in PDF | |
2:00 PM - 2:06 PM | Panel Discussion |
END OF SESSION 89 | |
SESSION 90 SCHEDULE | |
Friday
SESSION 90:
PROGRESS AND UPDATES ON MEDICAL TREATMENTS AND OTHER SUBJECTS
Moderators:Elliot L. Chaikof, MD, PhD / Andrew N. Nicolaides, MS, FRCS
|
|
x | |
MEDICAL TREATMENTS | |
2:06 PM - 2:11 PM | How To Incorporate A Dedicated Cardiovascular Disease Prevention Program Into A Vascular Practice And Make It Work |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Value Of Cilostazol (Pletal) In Vascular Patients: It’s Not Just For Claudication: Beneficial Effects, Who Should Get And At What Dose |
Presenter(s):Richard J. Powell, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | With Vascular Patients And Vascular Procedures, When Are Beta Blockers Helpful: In What Dose And With What Precautions |
Presenter(s):Mark L. Friedell, MD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Preoperative Beta Blockers Reduce Operative Mortality (30-Day) And Non-Cardiac Morbidity After Elective Open AAA Repair |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Slides in PDF | |
2:30 PM - 2:35 PM | What Is New In Best Medical Therapy For Vascular Patients: How Can Its Effectiveness Be Measured: What LDL Level Should We Strive For; Can The LDL Level Ever Be Too Low |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
View Slides in PDF | |
2:36 PM - 2:41 PM | When And Why Should Vascular Surgeons Prescribe Maximal Dose Statins: What Dose Is This And What Are The Risks |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
2:42 PM - 2:47 PM | High Dose Ruvostatin (Crestor) Leads To Decreased Renal Damage After Contrast Arteriography: Should It Be Used More Widely As A Renal Protective Agent |
Presenter(s):Olivier H.J. Koning, MD, PhD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | When After Coronary Stenting With A DES Or BMS Is It Safe To Stop Clopidogrel And Perform An Open Operation: The Latest Update |
Presenter(s):Don Poldermans, MD | |
View Slides in PDF | |
2:54 PM - 3:02 PM | Panel Discussion |
Moderator(s): Anthony J. Comerota, MD, FACS, FACC / Russell H. Samson, MD, RVT, FACS | |
3:02 PM - 3:07 PM | Mortality Is A More Important End Point Than Stroke In Patients With An Asymptomatic Carotid Stenosis: What Can Be Done About It |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Slides in PDF | |
3:08 PM - 3:13 PM | Postoperative And Post-Procedural Myocardial Infarctions (MIs): Evaluation, Risk Factors And Optimal Prevention And Treatment: We Can Do More |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
CCSVI (SEE ALSO SESSION 97) | |
3:14 PM - 3:19 PM | Update On CCSVI And Interventions For MS: Role Of Autonomic Nervous System And Is There Still A Role For Angioplasty Of Vein Stenoses |
Presenter(s):Donald B. Reid, MD | |
3:20 PM - 3:25 PM | How Are 3D Navigational Tools Helpful In Lower Extremity Interventions |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Slides in PDF | |
3:26 PM - 3:31 PM | When Is Duplex Ultrasound Surveillance A Safe Alternative For CT Or MR – After EVAR; After Lower Extremity Revascularizations: What Are The Requirements |
Presenter(s):Keith D. Calligaro, MD / Matthew J. Dougherty, MD | |
View Slides in PDF | |
3:32 PM - 3:39 PM | Panel Discussion |
3:40 PM - 4:00 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 90 | |
SESSION 91 SCHEDULE | |
Friday
SESSION 91:
RECORDED LIVE CASES ON COMPLEX AAA AND TAAA REPAIRS WITH FENESTRATED AND BRANCHED ENDOGRAFTS
|
|
x | |
4:00 PM - 4:20 PM | Complex Cases From Mϋnster |
Presenter(s):Martin J. Austermann, MD / Giovanni Torsello, MD | |
View Slides in PDF | |
4:20 PM - 4:27 PM | Questions And Discussion |
4:28 PM - 4:48 PM | Complex Cases From The Mayo Clinic |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
4:48 PM - 4:55 PM | Questions And Discussion |
END OF SESSION 91 | |
SESSION 92 SCHEDULE | |
Friday
SESSION 92:
NEW CONCEPTS AND TECHNIQUES AND RADIATION SAFETY
Moderators:Lindsay Machan, MD / Barry T. Katzen, MD
|
|
x | |
4:55 PM - 5:00 PM | New Dose Aware System For Monitoring Staff Radiation Exposure As It Occurs |
Presenter(s):Mario L. Lachat, MD | |
View Slides in PDF | |
5:01 PM - 5:06 PM | Innovative Approach To Angiogenic Cell Therapy For CLI: Hope For The Future And BOLD MRI: A New Method To Measure Calf Perfusion To Monitor Its Effects |
Presenter(s):Bijan Modarai, PhD, FRCS | |
View Slides in PDF | |
5:07 PM - 5:12 PM | Duplex Imaging Is The Best Surveillance Method After EVAR With Chimney Grafts |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
RADIATION SAFETY | |
5:13 PM - 5:18 PM | Radiation Protection Training And Coaching In A Simulated Hybrid Suite Markedly Reduces Radiation Exposure To Patients And Staff |
Presenter(s):Lars B. Lonn, MD, PhD | |
View Slides in PDF | |
5:19 PM - 5:24 PM | New Developments In Radiation Safety: Proper C-Arm Angulation, Dynamic Computer Assisted Collimation (Ikomed Technologies), Radiation Reducing Cap (No Brainer) And Avoiding Mag Views |
Presenter(s):Lindsay Machan, MD | |
View Slides in PDF | |
5:25 PM - 5:30 PM | Disposable Radiation Absorbing Surgical Drapes Reduces X-ray Exposure To Operators And Nurses |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Slides in PDF | |
5:31 PM - 5:36 PM | Fixed vs. Mobile Imaging For Endovascular Procedures: Comparative Radiation Exposure To Staff Members: How Should Staff Dosage Best Be Quantitated |
Presenter(s):Vikram S. Kashyap, MD | |
View Slides in PDF | |
5:37 PM - 5:42 PM | Surgeon Or Operator Radiation Dose During Simple And Complex Endovascular Interventions: How Many Procedures Can An Operator Do Safely And How Can Dosage Be Decreased |
Presenter(s):Carlos H. Timaran, MD | |
View Slides in PDF | |
5:43 PM - 5:48 PM | How To Reduce Radiation Exposure With Endovascular Procedures |
Presenter(s):Barry T. Katzen, MD | |
View Slides in PDF | |
5:49 PM - 5:56 PM | Panel Discussion End of Program L |
END OF SESSION 92 | |
SESSION 93 SCHEDULE | |
Friday
SESSION 93:
VENOUS CROSS-SECTIONAL IMAGING TECHNIQUES, PELVIC VENOUS INCOMPETENCE
|
|
x | |
7:00 AM - 7:05 AM | Introduction |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
7:06 AM - 7:11 AM | The Use Of IVUS To Document May-Thurner Anatomy |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
7:12 AM - 7:17 AM | How To Measure Iliac Vein Stenosis |
Presenter(s):Seshadri Raju, MD | |
View Slides in PDF | |
7:18 AM - 7:23 AM | Compare IVUS And Multi-Planar Venography For Proper Characterization Of The Occlusive Disease In The Iliac Veins And CFV |
Presenter(s):Paul J. Gagne, MD, FSIR, FACR | |
View Slides in PDF | |
7:24 AM - 7:29 AM | Novel Imaging Techniques With MRI For Thrombus Aging |
Presenter(s):Stephen A. Black, MD | |
View Slides in PDF | |
7:30 AM - 7:35 AM | MRV And CTV In Imaging Of Pelvic And Abdominal Venous Compressive Syndromes: Which Is Better And Why |
Presenter(s):Constantino Pena, MD / Barry Stein, MD, FSIR, FACR | |
View Slides in PDF | |
7:36 AM - 7:41 AM | Image Fusion With MRV For 3D Guidance Of Deep Venous Interventions |
Presenter(s):Rick De Graaf, MD, PhD | |
View Slides in PDF | |
7:42 AM - 7:47 AM | Cone Beam CT vs. IVUS In Iliac Venous Stenting |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Slides in PDF | |
7:48 AM - 7:52 AM | Panel Discussion |
7:53 AM - 7:58 AM | Pelvic Venous Duplex: How To Find The Pathology |
Presenter(s):Jan M. Sloves, RVT | |
View Slides in PDF | |
7:59 AM - 8:04 AM | Anatomy Of Pelvic Pathology |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
8:05 AM - 8:10 AM | How To Treat Vulvar Veins Before Or After Pelvic Embolization |
Presenter(s):Barrie A. Price, Mr, MD, MS, FRCS | |
View Slides in PDF | |
8:11 AM - 8:16 AM | How To Treat Peroneal Varicosities With Pelvic Symptoms: Combined Approach |
Presenter(s):Melvin Rosenblatt, MD | |
View Slides in PDF | |
8:17 AM - 8:22 AM | Embolization Has A Major Role In The Treatment Of Varicocele And Pelvic Congestion Syndrome |
Presenter(s):Lindsay Machan, MD | |
View Slides in PDF | |
8:23 AM - 8:28 AM | The Safety Of Coil Embolization Of Pelvic Veins And Subsequent Pregnancy |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Slides in PDF | |
8:29 AM - 8:34 AM | Ovarian Vein, Hypogastric Vein Incompetence Or Compression Syndrome: Coil, Stent, Both, Neither |
Presenter(s):Constantino Pena, MD | |
View Slides in PDF | |
8:35 AM - 8:40 AM | Should You Worry About The Left Renal Vein When Occluding The Left Ovarian Vein |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
8:41 AM - 8:46 AM | Acute Or Chronic Ovarian Vein Thrombosis: What To Do |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
8:47 AM - 8:52 AM | Nutcracker Syndrome: Favorable Outcomes With Endovascular Intervention (Over Open Repair) |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
8:53 AM - 8:58 AM | Panel Discussion |
END OF SESSION 93 | |
SESSION 94 SCHEDULE | |
Friday
SESSION 94:
FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION, HOT IDEAS FOR RECANALIZING CHRONIC TOTAL OCCLUSIONS
|
|
x | |
8:59 AM - 9:04 AM | Quality Of Life Assessment After Iliac Vein Stenting For DVT From May-Thurner Syndrome |
Presenter(s):Todd Berland, MD | |
View Slides in PDF | |
9:05 AM - 9:10 AM | Classification Of Anatomic Involvement Of The Iliocaval Venous Outflow Tract And Its Relationship To Outcomes After Iliocaval Venous Stenting |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
9:11 AM - 9:16 AM | Should Venous Interventions Be Performed In Patients With Right Heart Failure |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
9:17 AM - 9:22 AM | Crossing Femoro-Iliocaval Chronic Total Occlusions: Graduated Support And Tinkering |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
9:23 AM - 9:28 AM | Occluded Iliac Venous Stents: How I Recanalize |
Presenter(s):Seshadri Raju, MD / Erin H. Murphy, MD | |
View Slides in PDF | |
9:29 AM - 9:34 AM | Cutting Balloon Angioplasty For Femoropopliteal Stenoses/Synechiae Causing Venous Post-Thrombotic Syndrome |
Presenter(s):Thomas O. McNamara, MD | |
View Slides in PDF | |
9:35 AM - 9:40 AM | Technical Considerations And Emerging Technology For Chronic Venous Occlusions |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
9:41 AM - 9:46 AM | Update On EKOS “ACCESS DVT” Trial For Post-Thrombotic Syndrome |
Presenter(s):Mark J. Garcia, MD | |
View Slides in PDF | |
9:47 AM - 9:52 AM | What To Do When Inflow To Groin Is Poor |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Slides in PDF | |
9:53 AM - 9:58 AM | Selection Criteria For Venous Angioplasty To Treat Post-Thrombotic Syndrome |
Presenter(s):Thomas O. McNamara, MD | |
View Slides in PDF | |
9:59 AM - 10:04 AM | An Update On VIVO-EU – The Zilver Vena Venous Stent Study In Europe |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Slides in PDF | |
10:05 AM - 10:10 AM | VIRTUS: An Evaluation Of The VICI Venous Stent System In Patients With Chronic Iliofemoral Venous Outflow Obstruction |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
10:11 AM - 10:16 AM | The UK Iliac Vein Stent Experience |
Presenter(s):Stephen A. Black, MD | |
View Slides in PDF | |
10:17 AM - 10:22 AM | When And How To Use Sharp Devices For Iliocaval Recanalization |
Presenter(s):Mark J. Garcia, MD | |
View Slides in PDF | |
10:23 AM - 10:28 AM | Stent Fenestration, Z-Stents, Or Use Of The Azygous For Difficult Iliocaval Outflow |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
10:29 AM - 10:34 AM | What Is The Ideal Venous Stent |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
10:35 AM - 10:40 AM | Panel Discussion |
END OF SESSION 94 | |
SESSION 95 SCHEDULE | |
Friday
SESSION 95:
STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION, WOUNDS AND NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
|
|
x | |
10:41 AM - 10:46 AM | Surgical Reconstruction Of The Deep Veins |
Presenter(s):Stephen A. Black, MD | |
View Slides in PDF | |
10:47 AM - 10:52 AM | Chronic Deep Venous Occlusive Disease: What Is The True Extent Of The Problem; Do We Know; Optimal Anticoagulation After Deep Venous Stenting |
Presenter(s):Manj S. Gohel, MD, RCS, FEBVS | |
View Slides in PDF | |
10:53 AM - 10:58 AM | Causes Of Failure Of Iliac Vein Stenting And What To Do About Them |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
10:59 AM - 11:04 AM | New Techniques In The Evaluation Of Lymphedema: Defining The Pathophysiology |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
11:05 AM - 11:10 AM | Deep Venous Valve Treatment: When And Why |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
11:11 AM - 11:16 AM | A Novel Solution For Deep Venous Reflux: Endovenous Neovalve |
Presenter(s):Fedor Lurie, MD, PhD | |
View Slides in PDF | |
WOUNDS AND NEW HORIZONS | |
11:17 AM - 11:22 AM | RCT Demonstrating The Efficacy And Benefits Of Sulodexide Treatment In Patients With Venous Ulcers |
Presenter(s):Joseph D. Raffetto, MD | |
View Slides in PDF | |
11:23 AM - 11:28 AM | Definition Of Venous Ulcer: Clinical Evaluation Wound Care, Compression, Surgical Treatment, Ancillary Measures And Primary Prevention |
Presenter(s):Marc A. Passman, MD | |
View Slides in PDF | |
11:29 AM - 11:34 AM | Important RCTs For Venous Wound Healing |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
11:35 AM - 11:40 AM | The Argument For Surgical Intervention In Patients With Venous Ulcer, Based On Healthcare Savings |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
11:41 AM - 11:46 AM | Proteomics And Degradomics In Venous Leg Ulcers |
Presenter(s):Joseph D. Raffetto, MD | |
View Slides in PDF | |
11:47 AM - 11:52 AM | Not All Leg Ulcers Are Venous |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
11:53 AM - 11:59 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 95 | |
SESSION 96 SCHEDULE | |
Friday
SESSION 96:
STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM, INCLUDING THE AXILLOSUBCLAVIAN SYSTEM
Moderators:Joann Lohr, MD / Gregory L. Moneta, MD
|
|
x | |
1:00 PM - 1:05 PM | Do The NOACs Have Anti-Inflammatory Effects |
Presenter(s):Dawn M. Coleman, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Update On Reversal Agents For The NOACs |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Economy Class Syndrome: Air Travel-Related DVT And PE |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Isolated Soleal And Gastrocnemius Vein Thrombosis |
Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Neurological Presentation Of IVC Occlusion During Pregnancy With No Visible Changes Of Venous Hypertension |
Presenter(s):Joann Lohr, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Biomarkers Of Venous Thromboembolism |
Presenter(s):Thomas W. Wakefield, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Unusual Presentation/Complications Of Undiagnosed Thrombophilia |
Presenter(s):Joann Lohr, MD | |
View Slides in PDF | |
1:42 PM - 1:48 PM | Infection/Inflammation Associated With Acute DVT: From The Clinic To Bench |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
1:49 PM - 1:54 PM | Experimental Insights Into PTS |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
VTE INTERVENTIONAL | |
1:55 PM - 2:00 PM | Endovascular Management Of Ilio-Femoral DVT With Percutaneous Thrombectomy And Thrombolysis; Indications, Techniques And Results |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
2:01 PM - 2:06 PM | Pharmacomechanical Thrombolysis Of Large Volume (Extensive) DVT Using The Rapid Lysis Technique |
Presenter(s):Mark J. Garcia, MD | |
View Slides in PDF | |
2:07 PM - 2:12 PM | ATTRACT Study: A Multicenter Randomized Trial To Evaluate Pharmacomechanical Catheter-Directed Thrombolysis |
Presenter(s):Constantino Pena, MD | |
View Slides in PDF | |
2:13 PM - 2:18 PM | First In Human Analysis Of The Aspirex Rotational Thrombectomy Catheter For Iliofemoral DVT |
Presenter(s):Michael K.W. Lichtenberg, MD | |
View Slides in PDF | |
2:19 PM - 2:23 PM | D-Dimer And/Or Duplex Findings To Manage DVT |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Impact Of Caval Occlusion On The Outcomes Of Thrombolysis For Iliofemoral DVT |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Venous Issues In Thoracic Outlet Syndrome: Lysis, Venoplasty, First Rib Resection: Staged Or Same Setting |
Presenter(s):Enrique Criado, MD, FACS | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Management Of Paget Schroetter Syndrome In Athletes |
Presenter(s):Handel R. Robinson, MD | |
View Slides in PDF | |
2:42 PM - 2:47 PM | Incidence Of Upper Extremity DVT After Central Venous Catheterization And What To Do |
Presenter(s):Gregory L. Moneta, MD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | Panel Discussion |
END OF SESSION 96 | |
SESSION 97 SCHEDULE | |
Friday
SESSION 97:
ENDOVASCULAR AND OPEN SOLUTIONS FOR INFERIOR VENA CAVA TUMORS AND OCCLUSIONS, VENA CAVA FILTRATION STRATEGIES, PITFALLS, AND COMPLICATIONS AND MORE ABOUT ILIAC VEIN STENTING
Moderators:Peter Gloviczki, MD / William J. Quinones-Baldrich, MD
|
|
x | |
MORE FEMORAL-ILIOCAVAL FLOW ISSUES | |
2:54 PM - 2:59 PM | IVC Agenesis: Is This A Real Entity |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Caval Tumors |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
3:06 PM - 3:11 PM | Evolution Of Venous In-Stent Stenosis: Do Anti-Platelet Agents Help Mitigate |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
3:12 PM - 3:17 PM | QOL After Deep Venous Recanalization Procedures: Any Relation To Patency |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Slides in PDF | |
3:18 PM - 3:23 PM | Conduit Choices For In-Line Caval Reconstruction |
Presenter(s):Peter Gloviczki, MD | |
View Slides in PDF | |
3:24 PM - 3:29 PM | IVC Replacement For Malignancy: How To Do It And What Is The Best Graft |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
3:30 PM - 3:35 PM | Difficult Femoral And Iliocaval Endovascular Reconstructions: Lessons Learned |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
3:36 PM - 3:41 PM | Patient Selection For In-Line Caval Reconstruction |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Slides in PDF | |
3:42 PM - 3:47 PM | Endovascular Treatment Of Superior Vena Cava Syndrome Because Of Central Vein Occlusion |
Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
View Slides in PDF | |
3:48 PM - 3:53 PM | Venous Atherectomy: Just Saying |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
3:54 PM - 3:59 PM | Open Surgery For CCSVI Reduces The Brain Ventricles Volume |
Presenter(s):Paolo Zamboni, MD | |
View Slides in PDF | |
CAVAL FILTRATION ISSUES | |
4:00 PM - 4:05 PM | Indications For IVC Filters: Are They Being Observed |
Presenter(s):John E. Rectenwald, MD, MS | |
View Slides in PDF | |
4:06 PM - 4:11 PM | Update On The Sentry Bioconvertible Non-Retrieval IVC Filter |
Presenter(s):David Rosenthal, MD | |
View Slides in PDF | |
4:12 PM - 4:17 PM | Robotic Vena Cava Surgery |
Presenter(s):Samuel R. Money, MD, MBA | |
View Slides in PDF | |
4:18 PM - 4:23 PM | The PREPIC Trial: Fact Or Fiction |
Presenter(s):John E. Rectenwald, MD, MS | |
View Slides in PDF | |
4:24 PM - 4:29 PM | Update On The PRESERVE Vena Cava Filter Study |
Presenter(s):David L. Gillespie, MD | |
View Slides in PDF | |
4:30 PM - 4:35 PM | Early Clinical Experience With The Celect Platinum Filter, With Focused Pre-Retrieval Imaging Planning |
Presenter(s):Atul Gupta, MD | |
View Slides in PDF | |
4:36 PM - 4:41 PM | Major Complications After IVC Filter Placement And How To Avoid Them |
Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
View Slides in PDF | |
4:42 PM - 4:47 PM | IVC Filter Retrieval Rates: The Influence Of Filter Design, Practice Administration And The Operator |
Presenter(s):Richard G. McWilliams, FRCR, EBIR | |
View Slides in PDF | |
4:48 PM - 4:53 PM | IVC Recanalization In The Presence Of A Thrombosed IVC Filter |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
4:54 PM - 5:00 PM | Panel Discussion End of Program M |
END OF SESSION 97 | |
SESSION 98 SCHEDULE | |
Friday
SESSION 98:
CLASSIFICATION, IMAGING, AND PHARMCO-THERAPY
|
|
x | |
7:55 AM - 8:00 AM | Introduction |
Presenter(s):Krassi Ivancev, MD, PhD | |
8:00 AM - 8:10 AM | Current Classification And Nomenclature Of Vascular Malformations |
Presenter(s):Patricia E. Burrows, MD | |
View Slides in PDF | |
8:10 AM - 8:20 AM | The Hamburg Classification In Vascular Malformations: Clinical Applications Of The System |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
8:20 AM - 8:30 AM | 2015 ISSVA Classification Update |
Presenter(s):Francine Blei, MD, MBA | |
View Slides in PDF | |
8:30 AM - 8:40 AM | Vascular Tumors Confused With Vascular Malformations |
Presenter(s):Francine Blei, MD, MBA | |
View Slides in PDF | |
8:40 AM - 8:50 AM | New Imaging Modalities Essential For Accurate Diagnosis Of Vascular Malformations |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
8:50 AM - 9:00 AM | The Houdart CNS AVM Classification, The Do Peripheral AVM Classification, And The Yakes AVM Classification And Its Therapeutic Implications |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
9:00 AM - 9:10 AM | Update On the Role Of Pharmco-Therapy In Vascular Malformations |
Presenter(s):Gresham T. Richter, MD | |
9:10 AM - 9:20 AM | The Role Of Medical Therapies For Pediatric Hemangioma And Vascular Malformations |
Presenter(s):Francine Blei, MD, MBA | |
View Slides in PDF | |
9:20 AM - 9:40 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 98 | |
SESSION 99 SCHEDULE | |
Friday
SESSION 99:
HEAD AND NECK VASCULAR MALFORMATION TREATMENT ISSUES
|
|
x | |
9:40 AM - 9:50 AM | Dangerous Arterial Connections In The Head And Neck: Avoiding Vascular Neurological Complications And The Judicious Use Of Embolic Agents |
Presenter(s):Guilherme Dabus, MD | |
View Slides in PDF | |
9:50 AM - 10:00 AM | Endovascular Treatment Of Retinoblastoma: A Primary Form Of Therapy |
Presenter(s):Pierre Gobin, MD | |
View Slides in PDF | |
10:00 AM - 10:10 AM | Endovascular Treatment Of Dural AVF: A Complex Acquired Vascular Lesion With Microfistulae Involving The Dural Sinuses |
Presenter(s):Philip M. Meyers, MD | |
View Slides in PDF | |
10:10 AM - 10:20 AM | Liquid Embolic Agents In The Treatment Of Craniofacial AVMs And AVSs: Techniques And Results |
Presenter(s):Guilherme Dabus, MD | |
View Slides in PDF | |
10:20 AM - 10:30 AM | Management Of Complex Head And Neck Low-Flow Venous And Lymphatic Malformations |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
10:30 AM - 10:40 AM | AVMs: Staged Multimodal Therapy For the Most Aggressive Head And Neck Vascular Malformations |
Presenter(s):Gresham T. Richter, MD | |
10:40 AM - 10:50 AM | The Otolaryngologist’s Distinct Role In The Multidisciplinary Vascular Malformation Management Team |
Presenter(s):Edward J. Hepworth, MD | |
View Slides in PDF | |
10:50 AM - 11:00 AM | Current Surgical Indications For Infantile Hemangioma In The Era Of Propranolol |
Presenter(s):Gresham T. Richter, MD | |
11:00 AM - 11:10 AM | Surgical Reconstructive Techniques Post-Endovascular Ablation Of Head And Neck Vascular Malformation |
Presenter(s):Randolph C. Robinson, MD, DDS | |
View Slides in PDF | |
11:10 AM - 11:15 AM | Onyx AVM Embolotherapy: The Histologic Tissue Changes, Tissue Inflammatory Response, Fluoroscopy Issues, And Endovascular Issues With Its Use |
Presenter(s):Mollie Meek, MD | |
View Slides in PDF | |
11:15 AM - 11:25 AM | Laser Therapy For Cutaneous Vascular Anomalies |
Presenter(s):Gresham T. Richter, MD | |
11:25 AM - 11:35 AM | Curative Endovascular Treatment Of Complex Multiple AVMs Of The Head And Neck |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
11:35 AM - 12:55 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (3rd Floor) |
END OF SESSION 99 | |
SESSION 100 SCHEDULE | |
Friday
SESSION 100:
EXTREMITY LOW-FLOW VASCULAR MALFORMATION MANAGEMENT ISSUES
|
|
x | |
12:55 PM - 1:05 PM | Pitfalls In Superficial Vascular Malformation Endovascular Management |
Presenter(s):Emmanuel M. Houdart, MD | |
View Slides in PDF | |
1:05 PM - 1:15 PM | Management Of Vascular Anomalies In Genetic And Syndromic Disorders |
Presenter(s):Ahmad Alomari, MD, MSc, FSIR | |
View Slides in PDF | |
1:15 PM - 1:25 PM | Treatment Of Vascular Malformations In Infants |
Presenter(s):Patricia E. Burrows, MD | |
View Slides in PDF | |
1:25 PM - 1:35 PM | Special Diagnostic Considerations In Vascular Malformation Patients |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
1:35 PM - 1:45 PM | Treatment Of Intramuscular Venous Malformations Of The Extremities |
Presenter(s):Robert J. Rosen, MD | |
View Slides in PDF | |
1:45 PM - 1:55 PM | Ethanol Ablation Of Venous Malformations Of The Chest, Abdomen, And Buttocks |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
1:55 PM - 2:05 PM | Surgical Approaches To Vascular Malformation M anagement: Triumphs And Pitfalls |
Presenter(s):Christopher J. Morin, MD | |
View Slides in PDF | |
2:05 PM - 2:15 PM | Surgical Concepts To Treat The Lateral Marginal Vein Of The Lower Extremity |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
2:15 PM - 2:25 PM | Imaging And Management Of Chylous Leak |
Presenter(s):Ahmad Alomari, MD, MSc, FSIR | |
View Slides in PDF | |
2:25 PM - 2:35 PM | Extensive Venous Malformations: How To Proceed With Low Platelets, Low Fibrinogen, And High D-Dimers |
Presenter(s):Iris Baumgartner, MD | |
View Slides in PDF | |
2:35 PM - 2:45 PM | Venous Malformations Of The Lower Extremity: Long-Term Follow-Up |
Presenter(s):Patricia E. Burrows, MD | |
View Slides in PDF | |
2:45 PM - 3:05 PM | Break – Visits Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 100 | |
SESSION 101 SCHEDULE | |
Friday
SESSION 101:
AV MANAGEMENT: CURRENT CONTROVERSIES IN VARIOUS TREATMENT STRATEGIES
|
|
x | |
3:05 PM - 3:15 PM | Common Femoral And Iliac Arterial Sparing Endovascular Techniques In Neonates |
Presenter(s):Patricia E. Burrows, MD | |
3:15 PM - 3:25 PM | Non-Traumatic Acquired AVMs: More Common Than We Realize |
Presenter(s):Robert L. Vogelzang, MD | |
3:25 PM - 3:35 PM | Fibro-Adipose Vascular Anomaly (FAVA) Of The Extremities: A Clinical-Radiological-Pathologic Review |
Presenter(s):Ahmad Alomari, MD, MSc, FSIR | |
3:35 PM - 3:45 PM | Curative Treatment Of Complex And Multiple Intraosseous AVMs |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
3:45 PM - 3:55 PM | Long-Term Outcomes For The Treatment Of Vascular Malformations: The Chicago Northwestern Experience |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
3:55 PM - 4:05 PM | Staged Endovascular Management Of Pelvic AVMs With nBCA |
Presenter(s):Robert J. Rosen, MD | |
View Slides in PDF | |
4:05 PM - 4:15 PM | Transvenous Endovascular And Percutaneous Treatment Of AVMs: Determining The Pathologic Aneurysmal Vein |
Presenter(s):Robert L. Vogelzang, MD | |
4:15 PM - 4:25 PM | Vascular Malformation Repair Procedures: An International Road Show – Lessons Learned |
Presenter(s):Krassi Ivancev, MD, PhD | |
4:25 PM - 4:35 PM | Endovascular Management Of Thoracic, Abdominal, And Mesenteric/Small Bowel AVMs |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
4:35 PM - 4:45 PM | Current Percutaneous Embolotherapy Techniques For Curative Treatment Of AVMs Of The Foot |
Presenter(s):Iris Baumgartner, MD | |
View Slides in PDF | |
4:45 PM - 4:55 PM | Intralipomatous Capillary-Venous Malformations: Endovascular And Surgical Considerations Of A Challenging New Entity |
Presenter(s):Christopher J. Morin, MD | |
View Slides in PDF | |
4:55 PM - 5:05 PM | Curative Endovascular Management Strategies For Yakes Types IIb, IIIa, And IIIb AVMs |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
5:05 PM - 5:10 PM | The Yakes Type IV AVM (Characterized By Total Tissue AVM Infiltration Complicated By Capillaries Admixed Within The Innumerable AVFs): Angio-Architecture Features And Curative Endovascular Treatment Strategies To Preserve The Involved Tissue |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
5:10 PM - 5:15 PM | Closing Remarks |
Presenter(s):Robert L. Vogelzang, MD | |
5:15 PM - 5:15 PM | End of Program N |
END OF SESSION 101 | |
Saturday, November 21, 2015
Print Entire 2015 Program:
|
|
SESSION 102 SCHEDULE | |
Saturday
SESSION 102:
NEW DEVELOPMENTS IN DISEASES OF THE LOWER EXTREMITY, ILIAC AND RENAL ARTERIES (4 ˝-Minute Hit The Highlights Talks)
Moderators:Patrice F. Bergeron, MD / Frank J. Veith, MD
|
|
x | |
6:45 AM - 6:50 AM | Why Your Patient’s Primary Care Physician And Internist Are As Responsible As You For The Outcome Of Your Lower Extremity Revascularization |
Presenter(s):Philip P. Goodney, MD, MS | |
View Slides in PDF | |
6:50 AM - 6:55 AM | Health Care Benefits One Year After Invasive Treatment For Lower Extremity Ischemia: The Patient’s Baseline Status Is Key |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS | |
View Slides in PDF | |
6:55 AM - 7:00 AM | DEBATE: Endo First Approach For Lower Extremity Ischemia Does Not Compromise Later Open Bypass Procedures Or Their Results |
Presenter(s):Craig M. Walker, MD | |
View Slides in PDF | |
7:00 AM - 7:05 AM | DEBATE: Endo First Approach For All Lower Extremity Ischemia Sometimes Leads To Worse Outcomes If A Subsequent Bypass Is Required – Especially With TASC C And D Lesions: Some Patients Should Have A Bypass First |
Presenter(s):Fred A. Weaver, MD | |
View Slides in PDF | |
7:05 AM - 7:10 AM | With The Supera Stent Proper Artery Preparation And Deployment Techniques Are Important To Getting Good Results – Especially With Long Or Calcified Lesions: A Real World Experience |
Presenter(s):Donald L. Jacobs, MD | |
View Slides in PDF | |
7:10 AM - 7:15 AM | The Supera Stent And Vasculomimetic Technology: Why It Works So Well |
Presenter(s):Peter C.J. Goverde, MD | |
View Slides in PDF | |
7:15 AM - 7:20 AM | Endovascular Treatment Of A Large Aorta-To-Renal Vein Fistula (AVF): It’s Not Simple |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Slides in PDF | |
7:20 AM - 7:25 AM | Long-Term Results Of The COBEST Trial Comparing Covered And Bare Metal Stents For Treatment Of Complex Aortoiliac Occlusive Lesions |
Presenter(s):B. Patrice Mwipatayi, FRACS | |
View Slides in PDF | |
7:25 AM - 7:30 AM | Panel Discussion |
Moderator(s): Enrico Ascher, MD / John B. Chang, MD | |
7:30 AM - 7:35 AM | Advantages Of Intraluminal vs. Subintimal Routes For Recanalization Of SFA CTOs: How To Achieve Them |
Presenter(s):Enrico M. Marone, MD | |
View Slides in PDF | |
7:35 AM - 7:40 AM | Should Transpedal Access Be Used More Widely For Lower Extremity Revascularizations: Pluses And Minuses |
Presenter(s):Mark H. Wholey, MD | |
View Slides in PDF | |
7:40 AM - 7:45 AM | Limitations Of Pedal And Other Retrograde Approaches For Lower Extremity Revascularizations |
Presenter(s):Fabrizio Fanelli, MD, EBIR | |
View Slides in PDF | |
7:45 AM - 7:50 AM | Lower Extremity Interventions And CAS Can Be Improved And Made Easier By New Better Imaging |
Presenter(s):Koen Deloose, MD | |
View Slides in PDF | |
7:50 AM - 7:55 AM | What Intervention Can Be Done For Failed SFA Stents: Minimally Invasive Lesion And Stent Removal With Long Endarterectomy Followed By PTFE Lining: Another Option Before Open Surgery – Technique And Results |
Presenter(s):Patrice F. Bergeron, MD / Dieter Raithel, MD, PhD | |
View Slides in PDF | |
7:55 AM - 8:00 AM | Puncture Of The Occluded SFA As A Better Access Route For Treatment Of TASC D Lesions |
Presenter(s):Aravinda Nanjundappa, MD | |
View Slides in PDF | |
8:00 AM - 8:05 AM | Panel Discussion |
END OF SESSION 102 | |
SESSION 103 SCHEDULE | |
Saturday
SESSION 103:
MORE EXCITING NEW DEVELOPMENTS IN LOWER EXTREMITY DISEASE AND ITS TREATMENT (4 1/2-Minute Hit The Highlights Talks)
Moderators:Iris Baumgartner, MD / Kenneth Ouriel, MD, MBA
|
|
x | |
8:05 AM - 8:10 AM | Special Considerations In Treating CLI In ESRD-Dialysis Patients Endovascularly |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
8:10 AM - 8:15 AM | Objective Performance Goals For Lower Extremity CLI Bypasses With And Without ESRD |
Presenter(s):Mark Conrad, MD, MMSc | |
View Slides in PDF | |
8:15 AM - 8:20 AM | With Severe CLI (Rutherford 5 And 6) Patient Survival After Endo Treatment Is Poor And Better With Open Surgery Treatment |
Presenter(s):Francesco Spinelli, MD | |
View Slides in PDF | |
8:20 AM - 8:25 AM | The Positive Correlation Between Osteoporosis And Arterial Disease: What Is Its Significance |
Presenter(s):Caron B. Rockman, MD | |
View Slides in PDF | |
8:25 AM - 8:30 AM | Micro-Oxygen Sensors (MOXYs) On Feet To Monitor The Effectiveness In Real Time Of Endovascular Treatments In CLI Patients |
Presenter(s):Miguel F. Montero-Baker, MD | |
View Slides in PDF | |
8:30 AM - 8:35 AM | DEBATE: How To Deal With Occluded Fempop Grafts Endovascularly: No Open Treatment Is Ever Needed |
Presenter(s):Marcelo Guimaraes, MD, FSIR | |
View Slides in PDF | |
8:35 AM - 8:40 AM | DEBATE: Not So: There Is A Hybrid (Open/Endo) Technique Which Works Well When Endo Treatments Fail: Technique And Results |
Presenter(s):Neal S. Cayne, MD | |
View Slides in PDF | |
8:40 AM - 8:45 AM | Panel Discussion |
Moderator(s): Caron B. Rockman, MD / Daniel G. Clair, MD | |
8:45 AM - 8:50 AM | Treating Dissection, Perforations, Embolization And Other Complications Of Lower Extremity Interventions When Endo Rescue Fails: Tips And Tricks |
Presenter(s):Scott L. Stevens, MD | |
View Slides in PDF | |
8:50 AM - 8:55 AM | DEBATE: Statins After Infrainguinal Treatments For CLI Improves Patient Survival But With No Improved Patency |
Presenter(s):Philip P. Goodney, MD, MS | |
View Slides in PDF | |
8:55 AM - 9:00 AM | DEBATE: Statins After Infrainguinal Treatments For CLI Improves Patency As Well As Patient Survival |
Presenter(s):Iris Baumgartner, MD | |
View Slides in PDF | |
9:00 AM - 9:05 AM | 2-Year Results With The Stellarex DEB Without Pre-Dilatation Show Durable Results With TASC A And B Lesions: The ILLUMENATE FIH Trial |
Presenter(s):Koen Deloose, MD / Marianne Brodmann, MD | |
View Slides in PDF | |
9:05 AM - 9:10 AM | Not All ISR Lesions Need To Be Treated And Duplex Surveillance Predict ISR Lesions Requiring Treatment: Lesions >80% Require Treatment; Those <80% Can Be Observed |
Presenter(s):Miguel F. Montero-Baker, MD | |
View Slides in PDF | |
9:10 AM - 9:15 AM | Pathologic Insight Into The Safety And Efficacy Of Various Endovascular Treatments For ISR And CLI |
Presenter(s):Renu Virmani, MD | |
View Slides in PDF | |
9:15 AM - 9:20 AM | Durable Value Of DESs In Tibial Arteries For CLI: 3-4 Year Results: Indications And Contraindications |
Presenter(s):Michael J. Wilderman, MD | |
View Slides in PDF | |
9:20 AM - 9:30 AM | Panel Discussion And Break Visit Exhibits And Pavilions (3rd Floor) |
END OF SESSION 103 | |
SESSION 104 SCHEDULE | |
Saturday
SESSION 104:
MORE EXCITING NEW DEVELOPMENTS IN LOWER EXTREMITY DISEASE AND ITS TREATMENT (4 ˝-Minute Hit The Highlights Talks)
Moderators:James F. McKinsey, MD / Neal S. Cayne, MD
|
|
x | |
9:30 AM - 9:35 AM | Treatment Algorithm For Fempop Occlusive Disease: Which Treatment For Which Patient And Which Disease Pattern |
Presenter(s):Gary M. Ansel, MD | |
View Slides in PDF | |
9:35 AM - 9:40 AM | Value Of Sequential Biomechanical Compression Therapy In CLI: Does It Really Help In Patients With Rest Pain; With Ulceration And Gangrene |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Slides in PDF | |
9:40 AM - 9:45 AM | Novel Endovascular Method For Percutaneous Fempop Bypass Via The Venous System |
Presenter(s):Albrecht H. Kramer, MD / James D. Joye, DO | |
View Slides in PDF | |
9:45 AM - 9:50 AM | Status Of The SPINACH Registry From Japan Comparing Endo With Open Treatment For CLI: When Will We Have Answers |
Presenter(s):Nobuyoshi Azuma, MD / Osamu Iida, MD | |
View Slides in PDF | |
9:50 AM - 9:55 AM | DESs vs. DEBs: Which Is Best In What Setting |
Presenter(s):D. Christopher Metzger, MD / Thomas Zeller, MD | |
View Slides in PDF | |
9:55 AM - 10:00 AM | When Are DESs (Zilver PTX) Needed For CTOs In The SFA: Will Its New Delivery System Be Helpful |
Presenter(s):Fabrizio Fanelli, MD, EBIR | |
View Slides in PDF | |
10:00 AM - 10:05 AM | Panel Discussion |
Moderator(s): Fabrizio Fanelli, MD, EBIR / Gary M. Ansel, MD | |
10:05 AM - 10:10 AM | New Results With DESs For BTK Lesions For CLI: Results From The PES BTK-70 Trial (Stentys Stent With Paclitaxel); The PREVENT Trial (Promus Stent With Everolimus) And The DESTINY 2 Trial (XIENCE-PRIME Stent With Everolimus) |
Presenter(s):Koen Deloose, MD / Marc Bosiers, MD | |
View Slides in PDF | |
10:10 AM - 10:15 AM | Present Status Of Atherectomy Devices For Lower Limb Ischemia: Advantages Of The Different Devices: An Interventionalist’s View |
Presenter(s):John R. Laird, MD | |
View Slides in PDF | |
10:15 AM - 10:20 AM | Present Status Of Atherectomy Devices For Lower Limb Ischemia: How Solid Is The Evidence That They Make A Difference: A Surgeon’s View |
Presenter(s):James F. McKinsey, MD | |
View Slides in PDF | |
10:20 AM - 10:25 AM | Use Of Directional Atherectomy Via Retrograde Access From Pedal Or Popliteal Sites: Technique And Advantages |
Presenter(s):Syed M. Hussain, MD | |
View Slides in PDF | |
10:25 AM - 10:30 AM | Distal Embolic Protection For Lower Extremity Interventions: When, Why And How |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
View Slides in PDF | |
10:30 AM - 10:35 AM | Panel Discussion |
END OF SESSION 104 | |
SESSION 105 SCHEDULE | |
Saturday
SESSION 105:
MORE EXCITING NEW DEVELOPMENTS IN LOWER EXTREMITY DISEASE AND ITS TREATMENT (4 ˝-Minute Hit The Highlights Talks)
Moderators:Andrej Schmidt, MD / Amman Bolia, MD
|
|
x | |
10:35 AM - 10:40 AM | Sustained >1 Year Effectiveness Of Interventions For CLI Is Improving: The Data Prove It And Why |
Presenter(s):Iris Baumgartner, MD | |
View Slides in PDF | |
10:40 AM - 10:45 AM | Overview Of Lower Extremity Occlusive Disease Treatment In Germany: Claudication vs. CLI; Endo vs. Open |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Slides in PDF | |
10:45 AM - 10:50 AM | Does The In.Pact Admiral DEB Work For TASC C And D Lesions And For ISR |
Presenter(s):Gary M. Ansel, MD | |
View Slides in PDF | |
10:50 AM - 10:55 AM | What Treatment Currently Works Best For Long Or Complex SFA Lesions |
Presenter(s):Koen Deloose, MD / Marc Bosiers, MD / Patrick Peeters, MD | |
View Slides in PDF | |
10:55 AM - 11:00 AM | DEBATE: Open Surgery Is The Best Treatment For Common Femoral Artery (CFA) Lesions |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Slides in PDF | |
11:00 AM - 11:05 AM | DEBATE: Techniques That Work For The Endovascular Treatment Of SFA Lesions: Midterm Results Justify Their Use |
Presenter(s):Andrej Schmidt, MD / Thomas Zeller, MD | |
View Slides in PDF | |
11:05 AM - 11:10 AM | Panel Discussion |
Moderator(s): Thomas Zeller, MD / Sebastian E. Debus, MD, PhD | |
11:10 AM - 11:15 AM | DEBATE: Subintimal Guidewire Passage And Treatment Is The Best And Cheapest Technique For Fempop And BTK Lesions: How To Leave And Re-Enter The Lumen |
Presenter(s):Amman Bolia, MD | |
View Slides in PDF | |
11:15 AM - 11:20 AM | DEBATE: Intraluminal Guidewire Passage And Treatment Is The Best Technique For Most Lesions: How To Stay Intraluminal And Know It |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
11:20 AM - 11:25 AM | DEBATE: Both Techniques Are Useful And Sometimes Required: Tips And Tricks |
Presenter(s):Andrej Schmidt, MD | |
View Slides in PDF | |
11:25 AM - 11:30 AM | Status Of The BEST Trial Comparing Endo And Open Treatments For Lower Extremity Occlusive Disease: Number Of Patients Recruited And When Will It Have Answers |
Presenter(s):Matthew T. Menard, MD / Alik Farber, MD / Kenneth Rosenfield, MD | |
View Slides in PDF | |
11:30 AM - 11:35 AM | The Truth About The BEST Trial |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD | |
View Slides in PDF | |
11:35 AM - 11:40 AM | In Young Patients With Intermittent Claudication: Some Uncommon Etiologies And How They Should Be Treated |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
11:40 AM - 11:45 AM | Panel Discussion |
11:45 AM - 12:40 PM | Lunch Break Visit Exhibits And Pavilions (3rd Floor) |
END OF SESSION 105 | |
SESSION 106 SCHEDULE | |
Saturday
SESSION 106:
NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT (4 ˝-Minute Hit The Highlights Talks)
Moderators:Peter F. Lawrence, MD / Ali F. AbuRahma, MD
|
|
x | |
12:40 PM - 12:45 PM | CEA Outcomes Are Improving Over The Years: How Much |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
View Slides in PDF | |
12:45 PM - 12:50 PM | Comparative Learning Curves And Procedural Times For Transfemoral CAS And Transcervical CAS Via An Open Exposure Of The Common Carotid: The Latter Is Easier |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
View Slides in PDF | |
12:50 PM - 12:55 PM | When Is Open Surgery Indicated After CAS With ISR: What Procedure Should Be Done So It Is Safe |
Presenter(s):Giustino Marcucci, MD | |
View Slides in PDF | |
12:55 PM - 1:00 PM | Pitfalls In Carotid Duplex Exams: How They Can Lead To False Positive And False Negative Results |
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
View Slides in PDF | |
1:00 PM - 1:05 PM | CEA Is Safe When Done Early After Thrombolytic Treatment For Acute Stroke |
Presenter(s):Martin Bjorck, MD, PhD | |
View Slides in PDF | |
1:05 PM - 1:10 PM | CAS Early After Symptom Onset Can Be Safe Under Certain Circumstances And With Specific Technical Precautions |
Presenter(s):Gioachino Coppi, MD | |
View Slides in PDF | |
1:10 PM - 1:15 PM | Panel Discussion |
Moderator(s): Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh / Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
1:15 PM - 1:20 PM | Carotid Duplex Surveillance Is Not Necessary After CEA With Patch Closure |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
1:20 PM - 1:25 PM | Tips And Tricks For Performing CAS With Proximal Embolic Protection |
Presenter(s):D. Christopher Metzger, MD | |
View Slides in PDF | |
1:25 PM - 1:30 PM | Retinal Embolization After Carotid Interventions (CEA Or CAS): Should It Be Used As A Surrogate End-Point In Asymptomatic Carotid Trials |
Presenter(s):Athanasios D. Giannoukas, MSc, MD, PhD, FEBVS | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Effect Of Statins On Early And Late Outcomes Of CAS: Drug Dosage And Timing Of Administration Matter |
Presenter(s):Fabio Verzini, MD, PhD / Paola De Rango, MD / Piergiorgio Cao, MD, FRCS | |
View Slides in PDF | |
1:35 PM - 1:40 PM | A Novel Frailty Risk Score Improves The Ability To Predict Outcomes Of CEA In Asymptomatic Carotid Stenosis Patients |
Presenter(s):Anton N. Sidawy, MD, MPH | |
View Slides in PDF | |
1:40 PM - 1:45 PM | Carotid Body Tumors: Update On Methods To Evaluate And Treat Including The Role Of Preop Embolization |
Presenter(s):Peter F. Lawrence, MD | |
View Slides in PDF | |
1:45 PM - 1:50 PM | Panel Discussion |
END OF SESSION 106 | |
SESSION 107 SCHEDULE | |
Saturday
SESSION 107:
MORE NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT (4 ˝-Minute Hit The Highlights Talks)
Moderators:Ross Naylor, MD, FRCS / Carlo Setacci, MD
|
|
x | |
1:50 PM - 1:55 PM | After Thrombolysis For Acute Stroke, Which Is A Better And Safer Way To Treat Carotid Stenosis – CEA Or CAS |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
View Slides in PDF | |
1:55 PM - 2:00 PM | Value Of Carotid Interposition PTFE Grafts For Failed, Difficult Or Redo CEA Procedures: Technical Tips, Precautions And Results |
Presenter(s):Dieter Raithel, MD, PhD | |
View Slides in PDF | |
2:00 PM - 2:05 PM | Gore Hybrid Vascular Grafts For Bailout Or Rescue For Intraoperative Problems During CEA |
Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS | |
View Slides in PDF | |
2:05 PM - 2:10 PM | What Are The Current Duplex Velocities For Performing CEA In Asymptomatic Carotid Stenosis Patients: Why Other Imaging Should Be Obtained Preoperatively |
Presenter(s):Jack L. Cronenwett, MD | |
View Slides in PDF | |
2:10 PM - 2:15 PM | Long-Term Comparative Results Of CEA With A Patch And Eversion Endarterectomy: Which Is Better And When |
Presenter(s):Ashraf Mansour, MD | |
View Slides in PDF | |
2:15 PM - 2:20 PM | Technical And Other Tips To Improve CAS Results |
Presenter(s):L. Nelson Hopkins, MD | |
View Slides in PDF | |
2:20 PM - 2:25 PM | Panel Discussion |
Moderator(s): L. Nelson Hopkins, MD / Jack L. Cronenwett, MD | |
2:25 PM - 2:30 PM | Interventionists And Surgeons Do Equally Well With CAS: But Experience Matters: What Are Valid Minimum Numbers Of Cases |
Presenter(s):Roy M. Fujitani, MD, FACS, MBA | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Lessons Learned From US Datasets With Outcomes After CEA And CAS: CAS Results Are Much Worse Than In CREST And Why |
Presenter(s):Ross Naylor, MD, FRCS | |
View Slides in PDF | |
2:35 PM - 2:40 PM | Tips And Tricks For Vertebral Interventions: When Are They Needed |
Presenter(s):D. Christopher Metzger, MD | |
View Slides in PDF | |
2:40 PM - 2:45 PM | New Transcranial Doppler Technology And How It Can Help In Carotid Treatment |
Presenter(s):Gioachino Coppi, MD | |
View Slides in PDF | |
2:45 PM - 2:50 PM | Optimal Treatment Of Carotid Restenosis After CEA; And After CAS |
Presenter(s):Carlo Setacci, MD | |
View Slides in PDF | |
2:50 PM - 2:55 PM | Octogenarians With Asymptomatic Carotid Stenosis Rarely Benefit From CEA Or CAS |
Presenter(s):Michael Belkin, MD | |
View Slides in PDF | |
2:55 PM - 3:05 PM | Panel Discussion And Break |
END OF SESSION 107 | |
SESSION 108 SCHEDULE | |
Saturday
SESSION 108:
NEW DEVELOPMENTS IN DISEASES OF THE AORTA AND THEIR TREATMENT (4˝-Minute Hit The Highlights Talks)
Moderators:Nicholas J.W. Cheshire, MD / Thomas S. Maldonado, MD
|
|
x | |
3:05 PM - 3:10 PM | Quantitation Of Aortic (AAA) Neck And Sac Thrombosis: What It Tells Us; Is Neck Thrombosis A Risk Factor For Unsuccessful EVAR |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
3:10 PM - 3:15 PM | Should Saccular AAAs Be Treated Differently From Other AAAs: What Are The Size Criteria |
Presenter(s):Benjamin M. Jackson, MD | |
View Slides in PDF | |
3:15 PM - 3:20 PM | Back Table Reversed Limb Endografts (Zenith And Endurant) Help In The Treatment Of Challenging Aorto-Iliac Pathology: Technique And Indications |
Presenter(s):Barend M.E. Mees, MD, PhD | |
View Slides in PDF | |
3:20 PM - 3:25 PM | There Is No Seasonality To Ruptured AAAs |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
View Slides in PDF | |
3:25 PM - 3:30 PM | Dedicated Workshop To Improve Treatment Of Ruptured AAAs: What Is Involved And What Benefits Are Derived |
Presenter(s):Zoran Rancic, MD, PhD / Dieter O. Mayer, MD / Mario L. Lachat, MD | |
View Slides in PDF | |
3:30 PM - 3:35 PM | Blunt Abdominal Aortic Injury: Incidence, Etiology, Diagnosis And Treatment |
Presenter(s):Zachary M. Arthurs, MD | |
View Slides in PDF | |
3:35 PM - 3:45 PM | Panel Discussion |
END OF SESSION 108 | |
SESSION 109 SCHEDULE | |
Saturday
SESSION 109:
MORE NEW DEVELOPMENTS IN AORTIC DISEASE, TRAUMA AND INTRAMURAL HEMATOMAS (4 ˝-Minute Hit The Highlights Talks)
Moderators:Ronald M. Fairman, MD / Edward Y. Woo, MD
|
|
x | |
3:45 PM - 3:50 PM | Blunt Aortic Traumas: When Not To Use Endovascular Treatments |
Presenter(s):Joseph S. Giglia, MD | |
View Slides in PDF | |
3:50 PM - 3:55 PM | DEBATE: Significance Of Intramural Aortic Hematomas With Trauma And Dissections: They Are A Real Entity: How Should They Be Treated |
Presenter(s):Michael D. Dake, MD | |
View Slides in PDF | |
3:55 PM - 4:00 PM | DEBATE: Intramural Hematomas After Trauma Are A Myth – Rarely If Ever Seen |
Presenter(s):Benjamin W. Starnes, MD | |
View Slides in PDF | |
4:00 PM - 4:05 PM | Retroperitoneal Approach For Complex AAAs Unsuitable For EVAR Or FEVAR Or CHEVAR: Tips And Tricks |
Presenter(s):R. Clement Darling III, MD | |
View Slides in PDF | |
4:05 PM - 4:10 PM | Renal Insufficiency Is Not A Contraindication To TEVAR, FEVAR Or CHEVAR: How Should Such Patients Be Managed |
Presenter(s):Giovanni Torsello, MD | |
View Slides in PDF | |
4:10 PM - 4:15 PM | EVAR Or Open Repair For AAA Patients With Renal Insufficiency: On Dialysis |
Presenter(s):Vicente Riambau, MD, PhD | |
View Slides in PDF | |
4:15 PM - 4:20 PM | Panel Discussion |
Moderator(s): R. Clement Darling III, MD / Benjamin W. Starnes, MD | |
4:20 PM - 4:25 PM | Failure Modes Of EVAR After 10 Years: When Can They Be Treated Endovascularly |
Presenter(s):Ronald M. Fairman, MD | |
View Slides in PDF | |
4:25 PM - 4:30 PM | The Scandal Of High Late Mortality After EVAR: What Causes It And How To Prevent It |
Presenter(s):Ciro Ferrer, MD / Piergiorgio Cao, MD, FRCS | |
View Slides in PDF | |
4:30 PM - 4:35 PM | A Normal AAA Screening Does Not Rule Out An AAA 5 Years Later |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Slides in PDF | |
4:35 PM - 4:40 PM | Contralateral Leg Cannulization In EVAR: Is It An Issue And How To Facilitate It |
Presenter(s):Willem Wisselink, MD | |
View Slides in PDF | |
4:40 PM - 4:45 PM | Isolated Infrarenal Aortic Dissection And Penetrating Aortic Ulcer: Non-Morbid Conditions: Indications For Treatment And How Should They Be Treated |
Presenter(s):Edward Y. Woo, MD | |
View Slides in PDF | |
4:45 PM - 4:50 PM | Panel Discussion End of Program O |
END OF SESSION 109 | |
SESSION 110 SCHEDULE | |
Saturday
SESSION 110:
PLANNING FOR HEMODIALYSIS ACCESS
Moderators:Larry A. Scher, MD / Anton N. Sidawy, MD, MPH
|
|
x | |
7:55 AM - 8:00 AM | Introduction |
Presenter(s):Anton N. Sidawy, MD, MPH / Larry A. Scher, MD | |
8:00 AM - 8:07 AM | Predialysis Care Of The Patient With Chronic Kidney Disease |
Presenter(s):Theodore F. Saad, MD | |
View Slides in PDF | |
8:08 AM - 8:15 AM | Choosing The Right Access For The Right Patient |
Presenter(s):Ingemar J.A. Davidson, MD, PhD, FACS | |
View Slides in PDF | |
8:16 AM - 8:23 AM | Role Of Vessel Mapping In Planning For Vascular Access |
Presenter(s):Surendra Shenoy, MD, PhD | |
View Slides in PDF | |
8:24 AM - 8:31 AM | Vascular Access In The UK: What Lessons Can We Learn In The US |
Presenter(s):Eric Chemla, MD | |
8:32 AM - 8:39 AM | Results Of The RAND Survey Of Optimal Practice Patterns In Dialysis Access |
Presenter(s):David L. Cull, MD, FACS | |
View Slides in PDF | |
8:40 AM - 8:50 AM | Panel Discussion |
8:51 AM - 8:58 AM | Do We Need Standardized Training And Certification In Dialysis Access |
Presenter(s):John R. Ross, Sr., MD | |
View Slides in PDF | |
8:59 AM - 9:06 AM | Preoperative Predictive Factors For AV Access Success Or Failure |
Presenter(s):Robyn A. Macsata, MD | |
View Slides in PDF | |
9:07 AM - 9:14 AM | DEBATE: Availability Of Ultrasound In The Dialysis Unit Is Essential |
Presenter(s):Eric Chemla, MD | |
View Slides in PDF | |
9:15 AM - 9:22 AM | DEBATE: Availability Of Ultrasound In The Dialysis Unit Is Not Practical |
Presenter(s):Deborah Brouwer-Maier, RN, CNN | |
View Slides in PDF | |
9:23 AM - 9:35 AM | Panel Discussion |
9:36 AM - 10:00 AM | Break – Visit Exhibits And Pavilions (3rd Floor) |
END OF SESSION 110 | |
SESSION 111 SCHEDULE | |
Saturday
SESSION 111:
OPTIMIZING OUTCOMES IN HEMODIALYSIS ACCESS
|
|
x | |
10:01 AM - 10:08 AM | Should AV Fistulas Be Ligated Or Preserved Following Renal Transplantation |
Presenter(s):David Fox, MD, FACS, RPVI | |
View Slides in PDF | |
10:09 AM - 10:16 AM | Strategies To Optimize Hemodialysis Catheter Dysfunction |
Presenter(s):Michele H. Mokrzycki, MD, MS | |
10:17 AM - 10:24 AM | Algorithms For Maturation Of AV Fistulas |
Presenter(s):John E. Aruny, MD | |
View Slides in PDF | |
10:25 AM - 10:32 AM | Hemodynamic Significance Of Access Stenosis: A Fluid Dynamic Analysis |
Presenter(s):Surendra Shenoy, MD, PhD | |
View Slides in PDF | |
10:33 AM - 10:40 AM | Novel Therapies For Hemodialysis Vascular Access Dysfunction |
Presenter(s):Jeffrey H. Lawson, MD, PhD | |
View Slides in PDF | |
10:41 AM - 10:48 AM | Why Do We Need A Vascular Access Coordinator |
Presenter(s):Deborah Brouwer-Maier, RN, CNN | |
View Slides in PDF | |
10:49 AM - 11:00 AM | Panel Discussion |
11:01 AM - 11:08 AM | Algorithms For Management Of Acute And Chronic Steal Syndrome |
Presenter(s):David L. Cull, MD, FACS | |
View Slides in PDF | |
11:09 AM - 11:16 AM | Indications For Inflow Reduction Of AV Access In The Absence Of Steal |
Presenter(s):Haimanot (Monnie) Wasse, MD, MPH, FASN | |
View Slides in PDF | |
11:17 AM - 11:25 AM | Does Balloon Assisted Maturation Increase The Risk Of Steal Syndrome |
Presenter(s):Gregg A. Miller, MD | |
View Slides in PDF | |
11:26 AM - 11:33 AM | Cost Effectiveness Of Early Cannulation Grafts |
Presenter(s):David Kingsmore, Mr, MD, FRCS (Ed), MBChB, BMedBiol | |
View Slides in PDF | |
11:33 AM - 11:40 AM | Expanding Role For Endoluminal Anastomosis In Vascular Access Surgery |
Presenter(s):Jeffrey H. Lawson, MD, PhD | |
View Slides in PDF | |
11:41 AM - 11:55 AM | Panel Discussion |
11:55 AM - 12:40 PM | Lunch Break – 3rd Floor Promenade Visit Exhibits And Pavilions (3rd Floor) |
END OF SESSION 111 | |
SESSION 112 SCHEDULE | |
Saturday
SESSION 112:
POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS
Moderators:Theodore F. Saad, MD / Robert Provenzano, MD
|
|
x | |
12:40 PM - 12:47 PM | End Stage Renal Disease Seamless Care Organizations (ESCO): Accepting Risk In A Dialysis Facility |
Presenter(s):Robert Provenzano, MD | |
View Slides in PDF | |
12:48 PM - 12:55 PM | Clinical Implications Of Healthcare Reform On Hospital Services |
Presenter(s):John Wigneswaran, MD, MBA | |
View Slides in PDF | |
12:56 PM - 1:03 PM | Financial Implications Of A Vascular Access Surveillance Program |
Presenter(s):Robert Provenzano, MD | |
View Slides in PDF | |
1:04 PM - 1:11 PM | Legal Implications Of The KDOQI And SVS Guidelines For Vascular Access |
Presenter(s):O. William Brown, MD, JD | |
View Slides in PDF | |
1:12 PM - 1:19 PM | What’s New In Dialysis Access Coding: What Is Happening To The Bundle |
Presenter(s):Sean P. Roddy, MD | |
View Slides in PDF | |
1:20 PM - 1:27 PM | Affordable Care Act: Are We Willing To Pay For Prevention |
Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
View Slides in PDF | |
1:28 PM - 1:38 PM | Panel Discussion |
END OF SESSION 112 | |
SESSION 113 SCHEDULE | |
Saturday
SESSION 113:
NEW TECHNOLOGIES AND CONCEPTS IN HEMODIALYSIS ACCESS
Moderators:Mitchell L. Henry, MD / Eric Chemla, MD
|
|
x | |
1:39 PM - 1:46 PM | Use Of Topical Elastase To Reduce AV Fistula Failure |
Presenter(s):Keith Ozaki, MD | |
View Slides in PDF | |
1:47 PM - 1:54 PM | Intergraft System For Minimally Invasive Sutureless Anastomosis |
Presenter(s):John R. Ross, Sr., MD | |
View Slides in PDF | |
1:55 PM - 2:02 PM | Use Of A Novel Pneumatic Compression Device To Improve Fistula Maturation |
Presenter(s):Tej M. Singh, MD, MBA | |
View Slides in PDF | |
2:03 PM - 2:10 PM | Percutaneous Creation Of Vascular Access: Results Of The NEAT Trial |
Presenter(s):Marc H. Glickman, MD | |
View Slides in PDF | |
2:11 PM - 2:18 PM | Treatment Of Central Venous Stenosis With The Angiosculpt Balloon |
Presenter(s):Thomas F. Panetta, MD | |
View Slides in PDF | |
2:19 PM - 2:26 PM | Inside Out Access For Central Vein Occlusions |
Presenter(s):John C. Gurley, MD | |
View Slides in PDF | |
2:27 PM - 2:34 PM | Results With Flixene IFG With Assisted Delivery In Hemodialysis Access |
Presenter(s):John R. Ross, Sr., MD | |
View Slides in PDF | |
2:35 PM - 2:42 PM | Use Of A Sirolimus-Eluting Collagen Implant To Improve Fistula Maturation |
Presenter(s):Sriram S. Iyer, MD, FACC | |
View Slides in PDF | |
2:43 PM - 2:53 PM | Panel Discussion |
END OF SESSION 113 | |
SESSION 114 SCHEDULE | |
Saturday
SESSION 114:
UPDATE ON CLINICAL ISSUES IN HEMODIALYSIS ACCESS
Moderators:David L. Cull, MD, FACS / Marc H. Glickman, MD
|
|
x | |
2:54 PM - 3:01 PM | Clinical Experience With An Early Cannulation Graft |
Presenter(s):Stephen E. Hohmann, MD | |
View Slides in PDF | |
3:02 PM - 3:09 PM | Role Of Biologic Grafts In Hemodialysis Access |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Slides in PDF | |
3:10 PM - 3:17 PM | Advantages Of Spiral Flow Grafts In Reducing Intimal Hyperplasia |
Presenter(s):Hosam F. El Sayed, MD | |
View Slides in PDF | |
3:18 PM - 3:25 PM | Successes And Failures Of The HeRO Graft |
Presenter(s):Stephen E. Hohmann, MD | |
View Slides in PDF | |
3:26 PM - 3:33 PM | Modification Of HeRO Graft To Allow Early Cannulation |
Presenter(s):Christie W. Gooden, MD, MPH | |
View Slides in PDF | |
3:34 PM - 3:43 PM | Panel Discussion |
3:44 PM - 3:51 PM | Strategies For Management Of Prosthetic Dialysis Graft Infections |
Presenter(s):Mitchell L. Henry, MD | |
View Slides in PDF | |
3:52 PM - 3:59 PM | Can Adjunctive Operative Techniques Improve Vascular Access Outcomes |
Presenter(s):Richard F. Neville, MD | |
View Slides in PDF | |
4:00 PM - 4:50 PM | Management Of AV Fistula Aneurysms |
Presenter(s):Karl A. Illig, MD | |
View Slides in PDF | |
4:08 PM - 4:15 PM | Conversion Of Nonmaturing Fistulas To AV Grafts |
Presenter(s):Marc H. Glickman, MD | |
View Slides in PDF | |
4:16 PM - 4:25 PM | Panel Discussion End of Program P |
END OF SESSION 114 | |
SESSION 115 SCHEDULE | |
Saturday
SESSION 115:
INTERESTING TOPICS RELATED TO THE ABDOMINAL AORTA AND ITS BRANCHES
Moderators:Hence J.M. Verhagen, MD, PhD / Richard M. Green, MD
|
|
x | |
6:54 AM - 6:59 AM | How To Treat Thrombosed (Occluded) AAAs And Iliac Arteries With Bifurcated Endografts |
Presenter(s):Giovanni Pratesi, MD | |
View Slides in PDF | |
7:00 AM - 7:05 AM | Use Of Microcatheter Techniques To Treat Acute Occlusions Of EVAR Limbs Or Aortobifemoral Grafts |
Presenter(s):Michael H. Wholey, MD, MBA | |
View Slides in PDF | |
7:06 AM - 7:11 AM | Causes Of Aortic Endograft Limb Occlusion: What Are The Best Treatment Strategies |
Presenter(s):Christos D. Liapis, MD | |
View Slides in PDF | |
7:12 AM - 7:17 AM | Contrast Enhanced Ultrasound Eliminates The Need For CT Scans After EVAR |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Slides in PDF | |
7:18 AM - 7:23 AM | DEBATE: Internal Iliac Arteries Must Be Revascularized In EVAR Procedures |
Presenter(s):Fabio Verzini, MD, PhD | |
View Slides in PDF | |
7:24 AM - 7:29 AM | DEBATE: Internal Iliac Arteries May Not Have To Be Revascularized In EVAR Procedures: It Is Usually Safe Not To Do So |
Presenter(s):Dieter Raithel, MD, PhD | |
View Slides in PDF | |
7:30 AM - 7:35 AM | Update On The Global Endurant Experience: Lessons Learned From The 5-Year Results Of The ENGAGE Registry |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Slides in PDF | |
7:36 AM - 7:41 AM | Update On Diagnosis And Treatment Of Ischemic Bowel With Ruptured AAAs |
Presenter(s):Mario L. Lachat, MD | |
View Slides in PDF | |
7:42 AM - 7:47 AM | Management Of SMA Dissections And Total Occlusions |
Presenter(s):Eric D. Endean, MD | |
View Slides in PDF | |
7:48 AM - 7:53 AM | Importance Of Endograft Tilt And Sealing In Angulated Aortic Necks: New Software To Predict It And What Can Be Done To Offset It |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Slides in PDF | |
7:54 AM - 8:03 AM | Panel Discussion |
END OF SESSION 115 | |
SESSION 116 SCHEDULE | |
Saturday
SESSION 116:
MORE TOPICS RELATED TO THE ABDOMINAL AORTA, ENDOLEAKS AND INFECTED GRAFTS
Moderators:James H. Black, III, MD / Fred A. Weaver, MD
|
|
x | |
8:04 AM - 8:09 AM | Aortic Neck Enlargement After EVAR Differs With Self-Expanding And Balloon Expandable Endografts: Why The Difference Is Important |
Presenter(s):Dainis K. Krievins, MD / Christopher K. Zarins, MD | |
View Slides in PDF | |
8:10 AM - 8:15 AM | Contemporary Life Expectancy And Causes Of Death After Repair Of Intact And Ruptured AAAs |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
8:16 AM - 8:21 AM | Fate Of 36 mm Endografts For Elective And Emergent (Rupture) Use: Are Such Larger Devices Still A Good Option |
Presenter(s):Michael J. Singh, MD | |
View Slides in PDF | |
8:22 AM - 8:27 AM | Endovascular Grafts And VAC Wound Treatment Of Infected Prosthetic Arterial Grafts Is A New Graft Preserving Strategy: Key Elements And Midterm Results |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Slides in PDF | |
8:28 AM - 8:33 AM | Value Of PET CT (With 18F-FDB) For Management And Decision-Making In Patients With Concurrent AAAs And Cancer |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | De Novo Periaortic Inflammatory Response After EVAR: What Is Its Significance |
Presenter(s):Andrea Stella, MD | |
View Slides in PDF | |
8:40 AM - 8:45 AM | Management Strategies For Proximal EVAR Failure: With These The Need For Open Conversion Should Be Rare |
Presenter(s):Murray L. Shames, MD | |
View Slides in PDF | |
8:46 AM - 8:51 AM | Intra- And Peri-Procedural Perigraft Access To The AAA Sac To Treat Endoleaks: How To Do It And Results |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Slides in PDF | |
8:52 AM - 8:57 AM | Massive Endoleaks Can Be Compatible With AAA Sac Shrinkage: How Can This Occur And What Is Its Implications For Preventing Spinal Cord Ischemia, Etc. |
Presenter(s):Martin Malina, MD, PhD | |
View Slides in PDF | |
8:58 AM - 9:04 AM | Panel Discussion |
END OF SESSION 116 | |
SESSION 117 SCHEDULE | |
Saturday
SESSION 117:
TOPICS RELATED TO THE THORACIC AORTA, THORACIC AND THORACOABDOMINAL ANEURYSMS
Moderators:Robert S. Crawford, MD / Martin Malina, MD, PhD
|
|
x | |
9:04 AM - 9:09 AM | Management Of Distal Aortic Failure After TEVAR: Tips And Tricks |
Presenter(s):James H. Black, III, MD | |
View Slides in PDF | |
9:10 AM - 9:15 AM | What Are The Expansion Rates Of Small Thoracic Aortic Aneurysms And How Should They Influence The Threshold For Repair |
Presenter(s):Matt M. Thompson, MD | |
View Slides in PDF | |
9:16 AM - 9:21 AM | Which TAAA Patient Can And Should Be Treated Conservatively: At What Size And Circumstance Should They Be Fixed |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Slides in PDF | |
9:22 AM - 9:27 AM | Tips And Tricks For Simplifying B/FEVAR |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
9:28 AM - 9:33 AM | Use Of Aortic Branch Balloons To Better Align Fenestrations With The Cook Z-FEN Device |
Presenter(s):David J. Minion, MD | |
View Slides in PDF | |
9:34 AM - 9:39 AM | Near-Infrared Spectroscopy To Non-Invasively Monitor Spinal Cord Perfusion: How Does It Work And Will It Replace Motor Evoked Potentials |
Presenter(s):Christian D. Etz, MD, PhD | |
View Slides in PDF | |
9:40 AM - 9:45 AM | New Developments In The Treatment Of Blunt Aortic Trauma: Is There Any RoleFor Open Surgery: Is Traumatic Intramural Hematoma Real And How Should It Be Treated |
Presenter(s):Ali Azizzadeh, MD | |
View Slides in PDF | |
9:46 AM - 9:58 AM | Panel Discussion And Break Visit Exhibits And Pavilions (3rd Floor) |
Moderator(s): Ali Azizzadeh, MD / David J. Minion, MD | |
9:58 AM - 10:03 AM | Effect Of TEVAR On Coronary Perfusion And Cardiac Function As Determined By Quantitative Dynamic MR Imaging |
Presenter(s):Rachel E. Clough, MD, PhD | |
View Slides in PDF | |
10:04 AM - 10:09 AM | Value Of PITON (Double Lumen And Double Exit) Guiding Sheaths And Steerable Catheters For TEVAR And B/FEVAR: How They Work |
Presenter(s):Gioachino Coppi, MD | |
View Slides in PDF | |
10:10 AM - 10:15 AM | DEBATE: Routine LSA Revascularization Is The Way To Go When TEVAR Covers The LSA Orifice |
Presenter(s):Matt M. Thompson, MD | |
View Slides in PDF | |
10:16 AM - 10:21 AM | DEBATE: Selective LSA Revascularization Is The Way To Go When TEVAR Covers The LSA Orifice |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
10:22 AM - 10:27 AM | Impact Of LSA Coverage During TEVAR On Stroke And SCI: From The VQI: Does Revascularization Help |
Presenter(s):Fred A. Weaver, MD | |
View Slides in PDF | |
10:28 AM - 10:33 AM | Value Of Vascular Plugs In The Treatment Of Residual Aneurysms After Open And Endovascular Procedures |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
10:34 AM - 10:39 AM | False Lumen Obliteration Improves Survival After TEVAR For Complex TBADs: How To Do It |
Presenter(s):Manish Mehta, MD, MPH | |
View Slides in PDF | |
10:40 AM - 10:47 AM | Panel Discussion |
END OF SESSION 117 | |
SESSION 118 SCHEDULE | |
Saturday
SESSION 118:
MORE THORACIC AORTIC TOPICS; VISCERAL ARTERY DISSECTIONS; A NEW EVAR DEVICE; NEW CONCEPTS AND UPDATES
Moderators:Manish Mehta, MD, MPH / K. Craig Kent, MD
|
|
x | |
10:47 AM - 10:52 AM | Hypogastric Revascularization During EVAR: Why Are Parallel Grafts Better Than Branched Endografts: Tips And Tricks To Do The Chimney And Sandwich Grafts For This Purpose |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
View Slides in PDF | |
10:53 AM - 10:58 AM | Natural History Of Intramural Hematomas In The Thoracic Aorta: When To Fix And When To Observe |
Presenter(s):O. William Brown, MD, JD | |
View Slides in PDF | |
10:59 AM - 11:04 AM | Diagnosis, Prognosis And Treatment Of Isolated Celiac And SMA Dissections |
Presenter(s):Enrique Criado, MD, FACS | |
View Slides in PDF | |
11:05 AM - 11:10 AM | Use Of The Branched Petticoat Technique To Treat Complex Aortic Dissections: How To Do It And Does It Promote Remodeling In The Visceral Aortic Segment |
Presenter(s):Lars R. Kock, MD | |
View Slides in PDF | |
11:11 AM - 11:16 AM | The Altura EVAR Device: What Is Special About It And Early Clinical Results |
Presenter(s):Albrecht H. Kramer, MD | |
View Slides in PDF | |
11:17 AM - 11:22 AM | Differential Effects Of Various Endograft Fabric Coverings On Arterial Stiffness And EVAR Outcomes |
Presenter(s):Christos D. Liapis, MD | |
View Slides in PDF | |
11:23 AM - 11:28 AM | How To Recognize And Safely Manage An Inadvertent Large Sheath Placement In The Subclavian Artery During CVP Line Insertion |
Presenter(s):Neal S. Cayne, MD | |
View Slides in PDF | |
11:29 AM - 11:34 AM | Effect Of Increasing Vessel Tortuosity On EVAR Outcomes: How To Quantitate And Offset It |
Presenter(s):Sharif H. Ellozy, MD | |
View Slides in PDF | |
11:35 AM - 11:40 AM | Through-The-Knee (Gritti-Stokes) Amputation Is Better For The Patient And Leads To More Mobility Than Standard Above-Knee Amputation: How To Do It |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Slides in PDF | |
11:41 AM - 11:50 AM | Panel Discussion |
11:50 AM - 12:45 PM | Lunch Break – 3rd Floor Promenade Visit Exhibits And Pavilions (3rd Floor) |
END OF SESSION 118 | |
SESSION 119 SCHEDULE | |
Saturday
SESSION 119:
UPDATES AND LATE BREAKING HOT TOPICS RELATED TO EXTREMITY AND OTHER TREATMENTS
Moderators:Jon S. Matsumura, MD / Luis A. Sanchez, MD
|
|
x | |
HOT NEW EXTREMITY TOPICS, CONCEPTS AND UPDATES | |
12:45 PM - 12:50 PM | Simple Techniques For Crossing CTOs Using Only Catheters And Wires: When And How Often Are Special Techniques Needed |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
12:51 PM - 12:56 PM | Novel Approaches To Drug Delivery To Vessel Walls To Prevent Restenosis After Open Vascular Surgery |
Presenter(s):K. Craig Kent, MD | |
View Slides in PDF | |
12:57 PM - 1:02 PM | Effectiveness And Safety Of DEBs In Treating SFA Occlusions: Based On A Chinese RCT |
Presenter(s):Wei Guo, MD | |
View Slides in PDF | |
1:03 PM - 1:08 PM | Interesting Results From The RAPID Trial: An RCT Comparing POBA With Legflow DEBs For Long Segment SFA Lesions |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Slides in PDF | |
1:09 PM - 1:14 PM | The Need For Dedicated Limb Salvage Teams To Get Optimal Results With CLI: What Are The Essential Components |
Presenter(s):Christopher J. Abularrage, MD | |
View Slides in PDF | |
1:15 PM - 1:20 PM | Current Status Of Atherectomy Devices For Lower Extremity Occlusive Lesions: Which One(s) Are Best And Why: Are The Costs Justified |
Presenter(s):Lawrence A. Garcia, MD | |
View Slides in PDF | |
1:21 PM - 1:26 PM | The Disturbing Facts About Diabetic Foot Infections In Brazil: They Carry High Mortality And Amputation Rates: What Can Be Done About It: This Problem Also Probably Applies To Areas In The US |
Presenter(s):Tulio P. Navarro, MD, PhD | |
View Slides in PDF | |
1:27 PM - 1:33 PM | Panel Discussion |
OTHER HOT NEW CONCEPTS OR UPDATES | |
Moderator(s): Kenneth Ouriel, MD, MBA / Enrico Ascher, MD | |
1:33 PM - 1:38 PM | Role Of The Vascular Surgeon In Oncologic Resections: Do Endo Skills And Techniques Help |
Presenter(s):Luis A. Sanchez, MD | |
View Slides in PDF | |
1:39 PM - 1:44 PM | Heparin Dosing During Vascular Procedures Should Be Monitored By ACT Levels To Be Safe And Effective |
Presenter(s):Arno M. Wiersema, MD, PhD | |
View Slides in PDF | |
1:45 PM - 1:50 PM | Pudendal Artery Angioplasty: Its Role And Results In Complex Drug Resistant Erectile Dysfunction |
Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
View Slides in PDF | |
1:51 PM - 1:56 PM | MRA Data And A Computerized Program Allows Non-Invasive Estimation Of Pressure Gradients Across Equivocal Iliac Stenoses |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Slides in PDF | |
1:57 PM - 2:02 PM | Technology To Convert A Doppler Waveform Non-Invasively Into Mean Blood Pressure And Flow Measurements |
Presenter(s):Patrick W. Kelly, MD | |
View Slides in PDF | |
2:03 PM - 2:08 PM | Update On Recognition And Treatment Of Abdominal Compartment Syndrome (ACS) – Especially After EVAR Treatment Of Ruptured AAAs |
Presenter(s):Dieter O. Mayer, MD / Zoran Rancic, MD, PhD / Mario L. Lachat, MD | |
View Slides in PDF | |
2:09 PM - 2:14 PM | Follow-Up Compliance After EVAR Is <50% At 5 Years: What Can Be Done About It |
Presenter(s):Andres Schanzer, MD | |
View Slides in PDF | |
2:15 PM - 2:27 PM | Panel Discussion |
END OF SESSION 119 | |
SESSION 120 SCHEDULE | |
Saturday
SESSION 120:
GAME-CHANGING UPDATES, NEW CONCEPTS OR TECHNIQUES
Moderators:Daniel G. Clair, MD / Frank J. Veith, MD
|
|
x | |
2:27 PM - 2:32 PM | When Should Ruptured AAA Patients Be Transferred: Tips And Tricks For Doing It Safely And Effectively |
Presenter(s):Matthew W. Mell, MD, MS | |
View Slides in PDF | |
2:33 PM - 2:38 PM | Combined Stent-Graft And Multilayer Bare Stents For Thoracoabdominal Aortic Pathologies |
Presenter(s):Guangqi Chang, MD / Li Zilun, MD | |
View Slides in PDF | |
2:39 PM - 2:44 PM | The Case For Urgent Carotid Duplex Scanning Before Starting Thrombolytic Therapy For Acute Strokes: How Can It Help To Determine Optimal Therapy |
Presenter(s):Laura Capoccia, MD, PhD | |
View Slides in PDF | |
2:45 PM - 2:50 PM | The Role Of Telemedicine In Vascular Care: Current Status And Future Potential |
Presenter(s):John (Jeb) W. Hallett, MD | |
View Slides in PDF | |
2:51 PM - 2:56 PM | How Can Surgeons Succeed As Inventors And Entrepreneurs: Tips And Tricks |
Presenter(s):Jeffrey P. Carpenter, MD | |
View Slides in PDF | |
2:57 PM - 3:02 PM | How To Prevent Popliteal Artery Injuries During Orthopedic Knee Surgery |
Presenter(s):Anders Wanhainen, MD, PhD / Martin Bjorck, MD, PhD | |
View Slides in PDF | |
3:03 PM - 3:08 PM | Stem Cell Treatment May Influence AAA Growth And Behavior |
Presenter(s):Peter L. Faries, MD, FACS | |
View Slides in PDF | |
3:09 PM - 3:14 PM | How Can The Hemodynamic Pressure Wire And Quantitative Perfusion Assessment Help In Treating CLI: Standard Methods With ABIs And PVRs Are Not Enough |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD | |
View Slides in PDF | |
3:15 PM - 3:20 PM | RCT Comparing Ultrasound Guided Femoral Access vs. Standard Fluoro Guided Access: Ultrasound Is Superior And Should Be Used Routinely |
Presenter(s):Patrick A. Stone, MD | |
View Slides in PDF | |
3:21 PM - 3:26 PM | Management Of Asymptomatic Thrombus Inside Endografts After EVAR: Should We Treat Or Not |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
3:27 PM - 3:32 PM | Percutaneous Deep Vein Arterialization (Limflow) As A Minimally Invasive Approach To Create Arterio-Venous Fistulas For The Treatment Of Critical Limb Ischemia: Results Of First Clinical Experience – 1 Year Follow-Up |
Presenter(s):Steven Kum, MD / Daniel G. Clair, MD | |
View Slides in PDF | |
3:33 PM - 3:40 PM | Panel Discussion End of Program Q Go to Grand Ballroom East for Additional Hot Topics. |
END OF SESSION 120 | |